TW201920427A - Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers - Google Patents

Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers Download PDF

Info

Publication number
TW201920427A
TW201920427A TW107123289A TW107123289A TW201920427A TW 201920427 A TW201920427 A TW 201920427A TW 107123289 A TW107123289 A TW 107123289A TW 107123289 A TW107123289 A TW 107123289A TW 201920427 A TW201920427 A TW 201920427A
Authority
TW
Taiwan
Prior art keywords
alkyl
sub
formula
ppm
group
Prior art date
Application number
TW107123289A
Other languages
Chinese (zh)
Inventor
洛史威 E 三世 金
衛那 霍茲
Original Assignee
德商巴地斯顏料化工廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德商巴地斯顏料化工廠 filed Critical 德商巴地斯顏料化工廠
Publication of TW201920427A publication Critical patent/TW201920427A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/524Esters of phosphorous acids, e.g. of H3PO3
    • C08K5/526Esters of phosphorous acids, e.g. of H3PO3 with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/005Stabilisers against oxidation, heat, light, ozone
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098Metal salts of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/101Esters; Ether-esters of monocarboxylic acids
    • C08K5/103Esters; Ether-esters of monocarboxylic acids with polyalcohols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/101Esters; Ether-esters of monocarboxylic acids
    • C08K5/105Esters; Ether-esters of monocarboxylic acids with phenols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/13Phenols; Phenolates
    • C08K5/134Phenols containing ester groups
    • C08K5/1345Carboxylic esters of phenolcarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1535Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3432Six-membered rings
    • C08K5/3435Piperidines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3477Six-membered rings
    • C08K5/3492Triazines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/521Esters of phosphoric acids, e.g. of H3PO4
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/521Esters of phosphoric acids, e.g. of H3PO4
    • C08K5/523Esters of phosphoric acids, e.g. of H3PO4 with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/524Esters of phosphorous acids, e.g. of H3PO3
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/527Cyclic esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/52Phosphorus bound to oxygen only
    • C08K5/529Esters containing heterocyclic rings not representing cyclic esters of phosphoric or phosphorous acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04Homopolymers or copolymers of ethene
    • C08L23/06Polyethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10Homopolymers or copolymers of propene
    • C08L23/12Polypropene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/019Specific properties of additives the composition being defined by the absence of a certain additive

Abstract

Polyolefin compositions comprising (i) a polyolefin, (ii) one or more phosphorus-containing benzofuranone compounds and (iii) one or more organophosphorus stabilizers are provided excellent protection against discoloration and enhanced thermal stability during melt processing as exhibited by improved retention of molecular weight and maintenance of polymer molecular architecture.

Description

包含苯并呋喃酮及有機磷安定劑之安定化聚烯烴組合物Stabilized polyolefin composition containing benzofuranone and organophosphorus stabilizer

本發明係關於聚烯烴組合物,其包含含磷之3-苯基-苯并呋喃-2-酮化合物及某些有機磷安定劑。聚烯烴組合物呈現極好色彩表現及熔融加工期間之經增強熱安定性。The present invention relates to a polyolefin composition, which contains a phosphorus-containing 3-phenyl-benzofuran-2-one compound and certain organic phosphorus stabilizers. The polyolefin composition exhibits excellent color performance and enhanced thermal stability during melt processing.

幾十年來已成功使用傳統的酚系/亞磷酸酯類抗氧化劑摻合物,以對聚烯烴提供良好熔體流動控制及可接受的色彩維持。然而,存在對於較淺色聚烯烴物件及經改良色彩維持之不斷增長的需求。For decades, traditional phenolic / phosphite antioxidant blends have been successfully used to provide good melt flow control and acceptable color maintenance for polyolefins. However, there is a growing demand for lighter colored polyolefin objects and improved color maintenance.

因此,揭示聚烯烴組合物,其包含i)聚烯烴、ii)一或多種含磷苯并呋喃酮化合物及iii)一或多種有機磷安定劑。含磷苯并呋喃酮化合物可屬於下文進一步描述之式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2。亦揭示了包含含磷苯并呋喃酮化合物及有機磷安定劑之添加劑組合物。Thus, a polyolefin composition is disclosed that includes i) a polyolefin, ii) one or more phosphorus-containing benzofuranone compounds, and iii) one or more organic phosphorus stabilizers. The phosphorus-containing benzofuranone compound may belong to formulae I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2 described further below. Also disclosed is an additive composition containing a phosphorus-containing benzofuranone compound and an organic phosphorus stabilizer.

亦揭示了針對熱、光及氧之有害效應使聚烯烴安定之方法,該方法包含將以下併入至聚烯烴中:ii)一或多種選自由式I-p1、I-p2、I-o1、I-o2、I-m1及I-m2組成之群組的苯并呋喃酮化合物及iii)一或多種有機磷安定劑。熱、光及氧之有害效應可導致非所需色彩。Also disclosed is a method for stabilizing polyolefins against the harmful effects of heat, light and oxygen, the method comprising incorporating the following into the polyolefin: ii) one or more selected from formulas I-p1, I-p2, I-o1 , I-o2, I-m1 and I-m2 benzofuran compounds and iii) one or more organic phosphorus stabilizers. The harmful effects of heat, light and oxygen can cause undesirable colors.

含磷之3-苯基-苯并呋喃-2-酮化合物可屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2(在本文中亦被稱作「苯并呋喃-2-酮」或「苯并呋喃酮」化合物)。 其中 X及Z獨立地為P或P=O;Yp 、Yo 及Ym 為氧或表示共價鍵; 當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或 R1p 連同R2p 、R1o 連同R2o 且R1m 連同R2m 表示子式III、IV或V中之一者或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或 R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代;R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 - C8 烷基, Rm1 、Rm3 、Rm5 及Rm6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 、及Rc4 各自獨立地為氫或C1 -C8 烷基。Phosphorus-containing 3-phenyl-benzofuran-2-one compounds can belong to formulas I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2 (also referred to herein as "Benzofuran-2-one" or "benzofuranone" compounds). Where X and Z are independently P or P = O; Y p , Y o and Y m are oxygen or represent covalent bonds; when Y p , Y o and Y m are oxygen, R 1p represents the sub-formula II-p , II-o or II-m R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m means sub-formula III, IV Or one of V Or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with the following: C 1 -C 8 alkyl group, C 1 -C 8 alkoxy group, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between or C 2 -C 16 alkyl group with a sulfur atom in between, R 2p represents one of sub-formula II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represents one of sub-formulas III, IV or V, or R 2p , R 2o and R 2m is C 6 -C 10 aryl, which is unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl group interrupted by one or more oxygen atoms of the C 2 -C 30 alkyl group or interrupted by a sulfur atom of a C 2 -C 16 alkyl; when Y p , Y o and Y m represent a covalent bond, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o Or one of II-m, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 Alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms interspersed or a sulfur atom interspersed C 2 -C 16 alkyl, R 2p , R 2o and R 2m are C 6 -C 10 aryl, which are unsubstituted or C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen Or a phenyl or halogen substitution; R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, and R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently hydrogen or C 1 - C 8 alkyl, R m1 , R m3 , R m5 and R m6 are each independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 Each is independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3 , and R c4 are each independently hydrogen or C 1 -C 8 alkyl.

子式II-p、II-o或II-m處之一個連接點由線之末端指示,該末端不攜帶字符且為空白。子式III、IV或V處之兩個連接點各由各別線之末端指示,該線之末端不攜帶字符且為空白。當R1p 連同R2p ,R1o 連同R2o 且R1m 連同R2m 表示子式III、IV或V中之一者時,則R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示同一子式。A connection point at the sub-formula II-p, II-o or II-m is indicated by the end of the line, which does not carry characters and is blank. The two connection points at sub-formulas III, IV or V are each indicated by the end of each line, which does not carry characters and is blank. When R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m represent one of sub-formulas III, IV or V, then R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m Represents the same subform.

式I-p1、I-p2、I-o1、I-o2、I-m1或1-m2之化合物具有至少一個不對稱碳原子,亦即在苯并呋喃-2-酮結構單元之3-位置處之碳原子。其他不對稱碳原子可存在於具有至少四個碳原子之烷基取代基中。經三個不同取代基取代之磷原子可展示位阻反轉,其可取決於溫度產生不對稱磷原子。本發明係關於此等對映異構體、所得非對映異構體或其混合物中之任一者。Compounds of formula I-p1, I-p2, I-o1, I-o2, I-m1 or 1-m2 have at least one asymmetric carbon atom, that is, at the 3-position of the benzofuran-2-one structural unit Carbon atom. Other asymmetric carbon atoms can be present in alkyl substituents having at least four carbon atoms. Phosphorus atoms substituted with three different substituents can exhibit steric inversion, which can produce asymmetric phosphorus atoms depending on temperature. The present invention relates to any of these enantiomers, the resulting diastereomers, or mixtures thereof.

未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基取代之C6 -C10 芳基為例如苯基、2-甲基-苯基、3-甲基-苯基、4-甲基-苯基、2,4-二甲基-苯基、3,5-二甲基-苯基、4-(1,1-二甲基乙基)-苯基、4-(1,1,3,3-四甲基戊基)-苯基、萘-1-基、萘-2-基、6-甲基萘-2-基、4-苯基-苯基、2-甲氧基-苯基、3-甲氧基-苯基、4-甲氧基-苯基、2-乙氧基苯基、3-乙氧基-苯基、3-(正丙氧基)-苯基、4-(1,1-二甲基乙氧基)-苯基、2-氯-苯基、3-氯苯基、4-氯苯基、2-氯-4-甲基苯基。在一些實施例中,C6 -C10 芳基未經取代或經C1 -C8 烷基或C1 -C8 烷氧基取代。在某些實施例中,芳基為未經取代或經C1 -C8 烷基取代之苯基。在其他實施例中,芳基為苯基。C 6 -C 10 aryl groups which are unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group are, for example, phenyl, 2-methyl-phenyl, 3 -Methyl-phenyl, 4-methyl-phenyl, 2,4-dimethyl-phenyl, 3,5-dimethyl-phenyl, 4- (1,1-dimethylethyl) -Phenyl, 4- (1,1,3,3-tetramethylpentyl) -phenyl, naphthalene-1-yl, naphthalene-2-yl, 6-methylnaphthalene-2-yl, 4-benzene -Phenyl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-ethoxyphenyl, 3-ethoxy-phenyl, 3 -(N-propoxy) -phenyl, 4- (1,1-dimethylethoxy) -phenyl, 2-chloro-phenyl, 3-chlorophenyl, 4-chlorophenyl, 2- Chloro-4-methylphenyl. In some embodiments, C 6 -C 10 aryl is unsubstituted or substituted with C 1 -C 8 alkyl or C 1 -C 8 alkoxy. In certain embodiments, the aryl group is unsubstituted or substituted with C 1 -C 8 alkyl. In other embodiments, the aryl group is phenyl.

C1 -C8 烷基為直鏈或分支鏈的且為例如甲基、乙基、正丙基、1-甲基-乙基、正丁基、1-甲基-丙基、2-甲基-丙基、1,1-二甲基-乙基、正戊基、1-甲基-丁基、3-甲基-丁基、正己基、1-甲基-戊基、2-甲基-戊基、4-甲基-戊基、2-乙基-丁基、正庚基、1-甲基-己基、正辛基、1-甲基-庚基、2-乙基-己基、5,5-二甲基-己基或1,1,3,3-四甲基-丁基。在一些實施例中,烷基為C1 -C4 烷基或C8 烷基,例如甲基、乙基、1-甲基-乙基、1-甲基-丙基、1,1-二甲基-乙基或1,1,3,3-四甲基-丁基。在某些實施例中,烷基為C1 -C4 烷基,諸如甲基、乙基、1-甲基-乙基、1-甲基-丙基、1,1-二甲基-乙基且在某些其他實施例中為甲基、1-甲基-丙基或1,1-二甲基-乙基。C 1 -C 8 alkyl is linear or branched and is, for example, methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methyl-propyl, 2-methyl -Propyl, 1,1-dimethyl-ethyl, n-pentyl, 1-methyl-butyl, 3-methyl-butyl, n-hexyl, 1-methyl-pentyl, 2-methyl -Pentyl, 4-methyl-pentyl, 2-ethyl-butyl, n-heptyl, 1-methyl-hexyl, n-octyl, 1-methyl-heptyl, 2-ethyl-hexyl , 5,5-dimethyl-hexyl or 1,1,3,3-tetramethyl-butyl. In some embodiments, the alkyl group is C 1 -C 4 alkyl or C 8 alkyl, such as methyl, ethyl, 1-methyl-ethyl, 1-methyl-propyl, 1,1-di Methyl-ethyl or 1,1,3,3-tetramethyl-butyl. In certain embodiments, the alkyl group is a C 1 -C 4 alkyl group, such as methyl, ethyl, 1-methyl-ethyl, 1-methyl-propyl, 1,1-dimethyl-ethyl And in certain other embodiments is methyl, 1-methyl-propyl or 1,1-dimethyl-ethyl.

C1 -C8 烷氧基為直鏈或分支鏈且為例如甲氧基、乙氧基、正丙氧基、1-甲基-乙氧基、正丁氧基、1-甲基-丙氧基、1,1-二甲基-乙氧基、正戊氧基、2-甲基-戊氧基、2-乙基-丁氧基、1-甲基-己氧基、正辛氧基、1-甲基-庚氧基、2-乙基-己氧基、1,1,3,3-四甲基-丁氧基。在一些實施例中,烷氧基為C1 -C4 烷氧基,諸如甲氧基。C 1 -C 8 alkoxy is straight or branched and is, for example, methoxy, ethoxy, n-propoxy, 1-methyl-ethoxy, n-butoxy, 1-methyl-prop Oxygen, 1,1-dimethyl-ethoxy, n-pentyloxy, 2-methyl-pentyloxy, 2-ethyl-butoxy, 1-methyl-hexyloxy, n-octyloxy Group, 1-methyl-heptoxy, 2-ethyl-hexyloxy, 1,1,3,3-tetramethyl-butoxy. In some embodiments, the alkoxy group is a C 1 -C 4 alkoxy group, such as methoxy.

鹵素為例如氟原子(氟)、氯原子(氯)、溴原子(溴)或碘原子(碘)。在某些實施例中,鹵素為氯原子或氟原子,在一些實施例中,鹵素為氟原子。The halogen is, for example, a fluorine atom (fluorine), a chlorine atom (chlorine), a bromine atom (bromine), or an iodine atom (iodine). In some embodiments, the halogen is a chlorine atom or a fluorine atom, and in some embodiments, the halogen is a fluorine atom.

C1 -C18 烷基為直鏈或分支鏈且為例如甲基、乙基、正丙基、1-甲基-乙基、正丁基、1-甲基-丙基、2-甲基-丙基、1,1-二甲基-乙基、正戊基、1-甲基-丁基、3-甲基-丁基、正己基、1-甲基-戊基、2-甲基-戊基、4-甲基-戊基、2-乙基-丁基、正庚基、1-甲基-己基、正辛基、1-甲基-庚基、2-乙基-己基、5,5-二甲基-己基、1,1,3,3-四甲基-丁基、正壬基、2-乙基-庚基、正癸基、十一基、正十二基、十三基、十四基、十五基、正十六基或正十八基。在一些實施例中,C1 -C18 烷基為直鏈或分支鏈C1 -C12 烷基。C 1 -C 18 alkyl is straight or branched and is, for example, methyl, ethyl, n-propyl, 1-methyl-ethyl, n-butyl, 1-methyl-propyl, 2-methyl -Propyl, 1,1-dimethyl-ethyl, n-pentyl, 1-methyl-butyl, 3-methyl-butyl, n-hexyl, 1-methyl-pentyl, 2-methyl -Pentyl, 4-methyl-pentyl, 2-ethyl-butyl, n-heptyl, 1-methyl-hexyl, n-octyl, 1-methyl-heptyl, 2-ethyl-hexyl, 5,5-dimethyl-hexyl, 1,1,3,3-tetramethyl-butyl, n-nonyl, 2-ethyl-heptyl, n-decyl, undecyl, n-dodecyl, Thirteen base, fourteen base, fifteen base, regular sixteen base or regular eighteen base. In some embodiments, the C 1 -C 18 alkyl group is a linear or branched C 1 -C 12 alkyl group.

C3 -C16 環烷基未經取代或經C1 -C4 烷基取代且為例如環丁基、環戊基、3,4-二甲基-環戊基、環己基、4-甲基-環己基、4-(1-甲基乙基)-環己基、4-(1,1-二甲基乙基)-環己基、3,5-二甲基-環己基、5-甲基-2-(1-甲基-乙基)-環己基、環庚基、環辛基或環十二基。在某些實施例中,C3 -C16 環烷基為C5 -C7 環烷基,諸如環己基。C 3 -C 16 cycloalkyl is unsubstituted or substituted with C 1 -C 4 alkyl and is, for example, cyclobutyl, cyclopentyl, 3,4-dimethyl-cyclopentyl, cyclohexyl, 4-methyl -Cyclohexyl, 4- (1-methylethyl) -cyclohexyl, 4- (1,1-dimethylethyl) -cyclohexyl, 3,5-dimethyl-cyclohexyl, 5-methyl Yl-2- (1-methyl-ethyl) -cyclohexyl, cycloheptyl, cyclooctyl or cyclododecyl. In certain embodiments, C 3 -C 16 cycloalkyl is C 5 -C 7 cycloalkyl, such as cyclohexyl.

C7 -C13 芳烷基為例如苯甲基、4-甲基-苯甲基、2-苯基-乙基、3,5-二甲基苯甲基、1-苯基-1,1-二甲基-甲基、3-苯基-丙基、3-苯基-2-甲基-丙基、3,5-二-第三丁基-苯甲基或4-苯基-苯基-甲基。在某些實施例中,芳烷基為苯甲基。C2 -C18 烯基為直鏈或分支鏈的且為例如乙烯基、烯丙基、Z-或E-丁-2-烯-基、或E-丁-3-烯-基、Z-或E-戊-2-烯-基、戊-4-烯-基、Z-或E-2-甲基-丁-2-烯-基、Z-或E-3-甲基-丁-3-烯-基、Z-或E-己-1-烯-基、Z-或E-十六-9-烯-基或Z-或E-十八-9-烯-基、(9Z,12Z)-十八-9,12-二烯-基或(9Z,12Z,15Z)-十八-9,12,15-三烯-基。在某些實施例中,烯基為烯丙基。C 7 -C 13 aralkyl is, for example, benzyl, 4-methyl-benzyl, 2-phenyl-ethyl, 3,5-dimethylbenzyl, 1-phenyl-1,1 -Dimethyl-methyl, 3-phenyl-propyl, 3-phenyl-2-methyl-propyl, 3,5-di-tert-butyl-benzyl or 4-phenyl-benzene -Methyl. In certain embodiments, the aralkyl group is benzyl. C 2 -C 18 alkenyl is linear or branched and is, for example, vinyl, allyl, Z- or E-but-2-en-yl, or E-but-3-en-yl, Z- Or E-pent-2-en-yl, pent-4-en-yl, Z- or E-2-methyl-but-2-en-yl, Z- or E-3-methyl-butan-3 -Alkenyl, Z- or E-hex-1-en-yl, Z- or E-hexadec-9-en-yl or Z- or E-octadec-9-en-yl, (9Z, 12Z ) -Eighteen-9,12-dien-yl or (9Z, 12Z, 15Z) -Eighteen-9,12,15-trien-yl. In certain embodiments, the alkenyl group is allyl.

間雜有一或多個氧原子之C2 -C30 烷基為直鏈或分支鏈的且為例如甲氧基-甲基、2-甲氧基-乙基、2-乙氧基-乙基、2-(2-甲氧基-乙氧基)-乙基、2-正丁氧基-乙基、2-[2-(2-甲氧基-乙氧基)-乙氧基]-乙基、2-[2-[2-(2-甲氧基-乙氧基)-乙氧基]-乙氧基]-乙基、2-(2-甲氧基-1-甲基-乙氧基)-1-甲基-乙基、3-(正丙氧基)-丙基、2-[2-[2-(2-正丁氧基-乙氧基)-乙氧基]-乙氧基]-乙基、2-[2-(2-正丁氧基-2-甲基-乙氧基)-2-甲基-乙氧基]-2-甲基-乙基或2-[(2-正十二基)-乙氧基]-乙基。在一些實施例中,間雜有一或多個氧原子之烷基為2-甲氧基-乙基或2-乙氧基-乙基。The C 2 -C 30 alkyl group with one or more oxygen atoms in between is linear or branched and is, for example, methoxy-methyl, 2-methoxy-ethyl, 2-ethoxy-ethyl, 2- (2-methoxy-ethoxy) -ethyl, 2-n-butoxy-ethyl, 2- [2- (2-methoxy-ethoxy) -ethoxy] -ethyl Group, 2- [2- [2- (2-methoxy-ethoxy) -ethoxy] -ethoxy] -ethyl, 2- (2-methoxy-1-methyl-ethyl Oxy) -1-methyl-ethyl, 3- (n-propoxy) -propyl, 2- [2- [2- (2-n-butoxy-ethoxy) -ethoxy]- Ethoxy] -ethyl, 2- [2- (2-n-butoxy-2-methyl-ethoxy) -2-methyl-ethoxy] -2-methyl-ethyl or 2 -[(2-n-dodecyl) -ethoxy] -ethyl. In some embodiments, the alkyl group doped with one or more oxygen atoms is 2-methoxy-ethyl or 2-ethoxy-ethyl.

間雜有一個硫原子之C2 -C16 烷基為直鏈或分支鏈的且為例如2-(甲基-硫基)-乙基、3-噻十一基或3-噻十五基。The C 2 -C 16 alkyl group interspersed with a sulfur atom is linear or branched and is, for example, 2- (methyl-thio) -ethyl, 3-thiundecyl, or 3-thiapentadecyl.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中R4 及R6 為氫,且R5 及R7 各自獨立地為氫或C1 -C8 烷基,例如氫或C1 -C4 烷基。在某些實施例中,R4 、R6 及R7 為氫且R5 為氫或C1 -C8 烷基,例如氫或C1 -C4 烷基。在一些實施例中,Rp2 及Rp6 各自獨立地為氫或C1 烷基,Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,Ro1 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ro2 為氫或C1 烷基且Ro5 為氫或C1 -C4 烷基,Rm1 為氫或C1 烷基,Rm3 及Rm5 各自獨立地為氫或C1 -C4 烷基,且Rm6 為氫或C1 -C8 烷基。In some embodiments, benzofuranone is of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, where R 4 and R 6 are hydrogen, and R 5 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, such as hydrogen or C 1 -C 4 alkyl. In certain embodiments, R 4 , R 6 and R 7 are hydrogen and R 5 is hydrogen or C 1 -C 8 alkyl, such as hydrogen or C 1 -C 4 alkyl. In some embodiments, R p2 and R p6 are each independently hydrogen or C 1 alkyl, R p3 and R p5 are each independently hydrogen or C 1 -C 4 alkyl, and R o1 and R o6 are each independently Hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen or C 1 alkyl and R o5 is hydrogen or C 1 -C 4 alkyl, R m1 is hydrogen or C 1 alkyl, R m3 and R m5 are each independent Ground is hydrogen or C 1 -C 4 alkyl, and R m6 is hydrogen or C 1 -C 8 alkyl.

在某些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Rp2 及Rp6 為氫,且Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,Ro1 為氫或C1 -C8 烷基,Ro2 為氫,Ro5 及Ro6 各自獨立地為氫或C1 -C4 烷基,Rm1 及Rm3 為氫或C1 烷基,Rm5 為氫或C1 -C3 烷基且Rm6 為氫或C1 -C8 烷基。在其他實施例中,Rp2 及Rp6 為氫,且Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,其中Rp3 及Rp5 中之一者不為C4 烷基,Ro1 為氫或C1 -C8 烷基,Ro2 為氫,Ro5 為氫或C1 - C3 烷基,及 Ro6 為氫或C1 -C4 烷基,且Rm1 及Rm3 為氫或C1 烷基,Rm5 為氫或C1 -C3 烷基且Rm6 為氫或C1 -C8 烷基。In certain embodiments, benzofuranone is of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, where R p2 and R p6 are hydrogen, and R p3 and R p5 is each independently hydrogen or C 1 -C 4 alkyl, R o1 is hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen, R o5 and R o6 are each independently hydrogen or C 1 -C 4 Alkyl, R m1 and R m3 are hydrogen or C 1 alkyl, R m5 is hydrogen or C 1 -C 3 alkyl and R m6 is hydrogen or C 1 -C 8 alkyl. In other embodiments, R p2 and R p6 are hydrogen, and R p3 and R p5 are each independently hydrogen or C 1 -C 4 alkyl, wherein one of R p3 and R p5 is not C 4 alkyl , R o1 is hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen, R o5 hydrogen or C 1 - C 3 alkyl, and R o6 is hydrogen or C 1 -C 4 alkyl, and R m1 and R m3 is hydrogen or C 1 alkyl, R m5 is hydrogen or C 1 -C 3 alkyl and R m6 is hydrogen or C 1 -C 8 alkyl.

在一些實施例中,Rp2 及Rp6 為氫且Rp3 及Rp5 中之一者為氫,而另一者為氫或C1 -C4 烷基,Ro1 為氫或C1 -C8 烷基,Ro2 為氫,Ro5 為氫或C1 烷基且Ro6 為氫或C1 -C4 烷基,且Rm1 、Rm3 及Rm5 為氫,且Rm6 為氫或C1 -C8 烷基。在某些實施例中,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C4 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C4 烷基且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C4 烷基。In some embodiments, R p2 and R p6 are hydrogen and one of R p3 and R p5 is hydrogen, while the other is hydrogen or C 1 -C 4 alkyl, and R o1 is hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen, R o5 is hydrogen or C 1 alkyl and R o6 is hydrogen or C 1 -C 4 alkyl, and R m1 , R m3 and R m5 are hydrogen, and R m6 is hydrogen or C 1 -C 8 alkyl. In certain embodiments, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 4 alkyl, and R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each Are independently hydrogen or C 1 -C 4 alkyl and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 4 alkyl.

在一些實施例中,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C4 烷基,Rb1 、Rb2 、Rb3 、Rb4 各自獨立地為氫或C1 -C4 烷基且Rb5 及Rb6 中之一者為C1 -C4 烷基,而另一者為氫且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C4 烷基。在某些實施例中,Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-P、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及且R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代,且R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C6 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C12 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或鹵素取代,該鹵素為氯或氟。In some embodiments, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 4 alkyl, and R b1 , R b2 , R b3 and R b4 are each independently hydrogen or C 1 -C 4 alkyl and one of R b5 and R b6 is C 1 -C 4 alkyl, and the other is hydrogen and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 4 alkyl. In certain embodiments, Y p , Y o and Y m are oxygen or represent covalent bonds; when Y p , Y o and Y m are oxygen, R 1p represents the sub-formula II-P, II-o or II One of -m, R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together R 2m represents one of sub-formulas III, IV, or V, or R 1p , R 1o, and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl, C 1- C 18 alkyl, C 3 -C 16 cycloalkyl or C 2 -C 18 alkenyl substitution, and R 2p represents one of the sub-formulas II-p, II-o or II-m, R 2o represents the sub-formula One of II-o or II-m, R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represents one of sub-formulas III, IV or V Or, R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 6 alkyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl Or C 2 -C 18 alkenyl substitution; when Y p , Y o and Y m represent a covalent bond, R 1p represents one of the sub-formula II-p, II-o or II-m, R 1o represents a sub II-o of formula II-m, or one of those, R 1m represents a sub-formula II-m, or R 1p, R 1o, and R 1m is a C 6 -C 12 aryl group, Unsubstituted or C 1 -C 8 alkyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl or C 2 -C 18 substituted alkenyl, and R 2p, R 2o and R 2m is C 6 -C 10 aryl group, which is unsubstituted or substituted by C 1 -C 8 alkyl or halogen, the halogen is chlorine or fluorine.

在一些實施例中,Yp 、Yo 及Ym 為氧或表示共價鍵; 當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-P,R1o 表示子式II-o,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及且R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代,且R2p 表示子式II-p,R2o 表示子式II-o,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p,R1o 表示子式II-o,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或鹵素取代,該鹵素為氯或氟。In some embodiments, Y p , Y o and Y m are oxygen or represent covalent bonds; when Y p , Y o and Y m are oxygen, R 1p represents sub-formula II-P, R 1o represents sub-formula II -o, R 1m represents the sub-formula II-m, or R 1p and R 2p , R 1o and R 2o and R 1m and R 2m represent one of the sub-formulas III, IV or V, or R 1p and R 1o And R 1m is C 6 -C 10 aryl, which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, or C 2 -C 18 alkenyl Substitution, and R 2p represents sub-formula II-p, R 2o represents sub-formula II-o, R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represents One of formulas III, IV, or V, or R 2p , R 2o, and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl , C 3 -C 16 cycloalkyl or C 2 -C 18 alkenyl substitution; when Y p , Y o and Y m represent a covalent bond, R 1p represents the sub-formula II-p, R 1o represents the sub-formula II- o, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by C 1 -C 8 alkyl, C 1 -C 18 alkyl , C 3 -C 16 cycloalkyl or C 2 -C 18 alkenyl substitution, and R 2p , R 2o and R 2m are C 6 -C 10 An aryl group, which is unsubstituted or substituted with a C 1 -C 8 alkyl group or a halogen, which is chlorine or fluorine.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p,R1o 表示子式II-o,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及且R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基、C3 -C16 環烷基或C2 -C18 烯基取代,且R2p 為R1p ,R2o 為R1o ,R2m 為R1m ,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III、IV或V中之一者;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p,R1o 表示子式II-o,R1m 表示子式II-m,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或鹵素取代,該鹵素為氯或氟。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents the sub-formula II-p, R 1o represents the sub-formula II-o, R 1m represents the sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m represent one of the sub-formulas III, IV or V, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by C 1 -C 8 alkyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl or C 2 -C 18 alkenyl substitution, and R 2p is R 1p , R 2o is R 1o , R 2m is R 1m , or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent one of the sub formulas III, IV or V; when Y p , Y o and Y m represent a covalent bond, R 1p Represents sub-formula II-p, R 1o represents sub-formula II-o, R 1m represents sub-formula II-m, and R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by C 1 -C 8 alkyl or halogen substituted, the halogen is chlorine or fluorine.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 且R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代,且R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 - C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基烷取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或氟取代。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o or II-m One of them, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m represents one of sub-formula III, IV or V, or R 1p , R 1o And R 1m is C 6 -C 10 aryl, which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl, or C 3 -C 16 cycloalkyl, and R 2p represents a subformula One of II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m, R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o R 2m and R 1m together represent sub formulas III, IV or V, one of those, or R 2p, R 2o and R 2m is a C 6 -C 10 aryl group, which is unsubstituted or C 1 - C 8 alkyl, C 1 -C 18 alkyl or C 3 -C 16 cycloalkyl substitution; when Y p , Y o and Y m represent a covalent bond, R 1p represents the sub-formula II-p, II-o II-m, or one of those, R 1o represents the sub-formula II-o II-m, or one of those, R 1m represents the sub-formula II-m, or R 1p R 1o, and R 1m is a C 6 -C 10 aryl group, which is unsubstituted or C 1 -C 8 alkyl, substituted C 1 -C 18 alkyl or C 3 -C 16 cycloalkylalkyl and R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl or fluorine.

在某些實施例中,Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及且R1m 連同R2m 表示子式III,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 -C18 烷基取代,且R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 且R2m 連同R1m 表示子式III;或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 - C18 烷基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 -C18 烷基取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或氟取代。In some embodiments, Y p , Y o and Y m are oxygen or represent a covalent bond; when Y p , Y o and Y m are oxygen, R 1p represents the sub-formula II-p, II-o or II One of -m, R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together R 2m represents sub-formula III, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl or C 1 -C 18 alkyl, and R 2p represents one of sub-formula II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m, R 2m represents sub-formula II-m, or R 2p together R 1p , R 2o together with R 1o and R 2m together with R 1m represent sub-formula III; or R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or C 1 -C 8 alkyl Or C 1 - C 18 alkyl substitution; when Y p , Y o and Y m represent a covalent bond, R 1p represents one of the sub formulas II-p, II-o or II-m, R 1o represents a sub One of formulas II-o or II-m, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or C 1 -C 8 alkyl or C 1 -C 18 alkyl substitution, and R 2p , R 2o and R 2m are C 6 -C 10 aryl, which are unsubstituted Or substituted by C 1 -C 8 alkyl or fluorine.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧或表示共價鍵;當Yp 及Yo 為氧時,R1p 、R2p 、R1o 或R2o 並不表示子式II-m;當Yp 及Yo 表示共價鍵時,R1p 或R1o 並不表示子式II-m。在某些實施例中,在式I-p1或I-p2之化合物中,Yp 為氧或表示共價鍵;當Yp 為氧時,R1p 或R2p 並不表示子式II-o或II-m;當Yp 表示共價鍵時,R1p 並不表示子式II-o或II-m。In some embodiments, benzofuranone belongs to formula I-p1, I-p2, I-o1, or I-o2, wherein Y p and Y o are oxygen or represent covalent bonds; when Y p and Y o are oxygen , R 1p , R 2p , R 1o or R 2o do not represent the sub-formula II-m; when Y p and Y o represent a covalent bond, R 1p or R 1o do not represent the sub-formula II-m. In certain embodiments, in the compound of formula I-p1 or I-p2, Y p is oxygen or represents a covalent bond; when Y p is oxygen, R 1p or R 2p does not represent sub-formula II-o Or II-m; when Y p represents a covalent bond, R 1p does not represent the sub-formula II-o or II-m.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o or II-m One of them, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl group, C 3 -C 16 cycloalkyl group, C 7 -C 13 aralkyl group, C 2 -C 18 alkenyl group, intermixed with one or C 2 -C 30 alkyl groups with multiple oxygen atoms or C 2 -C 16 alkyl groups with one sulfur atom interspersed, R 2p represents one of sub-formula II-p, II-o or II-m, R 2o Represents one of sub-formula II-o or II-m, R 2m represents sub-formula II-m, or R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by : C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl group interrupted by one or more oxygen atoms of the C 2 -C 30 alkyl interrupted by one sulfur or Son C 2 -C 16 alkyl; when Y p, Y o and Y m represents a covalent bond, R 1p represents the sub-formula II-p, II-o II-m, or one of those, R 1o represents a sub- One of formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or one phenyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between, or C 2 -C 16 alkyl with one sulfur atom in between, R 2p , R 2o and R 2m are C 6 -C 10 Aryl, which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, or a phenyl or halogen.

在某些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧。在一些實施例中,苯并呋喃酮屬於式I-p或I-o,其中Yp 及Yo 為氧,且R1p 、R2p 、R1o 或R2o 並不表示子式II-m。在其他實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧,R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者,且R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者。In certain embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m is oxygen. In some embodiments, benzofuranone belongs to formula Ip or Io, wherein Y p and Y o are oxygen, and R 1p , R 2p , R 1o or R 2o do not represent sub-formula II-m. In other embodiments, benzofuranone belongs to formulas I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, where Y p , Yo, and Y m are oxygen, and R 1p Together with R 2p , R 1o together with R 2o and R 1m together with R 2m represent one of sub formulas III, IV or V, and R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent sub formula III , IV, or V.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧,R1p 連同R2p 及R1o 連同R2o 表示子式III、IV或V中之一者,且R2p 連同R1p 及R2o 連同R1o 表示子式III、IV或V中之一者。在某些實施例中,苯并呋喃酮屬於式I-p1或I-p2,其中Yp為氧且R1p 連同R2p 表示子式III、IV或V中之一者。在一些實施例中,苯并呋喃酮屬於式I-p,其中Yp為氧且 R1p 連同R2p 表示子式IV。In some embodiments, benzofuranone belongs to formula I-p1, I-p2, I-o1 or I-o2, wherein Y p and Y o are oxygen, R 1p together with R 2p and R 1o together with R 2o represent One of formulas III, IV, or V, and R 2p together with R 1p and R 2o together with R 1o represents one of sub-formulas III, IV, or V. In certain embodiments, benzofuranone belongs to formula I-p1 or I-p2, where Yp is oxygen and R 1p together with R 2p represents one of sub-formulas III, IV, or V. In some embodiments, benzofuranone belongs to formula Ip, where Yp is oxygen and R 1p together with R 2p represents sub-formula IV.

以上引用之式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2之化合物的實施例單獨地指代式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2之結構單元。此等結構單元包含苯并呋喃-2-酮單元,其包括R4 、R5 、R6 及R7 ;連接伸苯基單元,其包括Rp2 、Rp3 、Rp5 、Rp6 、Ro1 、Ro2 、Ro5 、Ro6 、Rm1 、Rm3 、Rm5 及Rm6 ,及其它接近於磷原子的單元,其包括R1p 、R2p 、R1o 、R2o 、R1m 及R2m ,具有對於子式III、IV或V之取代基,亦即,Ra1 、Ra1 、Ra3 、Ra4 、Rb1 、Rb2 、Rb3 、Rb4 、Rb5 、Rb6 、Rc1 、Rc2 、Rc3 及Rc4 。可組合對三個結構單元之以上引用之實施例。以下提供其實例。The above cited examples of compounds of formulae I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2 individually refer to formulae I-p1, I-p2, I-o1, I -o2, I-m1 or I-m2 structural unit. These structural units include benzofuran-2-one units, including R 4 , R 5 , R 6, and R 7 ; connected phenylene units, including R p2 , R p3 , R p5 , R p6 , R o1 , R o2 , R o5 , R o6 , R m1 , R m3 , R m5 and R m6 , and other units close to the phosphorus atom, including R 1p , R 2p , R 1o , R 2o , R 1m and R 2m , With substituents for sub-formulas III, IV or V, that is, R a1 , R a1 , R a3 , R a4 , R b1 , R b2 , R b3 , R b4 , R b5 , R b6 , R c1 , R c2 , R c3 and R c4 . The above-cited embodiments of the three structural units can be combined. Examples are provided below.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -順-烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者, R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代;R4 及R6 為氫,R5 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 及Rp6 各自獨立地為氫或C1 烷基,Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,Ro1 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ro2 為氫或C1 烷基,Ro5 為氫或C1 -C4 烷基,Rm1 為氫或C1 烷基,Rm3 及Rm5 各自獨立地為氫或C1 -C4 烷基,Rm6 為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C4 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C4 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫C1 -C4 烷基。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o or II-m One of them, R 1m represents the sub-formula II-m, or R 1p and R 2p , R 1o and R 2o and R 1m and R 2m represent one of the sub-formulas III, IV or V, or R 1p and R 1o And R 1m is C 6 -C 10 aryl, which is unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl, C 1 -C 18 alkyl Group, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -cis-alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms interspersed or a sulfur atom C 2 -C 16 alkyl, R 2p represents one of sub-formula II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m, R 2m represents sub-formula Formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent one of the sub formulas III, IV or V, or R 2p , R 2o and R 2m are C 6 -C 10 aryl group, which is unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 Group, a halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl group interrupted by one or more oxygen atoms C 2 -C 30 alkyl group or C 2 -C 16 alkyl group with a sulfur atom in between; when Y p , Y o and Y m represent a covalent bond, R 1p represents the sub-formula II-p, II-o Or one of II-m, R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 Aryl, which is unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or one phenyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkane Group, C 7 -C 13 aralkyl group, C 2 -C 18 alkenyl group, C 2 -C 30 alkyl group with one or more oxygen atoms in between, or C 2 -C 16 alkyl group with one sulfur atom in between, R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl or halogen; R 4 And R 6 is hydrogen, R 5 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 and R p6 are each independently hydrogen or C 1 alkyl, R p3 and R p5 are each independently hydrogen or C 1 -C 4 alkyl, R o1 and each R o6 Site is hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen or a C 1 alkyl group, R o5 hydrogen or C 1 -C 4 alkyl, R m1 is hydrogen or a C 1 alkyl group, R m3, and R m5 Each is independently hydrogen or C 1 -C 4 alkyl, R m6 is hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 4 alkyl Radicals, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 -C 4 alkyl, and R c1 , R c2 , R c3 and R c4 are each independently hydrogen C 1 -C 4 alkyl.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代,且R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或氟取代;R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,Rm1 、Rm3 、Rm5 及Rm6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各獨立地為氫或C1 -C8 烷基。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o or II-m One of them, R 1m represents the sub-formula II-m, or R 1p and R 2p , R 1o and R 2o and R 1m and R 2m represent one of the sub-formulas III, IV or V, or R 1p and R 1o And R 1m is C 6 -C 10 aryl, which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl, or C 3 -C 16 cycloalkyl, and R 2p represents a subformula One of II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m, R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent one of sub-formulas III, IV or V, or R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by C 1- C 8 alkyl, C 1 -C 18 alkyl or C 3 -C 16 cycloalkyl substitution; when Y p , Y o and Y m represent a covalent bond, R 1p represents the sub-formula II-p, II-o Or one of II-m, R 1o represents one of sub-formula II-o or II-m, R 1m represents a sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl, or C 3 -C 16 cycloalkyl, and R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl or fluorine; R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are independently hydrogen or C 1 -C 8 alkyl, R m1 , R m3 , R m5 and R m6 are each independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3 and R c4 are each Independently hydrogen or C 1 -C 8 alkyl.

在某些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧或表示共價鍵;當Yp 及Yo 為氧時,R1p 表示子式II-p或II-o中之一者,R1o 表示子式II-o,或R1p 連同R2p 及R1o 連同R2o 表示子式III、IV或V中之一者,或R1p 及R1o 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p或II-o中之一者,R2o 表示子式II-o,或R2p 連同R1p 及R2o 連同R1o 表示子式III、IV或V中之一者,或R2p 及R2o 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 及Yo 表示共價鍵時,R1p 表示子式II-p或II-o中之一者,R1o 表示子式II-o,或R1p 及R1o 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 及R2o 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C6 烷氧基、鹵素或一個苯基或鹵素取代;R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C6 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 - C8 烷基 且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基。In certain embodiments, benzofuranone belongs to formula I-p1, I-p2, I-o1 or I-o2, wherein Y p and Y o are oxygen or represent covalent bonds; when Y p and Y o are In the case of oxygen, R 1p represents one of sub-formula II-p or II-o, R 1o represents sub-formula II-o, or R 1p together with R 2p and R 1o together with R 2o represents sub-formula III, IV or V Either one, or R 1p and R 1o are C 6 -C 10 aryl groups, which are unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, or a phenyl group , C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between Or a C 2 -C 16 alkyl group with a sulfur atom in between, R 2p represents one of the sub-formula II-p or II-o, R 2o represents the sub-formula II-o, or R 2p together with R 1p and R 2o Together with R 1o represents one of the sub-formulas III, IV or V, or R 2p and R 2o are C 6 -C 10 aryl groups, which are unsubstituted or substituted by the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl group, C 3 -C 16 cycloalkyl group, C 7 -C 13 aralkyl group, C 2 -C 18 alkenyl group, intermixed with one or C 2 -C 30 alkyl groups of multiple oxygen atoms may be intermixed C 2 -C 16 alkyl group of sulfur atom; when Y p and Y o represent a covalent bond, R 1p represents one of sub formula II-p or II-o, R 1o represents sub formula II-o, or R 1p and R 1o are C 6 -C 10 aryl groups, which are unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms interspersed or a sulfur Atomic C 2 -C 16 alkyl, R 2p and R 2o are C 6 -C 10 aryl, which are unsubstituted or substituted by C 1 -C 8 alkyl, C 1 -C 6 alkoxy, halogen or one Phenyl or halogen substitution; R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 6 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 - C 8 alkyl and R c1 , R c2 , R c3 and R c4 are each independent Ground is hydrogen or C 1 -C 8 alkyl.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧或表示共價鍵;當Yp 及Yo 為氧時,R1p 表示子式II-p或II-o中之一者,R1o 表示子式II-o,或R1p 連同R2p 及R1o 連同R2o 表示子式III,或R1p 及R1o 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 -C18 烷基取代,R2p 表示子式II-p或II-o中之一者, R2o 表示子式II-o,或R2p 連同R1p 及R2o 連同R1o 表示子式III,或R2p 及R2o 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 -C18 烷基取代;當Yp 及Yo 表示共價鍵時,R1p 表示子式II-p或II-o中之一者,R1o 表示子式II-o,或R1p 及R1o 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或C1 -C18 烷基取代,R2p 及R2o 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或氟取代;R4 及R6 為氫,R5 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 及Rp6 為氫,Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,其中Rp3 及Rp5 中之一者不為Ca 烷基,Ro1 為氫或C1 -C8 烷基,Ro2 為氫,Ro5 為氫或C1 -C3 烷基,Ro6 為氫或C1 -C4 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C4 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C4 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C4 烷基。In some embodiments, benzofuranone belongs to formula I-p1, I-p2, I-o1, or I-o2, wherein Y p and Y o are oxygen or represent covalent bonds; when Y p and Y o are oxygen , R 1p represents one of sub formula II-p or II-o, R 1o represents sub formula II-o, or R 1p together with R 2p and R 1o together with R 2o represents sub formula III, or R 1p and R 1o is a C 6 -C 10 aryl group, which is unsubstituted or substituted with a C 1 -C 8 alkyl group or a C 1 -C 18 alkyl group, R 2p represents one of the sub-formula II-p or II-o, R 2o represents sub-formula II-o, or R 2p together with R 1p and R 2o together with R 1o represents sub-formula III, or R 2p and R 2o are C 6 -C 10 aryl groups, which are unsubstituted or substituted by C 1- C 8 alkyl or C 1 -C 18 alkyl substitution; when Y p and Y o represent a covalent bond, R 1p represents one of sub formula II-p or II-o, R 1o represents sub formula II- o, or R 1p and R 1o are C 6 -C 10 aryl, which are unsubstituted or substituted with C 1 -C 8 alkyl or C 1 -C 18 alkyl, R 2p and R 2o are C 6 -C 10 aryl groups, which are unsubstituted or substituted with C 1 -C 8 alkyl or fluorine; R 4 and R 6 are hydrogen, R 5 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 and R p6 is hydrogen, R p3 and R p5 each independently hydrogen or C 1 -C 4 alkyl, wherein R p3 R p5 is not one of those C a alkyl group, R o1 is hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen, R o5 hydrogen or C 1 -C 3 alkyl, R o6 is hydrogen or C 1 -C 4 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 4 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each Independently is hydrogen or C 1 -C 4 alkyl, and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 4 alkyl.

在其他實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或 R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代;R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,且Rm1 、Rm3 、Rm5 及Rm6 各自獨立地為氫或C1 -C8 烷基。In other embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m represents an oxygen or co Valence bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o or II-m One of them, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl group, C 3 -C 16 cycloalkyl group, C 7 -C 13 aralkyl group, C 2 -C 18 alkenyl group, intermixed with one or C 2 -C 30 alkyl groups with multiple oxygen atoms or C 2 -C 16 alkyl groups with one sulfur atom interspersed, R 2p represents one of sub-formula II-p, II-o or II-m, R 2o Represents one of sub-formula II-o or II-m, R 2m represents sub-formula II-m, or R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by : C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl group interrupted by one or more oxygen atoms of the C 2 -C 30 alkyl interrupted by one sulfur or Son C 2 -C 16 alkyl; when Y p, Y o and Y m represents a covalent bond, R 1p represents the sub-formula II-p, II-o II-m, or one of those, R 1o represents a sub- One of formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or one phenyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between, or C 2 -C 16 alkyl with one sulfur atom in between, R 2p , R 2o and R 2m are C 6 -C 10 Aryl, which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl or halogen; R 4 , R 5 , R 6 and R 7 are each independently Hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently Hydrogen or C 1 -C 8 alkyl, and R m1 , R m3 , R m5 and R m6 are each independently hydrogen or C 1 -C 8 alkyl.

在一些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧,R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者,R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,Rm1 、Rm3 、Rm5 及Rm6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基。In some embodiments, belonging phthalide of formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p, Y o and Y m is oxygen, R 1p Together with R 2p , R 1o together with R 2o and R 1m together with R 2m represent one of sub-formulas III, IV or V, R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent sub-formula III, In one of IV or V, R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, and R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently hydrogen or C 1 -C 8 alkyl, R m1 , R m3 , R m5 and R m6 are each independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 Each is independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3, and R c4 are each independently hydrogen or C 1 -C 8 alkyl.

在某些實施例中,苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧,R1p 連同R2p 及R1o 連同R2o 表示子式III、IV或V中之一者,R2p 連同R1p 及R2o 連同R1o 表示子式III、IV或V中之一者,R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基。In certain embodiments, benzofuranone belongs to formula I-p1, I-p2, I-o1, or I-o2, wherein Y p and Y o are oxygen, R 1p together with R 2p and R 1o together with R 2o represent One of sub-formulas III, IV or V, R 2p together with R 1p and R 2o together with R 1o represents one of sub-formulas III, IV or V, R 4 , R 5 , R 6 and R 7 are each independently Is hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently Is hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 And R b6 are each independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3, and R c4 are each independently hydrogen or C 1 -C 8 alkyl.

在一些實施例中,苯并呋喃酮屬於式I-p1或I-p2,其中Yp 為氧,R1p 連同R2p 表示子式III、IV或V中之一者,R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基。In some embodiments, benzofuranone belongs to formula I-p1 or I-p2, where Y p is oxygen, R 1p together with R 2p represents one of sub-formulas III, IV, or V, R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, and R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are independently hydrogen or C 1 -C 8 alkyl, And R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 8 alkyl.

在一些實施例中,在式I-p1或I-p2之苯并呋喃酮化合物中,Yp 為氧,R1p 連同R2p 表示子式IV,R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,且Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基。In some embodiments, in the benzofuran compound of formula I-p1 or I-p2, Y p is oxygen, R 1p together with R 2p represents sub-formula IV, and R 4 , R 5 , R 6, and R 7 are each Independently hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, and R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 -C 8 alkyl.

在一些實施例中,苯并呋喃酮係選自式(101)至(133)之化合物。 In some embodiments, the benzofuranone is selected from compounds of formula (101) to (133).

可製備本發明之苯并呋喃酮,如US2017/0226323、US2017/0066905及公佈為WO2017/025431之美國專利第15/751497號中所揭示。The benzofuranone of the present invention can be prepared as disclosed in US2017 / 0226323, US2017 / 0066905, and US Patent No. 15/751497 published as WO2017 / 025431.

有機磷安定劑包括有機亞磷酸酯及有機亞膦酸二酯安定劑且包括例如亞磷酸三苯酯、亞磷酸二苯基烷基酯、亞磷酸苯基二烷基酯、亞磷酸參(壬基苯基)酯、亞磷酸三(十二烷基)酯、亞磷酸三(十八烷基)酯、亞磷酸參(2,4-二-第三丁基苯基)酯、亞磷酸參-(2-第二丁基苯基)酯(O)、二硬脂基季戊四醇二亞磷酸酯(F)、雙(2,4-二-α-茴香基苯基)季戊四醇二亞磷酸酯(K)、二異癸基季戊四醇二亞磷酸酯、雙(2,4-二-第三丁基苯基)季戊四醇二亞磷酸酯(D)、雙(2,6-二-第三丁基-4-甲基苯基)季戊四醇二亞磷酸酯(E)、二異癸氧基-季戊四醇二亞磷酸酯、雙(2,4-二-第三丁基-6-甲基苯基)季戊四醇二亞磷酸酯、雙(2,4,6-三第三丁基苯基)季戊四醇二亞磷酸酯、三硬脂基山梨醇三亞磷酸酯、肆(2,4-二-第三丁基苯基)4,4'-伸聯苯基-二亞磷酸酯(H)、6-異辛氧基-2,4,8,10-四第三丁基-二苯并[d,f][1,3,2]二氧雜磷雜庚英(C)、6-氟-2,4,8,10-四第三丁基-12-甲基-二苯并[d,g][1,3,2]二氧磷雜八環(A)、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)甲酯、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)乙酯(G)、2,2',2''-氮基[三乙基參(3,3'5,5'-四第三丁基-1,1'-聯苯基-2,2'-二基)亞磷酸酯](B)、亞磷酸雙(2,4-二-第三丁基苯基)辛酯、聚(4,4'-{2,2'-二甲基-5,5'-二-第三丁基苯基硫-}亞磷酸辛酯)、聚(4,4'{-亞異丙基二酚}-亞磷酸辛酯)、聚(4,4'-{亞異丙基雙[2,6-二溴苯酚]}-亞磷酸辛酯)、聚(4,4'-{2,2'-二甲基-5,5'-二-第三丁基苯基硫}-二亞磷酸季戊四醇酯)、亞磷酸、混合的2,4-雙(1,1-二甲基丙基)苯基與4-(1,1-二甲基丙基)苯基三酯(CAS編號939402-02-5)、亞磷酸、三苯酯、與α-氫-ω-羥基聚[氧基(甲基-1,2-乙烷二基]之聚合物、C10 -16 烷基酯(CAS編號1227937-46-3), Organic phosphorus stabilizers include organic phosphites and organic phosphonite diester stabilizers and include, for example, triphenyl phosphite, diphenyl alkyl phosphite, phenyl dialkyl phosphite, phosphite ginseng (non Phenyl), tris (dodecyl) phosphite, tris (octadecyl) phosphite, ginseng phosphite (2,4-di-third-butylphenyl) phosphite, ginseng phosphite -(2-Second butylphenyl) ester (O), distearyl pentaerythritol diphosphite (F), bis (2,4-di-α-anisylphenyl) pentaerythritol diphosphite ( K), diisodecyl pentaerythritol diphosphite, bis (2,4-di-tert-butylphenyl) pentaerythritol diphosphite (D), bis (2,6-di-tert-butyl- 4-methylphenyl) pentaerythritol diphosphite (E), diisodecoxy-pentaerythritol diphosphite, bis (2,4-di-tert-butyl-6-methylphenyl) pentaerythritol di Phosphite, bis (2,4,6-tri-tert-butylphenyl) pentaerythritol diphosphite, tristearyl sorbitol triphosphite, (2,4-di-tert-butylphenyl ) 4,4'-biphenylene-diphosphite (H), 6-isooctyloxy-2,4,8,10-tetra-tert-butyl-dibenzo [d, f] [1 , 3,2] diox Phosphagepta (C), 6-fluoro-2,4,8,10-tetra-tert-butyl-12-methyl-dibenzo [d, g] [1,3,2] dioxaphospha Octacyclic (A), bis (2,4-di-tert-butyl-6-methylphenyl) phosphite methyl ester, bis (2,4-di-tert-butyl-6-methyl phosphite) Phenyl) ethyl ester (G), 2,2 ', 2''-Azo [triethyl ginseng (3,3'5,5'-tetra-tert-butyl-1,1'-biphenyl- 2,2'-diyl) phosphite] (B), bis (2,4-di-tert-butylphenyl) octyl phosphite, poly (4,4 '-(2,2'-di Methyl-5,5'-di-tert-butylphenylthio-} octyl phosphite), poly (4,4 '{-isopropylidene diphenol} -octyl phosphite), poly (4 , 4 '-{isopropylidenebis [2,6-dibromophenol]}-octylphosphite), poly (4,4'-{2,2'-dimethyl-5,5'-di -Tert-butylphenylthio) -pentaerythritol diphosphite), phosphorous acid, mixed 2,4-bis (1,1-dimethylpropyl) phenyl and 4- (1,1-dimethyl Propylpropyl) phenyl triester (CAS No. 939402-02-5), phosphorous acid, triphenyl ester, and α-hydro-ω-hydroxy poly [oxy (methyl-1,2-ethanediyl) the polymer, C 10 - 16 alkyl ester (CAS No. 1227937-46-3), .

在一些實施例中,可採用一或多種有機磷安定劑之組合。In some embodiments, a combination of one or more organophosphorus stabilizers may be used.

在某些實施例中,有機磷安定劑係選自由以下組成之群:亞磷酸參-壬基苯基酯、雙(2,4-二-第三丁基苯基)季戊四醇二亞磷酸酯、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)乙酯、2,2',2''-氮基[三乙基參(3,3'5,5'-四第三丁基-1,1'-聯苯基-2,2'-二基)亞磷酸酯]、雙(2,4-二-α-茴香基苯基)季戊四醇二亞磷酸酯、亞磷酸參(2,4-二-第三丁基苯基)酯及其組合。In certain embodiments, the organic phosphorus stabilizer is selected from the group consisting of ginseng-nonylphenyl phosphite, bis (2,4-di-third butylphenyl) pentaerythritol diphosphite, Bis (2,4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 2,2 ', 2' '-nitrosyl [triethyl ginseng (3,3'5,5' -Tetra-tert-butyl-1,1'-biphenyl-2,2'-diyl) phosphite], bis (2,4-di-α-anisylphenyl) pentaerythritol diphosphite, Phosphorous ginseng (2,4-di-tert-butylphenyl) ester and combinations thereof.

基於聚烯烴之重量,所採用之苯并呋喃酮安定劑的量的範圍可為:按重量計約20 ppm、約30 ppm、約40 ppm、約50 ppm、約60 ppm、約70 ppm、約80 ppm、約90 ppm、約100 ppm、約110 ppm、約120 ppm、約130 ppm、約140 ppm、約150 ppm、約160 ppm、約170 ppm、約180 ppm、約190 ppm、約200 ppm、約250 ppm、約300 ppm、約350 ppm、約400 ppm、約450 ppm或約500 ppm中之任一者至約550 ppm、約600 ppm、約650 ppm、約700 ppm、約750 ppm、約800 ppm、約850 ppm、約900 ppm、約950 ppm、約1000 ppm、約1050 ppm、約1100 ppm、約1150 ppm、約1200 ppm、約1250 ppm、約1300 ppm、約1350 ppm或約1400 ppm中之任一者。Based on the weight of the polyolefin, the amount of benzofuran stabilizer used can range from about 20 ppm, about 30 ppm, about 40 ppm, about 50 ppm, about 60 ppm, about 70 ppm, about 80 ppm, about 90 ppm, about 100 ppm, about 110 ppm, about 120 ppm, about 130 ppm, about 140 ppm, about 150 ppm, about 160 ppm, about 170 ppm, about 180 ppm, about 190 ppm, about 200 ppm , About 250 ppm, about 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, or about 500 ppm to about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, About 800 ppm, about 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1050 ppm, about 1100 ppm, about 1150 ppm, about 1200 ppm, about 1250 ppm, about 1300 ppm, about 1350 ppm, or about 1400 Any of ppm.

在其他實施例中,基於聚烯烴之重量,所採用之本發明之苯并呋喃酮安定劑的量的範圍可為約0.05 wt% (重量百分比)、約0.07 wt%、約0.09 wt%、約0.10 wt%、約0.15 wt%、約0.20 wt%、約0.25 wt%、約0.30 wt%、約0.35 wt%、約0.40 wt%、約0.50 wt%、約0.60 wt%、約0.65 wt%、約0.70 wt%、約0.75 wt%、約0.80 wt%、約0.90 wt%、約1.0 wt%、約1.3 wt%、約1.5 wt%、約1.7 wt%、約2.0 wt%、約2.5 wt%、約3.0 wt%、約3.5 wt%、約4.0 wt%、約4.5 wt%、約5.0 wt%或約5.5 wt%中之任一者至約5.5 wt%、約6.0 wt%、約6.5 wt%、約7.0 wt%、約7.5 wt%、約8.0 wt%、約8.5 wt%、約9.0 wt%、約9.5 wt%或約10.0 wt%中之任一者。In other embodiments, based on the weight of the polyolefin, the amount of benzofuran ballast stabilizer used in the present invention may range from about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt%, about 0.20 wt%, about 0.25 wt%, about 0.30 wt%, about 0.35 wt%, about 0.40 wt%, about 0.50 wt%, about 0.60 wt%, about 0.65 wt%, about 0.70 wt%, about 0.75 wt%, about 0.80 wt%, about 0.90 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about Any of 3.0 wt%, about 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, or about 5.5 wt% to about 5.5 wt%, about 6.0 wt%, about 6.5 wt%, about Any one of 7.0 wt%, about 7.5 wt%, about 8.0 wt%, about 8.5 wt%, about 9.0 wt%, about 9.5 wt%, or about 10.0 wt%.

在其他實施例中,基於聚烯烴之重量,本發明之苯并呋喃酮安定劑的的量的範圍可為約1 wt%、約5 wt%、約10 wt%、約15 wt%、約20 wt%、約25 wt%或約30 wt%中之任一者至約35 wt%、約40 wt%、約45 wt%或約50 wt%中之任一者。In other embodiments, based on the weight of the polyolefin, the amount of the benzofuran stabilizer in the present invention may range from about 1 wt%, about 5 wt%, about 10 wt%, about 15 wt%, about 20 Any of wt%, about 25 wt%, or about 30 wt% to any of about 35 wt%, about 40 wt%, about 45 wt%, or about 50 wt%.

基於聚烯烴之重量,所採用之有機磷安定劑的量的範圍可為按重量計約20 ppm、約30 ppm、約40 ppm、約50 ppm、約60 ppm、約70 ppm、約80 ppm、約90 ppm、約100 ppm、約110 ppm、約120 ppm、約130 ppm、約140 ppm、約150 ppm、約160 ppm、約170 ppm、約180 ppm、約190 ppm、約200 ppm、約250 ppm、約300 ppm、約350 ppm、約400 ppm、約450 ppm或約500 ppm中之任一者至約550 ppm、約600 ppm、約650 ppm、約700 ppm、約750 ppm、約800 ppm、約850 ppm、約900 ppm、約950 ppm、約1000 ppm、約1050 ppm、約1100 ppm、約1150 ppm、約1200 ppm、約1250 ppm、約1300 ppm、約1350 ppm或約1400 ppm中之任一者。Based on the weight of the polyolefin, the amount of the organophosphorus stabilizer used can range from about 20 ppm, about 30 ppm, about 40 ppm, about 50 ppm, about 60 ppm, about 70 ppm, about 80 ppm, About 90 ppm, about 100 ppm, about 110 ppm, about 120 ppm, about 130 ppm, about 140 ppm, about 150 ppm, about 160 ppm, about 170 ppm, about 180 ppm, about 190 ppm, about 200 ppm, about 250 ppm, about 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, or about 500 ppm to about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, about 800 ppm , About 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1050 ppm, about 1100 ppm, about 1150 ppm, about 1200 ppm, about 1250 ppm, about 1300 ppm, about 1350 ppm or about 1400 ppm Any one.

在其他實施例中,基於聚烯烴之重量,所採用之有機磷安定劑的量的範圍可為約0.05 wt% (重量百分比)、約0.07 wt%、約0.09 wt%、約0.10 wt%、約0.15 wt%、約0.20 wt%、約0.35 wt%、約0.50 wt%、約0.75 wt%、約0.1 wt%、約0.2 wt%、約0.3 wt%、約0.4 wt%、約0.5 wt%、約0.6 wt%、約0.7 wt%、約0.8 wt%、約0.9 wt%、約1.0 wt%、約1.3 wt%、約1.5 wt%、約1.7 wt%、約2.0 wt%、約2.5 wt%、約3.0 wt%、約3.5 wt%、約4.0 wt%、約4.5 wt%、約5.0 wt%或約5.5 wt%中之任一者至約5.5 wt%、約6.0 wt%、約6.5 wt%、約7.0 wt%、約7.5 wt%、約8.0 wt%、約8.5 wt%、約9.0 wt%、約9.5 wt%或約10.0 wt%中之任一者。In other embodiments, based on the weight of the polyolefin, the amount of organophosphorus stabilizer used may range from about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt%, about 0.20 wt%, about 0.35 wt%, about 0.50 wt%, about 0.75 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about Any of 3.0 wt%, about 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, or about 5.5 wt% to about 5.5 wt%, about 6.0 wt%, about 6.5 wt%, about Any one of 7.0 wt%, about 7.5 wt%, about 8.0 wt%, about 8.5 wt%, about 9.0 wt%, about 9.5 wt%, or about 10.0 wt%.

在一些實施例中,一或多種苯并呋喃酮及一或多種有機磷安定劑可按以下重量/重量比採用:約1/99、約1/90、約1/80、約1/70、約1/60、約1/50、約1/40、約1/30、約1/20、約1/10、約1/9、約1/8、約1/7、約1/6、約1/5、約1/4、約1/3、約1/2或約1/1中之任一者至約2/1、約3/1、約4/1、約5/1、約6/1、約7/1、約8/1、約9/1、約10/1、約20/1、約30/1、約40/1、約50/1、約60/1、約70/1、約80/1、約90/1或約99/1中之任一者。In some embodiments, one or more benzofuranone and one or more organophosphorus stabilizers can be used in the following weight / weight ratio: about 1/99, about 1/90, about 1/80, about 1/70, About 1/60, about 1/50, about 1/40, about 1/30, about 1/20, about 1/10, about 1/9, about 1/8, about 1/7, about 1/6, Any one of about 1/5, about 1/4, about 1/3, about 1/2, or about 1/1 to about 2/1, about 3/1, about 4/1, about 5/1, About 6/1, about 7/1, about 8/1, about 9/1, about 10/1, about 20/1, about 30/1, about 40/1, about 50/1, about 60/1, Any one of about 70/1, about 80/1, about 90/1, or about 99/1.

在一些實施例中,相較於一或多種苯并呋喃酮,有機磷安定劑比相同或更高重量級使用。舉例而言,在一些實施例中,一或多種苯并呋喃酮與一或多種有機磷安定劑之重量/重量比可為約0.05、約0.10、約0.15、約0.20、約0.25、約0.30、約0.35、約0.40、約0.45或約0.50中之任一者至約0.55、約0.60、約0.65、約0.70、約0.75、約0.80、約0.85、約0.90、約0.95或約1.0中之任一者。In some embodiments, the organophosphorus stabilizer is used at the same or higher weight than one or more benzofuranone. For example, in some embodiments, the weight / weight ratio of one or more benzofuranone to one or more organophosphorus stabilizers may be about 0.05, about 0.10, about 0.15, about 0.20, about 0.25, about 0.30, Any of about 0.35, about 0.40, about 0.45, or about 0.50 to about 0.55, about 0.60, about 0.65, about 0.70, about 0.75, about 0.80, about 0.85, about 0.90, about 0.95, or about 1.0 By.

亦揭示了包含一或多種苯并呋喃酮化合物及一或多種有機磷安定劑之添加劑組合物。苯并呋喃酮與有機磷安定劑之重量/重量比可同上。An additive composition comprising one or more benzofuranone compounds and one or more organophosphorus stabilizers is also disclosed. The weight / weight ratio of benzofuranone and organophosphorus stabilizer can be the same as above.

在一些實施例中,組合物可進一步包含一或多種選自由以下組成之群的額外添加劑:抗氧化劑、紫外光吸收劑、受阻胺光安定劑、除酸劑、金屬去活化劑、羥胺、硝酮、胺N-氧化物、硫代增效劑、過氧化物清除劑、成核劑、填充劑、阻燃劑及抗靜電劑。In some embodiments, the composition may further include one or more additional additives selected from the group consisting of antioxidants, ultraviolet light absorbers, hindered amine light stabilizers, acid scavengers, metal deactivators, hydroxylamine, nitrate Ketones, amine N-oxides, thiosynergists, peroxide scavengers, nucleating agents, fillers, flame retardants and antistatic agents.

在一些實施例中,額外添加劑可包含塑化劑、潤滑劑、乳化劑、色素、染料、光學增亮劑、流變添加劑、催化劑、流量控制劑、助滑劑、交聯劑、交聯促進劑、鹵素清除劑、煙霧抑制劑、抗靜電劑或澄清劑,諸如經取代及未經取代之雙苯亞甲基山梨醇。In some embodiments, the additional additives may include plasticizers, lubricants, emulsifiers, pigments, dyes, optical brighteners, rheological additives, catalysts, flow control agents, slip agents, crosslinking agents, crosslinking promoters Agents, halogen scavengers, smoke inhibitors, antistatic agents or clarifiers, such as substituted and unsubstituted bisbenzylidene sorbitol.

基於聚烯烴之重量,額外添加劑的範圍單獨地或共同地可為:按重量計約20 ppm、約30 ppm、約40 ppm、約50 ppm、約60 ppm、約70 ppm、約80 ppm、約90 ppm、約100 ppm、約110 ppm、約120 ppm、約130 ppm、約140 ppm、約150 ppm、約160 ppm、約170 ppm、約180 ppm、約190 ppm、約200 ppm、約250 ppm、約300 ppm、約350 ppm、約400 ppm、約450 ppm或約500 ppm中之任一者至約550 ppm、約600 ppm、約650 ppm、約700 ppm、約750 ppm、約800 ppm、約850 ppm、約900 ppm、約950 ppm、約1000 ppm、約1050 ppm、約1100 ppm、約1150 ppm、約1200 ppm、約1250 ppm、約1300 ppm、約1350 ppm或約1400 ppm中之任一者。Based on the weight of the polyolefin, the range of additional additives individually or collectively may be: about 20 ppm, about 30 ppm, about 40 ppm, about 50 ppm, about 60 ppm, about 70 ppm, about 80 ppm, about 90 ppm, about 100 ppm, about 110 ppm, about 120 ppm, about 130 ppm, about 140 ppm, about 150 ppm, about 160 ppm, about 170 ppm, about 180 ppm, about 190 ppm, about 200 ppm, about 250 ppm , About 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, or about 500 ppm to about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, about 800 ppm, Any of about 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1050 ppm, about 1100 ppm, about 1150 ppm, about 1200 ppm, about 1250 ppm, about 1300 ppm, about 1350 ppm, or about 1400 ppm One.

在其他實施例中,基於聚烯烴之重量,可單獨地或共同地採用以下額外添加劑,約0.05 wt% (重量百分比)、約0.07 wt%、約0.09 wt%、約0.10 wt%、約0.15 wt%、約0.20 wt%、約0.35 wt%、約0.50 wt%、約0.75 wt%、約0.1 wt%、約0.2 wt%、約0.3 wt%、約0.4 wt%、約0.5 wt%、約0.6 wt%、約0.7 wt%、約0.8 wt%、約0.9 wt%、約1.0 wt%、約1.3 wt%、約1.5 wt%、約1.7 wt%、約2.0 wt%、約2.5 wt%、約3.0 wt%、約3.5 wt%、約4.0 wt%、約4.5 wt%、約5.0 wt%或約5.5 wt%中之任一者至約5.5 wt%、約6.0 wt%、約6.5 wt%、約7.0 wt%、約7.5 wt%、約8.0 wt%、約8.5 wt%、約9.0 wt%、約9.5 wt%或約10.0 wt%中之任一者。In other embodiments, based on the weight of the polyolefin, the following additional additives may be used individually or collectively, about 0.05 wt% (weight percent), about 0.07 wt%, about 0.09 wt%, about 0.10 wt%, about 0.15 wt %, About 0.20 wt%, about 0.35 wt%, about 0.50 wt%, about 0.75 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt %, About 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1.0 wt%, about 1.3 wt%, about 1.5 wt%, about 1.7 wt%, about 2.0 wt%, about 2.5 wt%, about 3.0 wt %, About 3.5 wt%, about 4.0 wt%, about 4.5 wt%, about 5.0 wt%, or about 5.5 wt% to about 5.5 wt%, about 6.0 wt%, about 6.5 wt%, about 7.0 wt %, About 7.5 wt%, about 8.0 wt%, about 8.5 wt%, about 9.0 wt%, about 9.5 wt%, or about 10.0 wt%.

在一些實施例中,受阻胺光安定劑為含有一或多種下式之部分的化合物其中R1 、R2 、R3 及R4 獨立地為甲基或乙基且其中R為H、甲基、羥基、丙氧基、辛氧基、環己氧基、醯氧基或N-(2-羥基-2-甲基丙氧基)。In some embodiments, the hindered amine light stabilizer is a compound containing one or more moieties of the formula Wherein R 1 , R 2 , R 3 and R 4 are independently methyl or ethyl and wherein R is H, methyl, hydroxy, propoxy, octoxy, cyclohexyloxy, acetyloxy or N- (2-hydroxy-2-methylpropoxy).

合適的受阻胺光安定劑為例如: (1) 1-環己氧基-2,2,6,6-四甲基-4-十八基胺基哌啶, (2) 雙(2,2,6,6-四甲基哌啶-4-基)癸二酸酯, (3) 雙(1-乙醯氧基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯, (4) 雙(1,2,2,6,6-五甲基哌啶-4-基)癸二酸酯, (5) 雙(1-環己氧基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯, (6) 雙(1-辛氧基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯; (7) 雙(1-醯基-2,2,6,6-四甲基哌啶-4-基)癸二酸酯, (8) 丙二酸雙(1,2,2,6,6-五甲基-4-哌啶基)正丁基-3,5-二-第三丁基-4-羥基苯甲酯 (9) 2,4-雙[(1-環己氧基-2,2,6,6-四甲基哌啶-4-基)丁胺基]-6-(2-羥乙基胺基)-s-三嗪, (10) 雙(1-環己氧基-2,2,6,6-四甲基哌啶-4-基)己二酸酯, (11) 2,4-雙[(1-環己氧基-2,2,6,6-哌啶-4-基)丁胺基]-6-氯-s-三嗪, (12) 1-(2-羥基-2-甲基丙氧基)-4-羥基-2,2,6,6-四甲基哌啶, (13) 1-(2-羥基-2-甲基丙氧基)-4-側氧基-2,2,6,6-四甲基哌啶, (14) 1-(2-羥基-2-甲基丙氧基)-4-十八醯氧基-2,2,6,6-四甲基哌啶, (15) 雙(1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基哌啶-4-基)癸二酸酯, (16) 雙(1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基哌啶-4-基)己二酸酯, (17) 2,4-雙{N-[1-(2-羥基-2-甲基丙氧基)-2,2,6,6-四甲基哌啶-4-基]-N-丁胺基}-6-(2-羥乙基胺基)-s-三嗪, (18) 4-苯甲醯基-2,2,6,6-四甲基哌啶, (19) 丙二酸二-(1,2,2,6,6-五甲基哌啶-4-基)對甲氧基苯亞甲酯, (20) 十八酸2,2,6,6-四甲基哌啶-4-基酯, (21) 丁二酸雙(1-辛氧基-2,2,6,6-四甲基哌啶基)酯, (22) 1,2,2,6,6-五甲基-4-胺基哌啶, (23) 2-十一基-7,7,9,9-四甲基-1-氧雜-3,8-二氮雜-4-側氧基-螺[4,5] 癸烷, (24) 參(2,2,6,6-四甲基-4-哌啶基)氮基三乙酸酯, (25) 參(2-羥基-3-(胺基-(2,2,6,6-四甲基哌啶-4-基)丙基)氮基三乙酸酯, (26) 肆(2,2,6,6-四甲基-4-哌啶基)-1,2,3,4-丁烷-四甲酸酯, (27) 肆(1,2,2,6,6-五甲基-4-哌啶基)-1,2,3,4-丁烷-四甲酸酯, (28) 1,1'-(1,2-乙烷二基)-雙(3,3,5,5-四甲基哌嗪酮), (29) 3-正辛基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸-2,4-二酮, (30) 8-乙醯基-3-十二烷基-7,7,9,9-四甲基-1,3,8-三氮雜螺[4.5]癸烷-2,4-二酮, (31) 3-十二烷基-1-(2,2,6,6-四甲基-4-哌啶基)吡咯啶-2,5-二酮, (32) 3-十二烷基-1-(1,2,2,6,6-五甲基-4-哌啶基)吡咯啶-2,5-二酮, (33) N,N'-雙甲醯基-N,N'-雙(2,2,6,6-四甲基-4-哌啶基)六亞甲基二胺, (33a) 碳酸雙(1-十一烷醯氧基-2,2,6,6-四甲基哌啶-4-基)酯, (34) 2,4-雙[(1-環己氧基-2,2,6,6-哌啶-4-基)丁胺基]-6-氯-s-三嗪與N,N'-雙(3-胺丙基)乙二胺之反應產物, (35) 1-(2-羥乙基)-2,2,6,6-四甲基-4-羥基哌啶與丁二酸之縮合物, (36) N,N'-雙(2,2,6,6-四甲基-4-哌啶基)-六亞甲基二胺與4-第三辛基胺基-2,6-二氯-1,3,5-三嗪之縮合物, (37) N,N'-雙(2,2,6,6-四甲基-4-哌啶基)-六亞甲基二胺與4-環己胺基-2,6-二氯-1,3,5-三嗪之縮合物, (38) N,N'-雙-(2,2,6,6-四甲基-4-哌啶基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物, (39) N,N'-雙-(1,2,2,6,6-五甲基-4-哌啶基)六亞甲基二胺與4-嗎啉基-2,6-二氯-1,3,5-三嗪之縮合物, (40) 2-氯-4,6-雙(4-正丁胺基-2,2,6,6-四甲基哌啶基)-1,3,5-三嗪與1,2-雙(3-胺基丙胺基)乙烷之縮合物, (41) 2-氯-4,6-二-(4-正丁胺基-1,2,2,6,6-五甲基哌啶基)-1,3,5-三嗪與及1,2-雙-(3-胺基丙胺基)乙烷之縮合物, (42) 7,7,9,9-四甲基-2-環十一烷基-1-氧雜-3,8-二氮雜-4-側氧基螺[4,5]癸烷與表氯醇之反應產物, (43) 聚[甲基(3-氧基-(2,2,6,6-四甲基哌啶-4-基)丙基)]矽氧烷,CAS#182635-99-0, (44) 順丁烯二酸酐-C18 -C22 -α-烯烴-共聚物與2,2,6,6-四甲基-4-胺基哌啶之反應產物, (45) 4,4'-六亞甲基雙(胺基-2,2,6,6-四甲基哌啶)與經2-氯-4,6-雙(二丁胺基)-s-三嗪封端的2,4-二氯-6-[(2,2,6,6-四甲基哌啶-4-基)丁胺基]-s-三嗪之寡聚縮合物, (46) 4,4'-六亞甲基雙(胺基-1,2,2,6,6-五甲基哌啶)與經2-氯-4,6-雙(二丁胺基)-s-三嗪封端之2,4-二氯-6-[(1,2,2,6,6-五甲基哌啶-4-基)丁胺基]-s-三嗪之寡聚縮合物, (47) 4,4'-六亞甲基雙(胺基-1-丙氧基-2,2,6,6-四甲基哌啶)與經2-氯-4,6-雙(二丁胺基)-s-三嗪封端之2,4-二氯-6-[(1-丙氧基-2,2,6,6-四甲基哌啶-4-基)丁胺基]-s-三嗪之寡聚縮合物, (48) 4,4'-六亞甲基雙(胺基-1-醯氧基-2,2,6,6-四甲基哌啶)與經2-氯-4,6-雙(二丁胺基)-s-三嗪封端之2,4-二氯-6-[(1-醯氧基-2,2,6,6-四甲基哌啶-4-基)丁胺基]-s-三嗪之寡聚縮合物, (49) 藉由使(a)與(b)獲得之產物,其中(a)為藉由使1,2-雙(3-胺基丙胺基)乙烷與三聚氯化氰反應獲得之產物,且(b)為(2,2,6,6-四甲基哌啶-4-基)丁胺, (50) (4-哌啶醇,2,2,6,6-四甲基-1-(十一烷氧基))-,4,4'-碳酸酯,及 (51) 1,3,5-三嗪-2,4,6-三胺,N2,N2'-1,6-己烷二基雙[N4,N6-二丁基-N2,N4,N6-參(2,2,6,6-四甲基-4-哌啶基)-,N-丙氧基。Suitable hindered amine light stabilizers are, for example: (1) 1-cyclohexyloxy-2,2,6,6-tetramethyl-4-octadecylaminopiperidine, (2) bis (2,2 , 6,6-tetramethylpiperidin-4-yl) sebacate, (3) bis (1-acetoxy-2,2,6,6-tetramethylpiperidin-4-yl) Sebacate, (4) bis (1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, (5) bis (1-cyclohexyloxy-2,2 , 6,6-tetramethylpiperidin-4-yl) sebacate, (6) bis (1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) dec Diester; (7) Bis (1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, (8) Malonate bis (1,2,2 , 6,6-pentamethyl-4-piperidinyl) n-butyl-3,5-di-tert-butyl-4-hydroxybenzyl ester (9) 2,4-bis [(1-cyclohexyl Oxy-2,2,6,6-tetramethylpiperidin-4-yl) butylamino] -6- (2-hydroxyethylamino) -s-triazine, (10) bis (1- Cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) adipate, (11) 2,4-bis [(1-cyclohexyloxy-2,2,6 , 6-piperidin-4-yl) butylamino] -6-chloro-s-triazine, (12) 1- (2-hydroxy-2-methylpropoxy) -4-hydroxy-2,2 , 6,6-tetramethylpiperidine, (13) 1- (2-hydroxy-2-methylpropoxy) -4-oxo-2,2,6,6-tetramethylpiperidine, (14) 1- (2-hydroxy-2- Propylpropoxy) -4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine, (15) bis (1- (2-hydroxy-2-methylpropoxy) -2 , 2,6,6-tetramethylpiperidin-4-yl) sebacate, (16) bis (1- (2-hydroxy-2-methylpropoxy) -2,2,6,6 -Tetramethylpiperidin-4-yl) adipate, (17) 2,4-bis {N- [1- (2-hydroxy-2-methylpropoxy) -2,2,6, 6-tetramethylpiperidin-4-yl] -N-butylamino} -6- (2-hydroxyethylamino) -s-triazine, (18) 4-benzyl-2,2 , 6,6-Tetramethylpiperidine, (19) Di- (1,2,2,6,6-pentamethylpiperidin-4-yl) -p-methoxybenzylidene malonate, ( 20) 2,2,6,6-tetramethylpiperidin-4-yl octadecanoate, (21) bis (1-octyloxy-2,2,6,6-tetramethylpiperyl succinate Pyridyl) ester, (22) 1,2,2,6,6-pentamethyl-4-aminopiperidine, (23) 2-undecyl-7,7,9,9-tetramethyl- 1-oxa-3,8-diaza-4-oxo-spiro [4,5] decane, (24) ginseng (2,2,6,6-tetramethyl-4-piperidinyl ) Nitrotriacetate, (25) ginseng (2-hydroxy-3- (amino- (2,2,6,6-tetramethylpiperidin-4-yl) propyl) nitrotriacetic acid Ester, (26) (2,2,6,6-tetramethyl-4-piperidinyl) -1,2,3,4-butane-tetracarboxylic acid ester, (27) (1,2) , 2,6,6-pentamethyl-4-piperidinyl) -1,2,3,4- Butane-tetraformate, (28) 1,1 '-(1,2-ethanediyl) -bis (3,3,5,5-tetramethylpiperazinone), (29) 3- N-octyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro [4.5] dec-2,4-dione, (30) 8-acetoyl-3-dec Dialkyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro [4.5] decane-2,4-dione, (31) 3-dodecyl-1 -(2,2,6,6-tetramethyl-4-piperidinyl) pyrrolidin-2,5-dione, (32) 3-dodecyl-1- (1,2,2,6 , 6-pentamethyl-4-piperidinyl) pyrrolidine-2,5-dione, (33) N, N'-bismethylformyl-N, N'-bis (2,2,6,6 -Tetramethyl-4-piperidinyl) hexamethylenediamine, (33a) bis (1-undecanecarbonyloxy-2,2,6,6-tetramethylpiperidin-4-yl carbonate ) Ester, (34) 2,4-bis [(1-cyclohexyloxy-2,2,6,6-piperidin-4-yl) butylamino] -6-chloro-s-triazine and N , N'-bis (3-aminopropyl) ethylenediamine reaction product, (35) 1- (2-hydroxyethyl) -2,2,6,6-tetramethyl-4-hydroxypiperidine and Succinic acid condensate, (36) N, N'-bis (2,2,6,6-tetramethyl-4-piperidinyl) -hexamethylenediamine and 4-third octylamine Condensate of yl-2,6-dichloro-1,3,5-triazine, (37) N, N'-bis (2,2,6,6-tetramethyl-4-piperidinyl)- Hexamethylenediamine and 4-cyclohexylamino-2,6-dichloro-1,3 , 5-triazine condensate, (38) N, N'-bis- (2,2,6,6-tetramethyl-4-piperidinyl) hexamethylenediamine and 4-morpholinyl -Condensate of 2,2,6-dichloro-1,3,5-triazine, (39) N, N'-bis- (1,2,2,6,6-pentamethyl-4-piperidinyl ) Condensate of hexamethylene diamine and 4-morpholinyl-2,6-dichloro-1,3,5-triazine, (40) 2-chloro-4,6-bis (4-n-butyl Amino-2,2,6,6-tetramethylpiperidinyl) -1,3,5-triazine and 1,2-bis (3-aminopropylamino) ethane condensate, (41) 2-chloro-4,6-di- (4-n-butylamino-1,2,2,6,6-pentamethylpiperidinyl) -1,3,5-triazine and 1,2- Condensate of bis- (3-aminopropylamino) ethane, (42) 7,7,9,9-tetramethyl-2-cycloundecyl-1-oxa-3,8-diaza The reaction product of hetero-4-oxo spiro [4,5] decane and epichlorohydrin, (43) poly [methyl (3-oxy- (2,2,6,6-tetramethylpiperidine -4-yl) propyl)] siloxane, CAS # 182635-99-0, (44) maleic anhydride-C 18 -C 22 -α-olefin-copolymer with 2,2,6,6 -The reaction product of tetramethyl-4-aminopiperidine, (45) 4,4'-hexamethylenebis (amino-2,2,6,6-tetramethylpiperidine) and 2- Chloro-4,6-bis (dibutylamino) -s-triazine-terminated 2,4-dichloro-6-[(2,2,6,6-tetramethylpiperidin-4-yl) butane Group] -s-triazine oligomeric condensate, (46) 4,4'-hexamethylene bis (amino-1,2,2,6,6-pentamethylpiperidine) and 2- Chloro-4,6-bis (dibutylamino) -s-triazine-terminated 2,4-dichloro-6-[(1,2,2,6,6-pentamethylpiperidine-4- Group) Butylamino] -s-triazine oligomeric condensate, (47) 4,4'-hexamethylenebis (amino-1-propoxy-2,2,6,6-tetramethyl Piperidine) and 2,4-dichloro-6-[(1-propoxy-2,2,2,2,2-chloro-4,6-bis (dibutylamino) -s-triazine 6,6-tetramethylpiperidin-4-yl) butylamino] -s-triazine oligomeric condensate, (48) 4,4'-hexamethylenebis (amino-1-amide) Yl-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-terminated with 2-chloro-4,6-bis (dibutylamino) -s-triazine [(1-Acetyloxy-2,2,6,6-tetramethylpiperidin-4-yl) butylamino] -s-triazine oligomeric condensate, (49) by using (a) The product obtained with (b), wherein (a) is a product obtained by reacting 1,2-bis (3-aminopropylamino) ethane with cyanuric chloride, and (b) is (2, 2,6,6-tetramethylpiperidin-4-yl) butylamine, (50) (4-piperidinol, 2,2,6,6-tetramethyl-1- (undecyloxy) )-, 4,4'-carbonate, and (51) 1,3,5-triazine-2,4,6-triamine, N2, N2'-1,6-hexanediylbis [N4, N6- Dibutyl-N2, N4, N6-ginseng (2,2,6,6-tetramethyl-4-piperidinyl)-, N-propoxy.

還包括以上提及之化合物中之任一者的位阻N-H、N-甲基、N-甲氧基、N-羥基、N-丙氧基、N-辛氧基、N-環己氧基、N-醯氧基及N-(2-羥基-2-甲基丙氧基)類似物。舉例而言,用N-甲基受阻胺替換N-H受阻胺會使用N-甲基類似物代替N-H。Also includes sterically hindered NH, N-methyl, N-methoxy, N-hydroxy, N-propoxy, N-octyloxy, N-cyclohexyloxy of any of the compounds mentioned above , N-acyloxy and N- (2-hydroxy-2-methylpropoxy) analogs. For example, replacing N-H hindered amines with N-methyl hindered amines will use N-methyl analogs instead of N-H.

出於說明之目的,上述化合物之結構中的一些展示如下。 For illustrative purposes, some of the structures of the above compounds are shown below.

在某些實施例中,組合物可進一步包含受阻酚系抗氧化劑,諸如β-(3,5-二-第三丁基-4-羥苯基)丙酸酯,例如一元醇或多元醇與例如甲醇、乙醇、正辛醇、異辛醇之酯、直鏈與分支鏈C7 -C9 烷醇、十八醇之混合物、直鏈與分支鏈C13 -C15 烷醇、1,6-己二醇、1,9-壬二醇、乙二醇、1,2-丙二醇、1,3-丙二醇、新戊二醇、1,4-環己烷二甲醇、甘油、硫代二甘醇、二甘醇、三甘醇、季戊四醇、異氰尿酸參(羥乙基)酯、N,N′-雙-(羥基-乙基)乙醯二胺、3-硫雜十一醇、3-硫雜十五醇、三甲基己二醇、三羥甲基丙烷、4-羥甲基-1-磷雜-2,6,7-三氧雜雙環[2.2.2]辛烷之混合物。In certain embodiments, the composition may further include hindered phenolic antioxidants, such as β- (3,5-di-third butyl-4-hydroxyphenyl) propionate, such as monohydric or polyhydric alcohols and For example, methanol, ethanol, n-octanol, isooctanol esters, mixtures of linear and branched C 7 -C 9 alkanols, stearyl alcohol, linear and branched C 13 -C 15 alkanols, 1,6 -Hexanediol, 1,9-nonanediol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, neopentyl glycol, 1,4-cyclohexanedimethanol, glycerin, thiodiglyme Alcohol, diethylene glycol, triethylene glycol, pentaerythritol, ginseng (hydroxyethyl) isocyanurate, N, N′-bis- (hydroxy-ethyl) ethylenediamine, 3-thiaundecyl alcohol, 3 -Thiapentadecanol, trimethylhexanediol, trimethylolpropane, 4-hydroxymethyl-1-phospha-2,6,7-trioxabicyclo [2.2.2] octane mixture .

在其他實施例中,受阻酚系抗氧化劑包括異氰尿酸參(3,5-二-第三丁基-4-羥基苯甲基)酯、1,3,5-參-(3,5-二-第三丁基-4-羥基苯甲基)-2,4,6-三甲苯、3,5-二-第三丁基-4-羥基苯甲基膦酸之單乙酯之鈣鹽、1,2-雙(3,5-二-第三丁基-4-羥基氫化苯丙烯醯基)肼、季戊四醇肆[3-(3,5-二-第三丁基-4-羥苯基)丙酸酯]、3-(3,5-二-第三丁基-4-羥苯基)丙酸十八酯、N,N′-六亞甲基雙(3,5-二-第三丁基-4-羥基氫化肉桂酸醯胺)、1,3,5-參-(4-第三丁基-3-羥基-2,6-二甲基苯甲基)-1,3,5-三嗪-2,4,6-(1H,3H,5H)-三酮、2,2'-亞甲基雙(4-甲基-6-第三丁基苯酚)單丙烯酸酯或α-生育酚。In other embodiments, the hindered phenolic antioxidants include ginseng isocyanurate (3,5-di-tert-butyl-4-hydroxybenzyl) ester, 1,3,5-ginseng- (3,5- Di-tert-butyl-4-hydroxybenzyl) -2,4,6-trimethylbenzene, calcium salt of 3,5-di-tert-butyl-4-hydroxybenzylphosphonic acid monoethyl ester , 1,2-bis (3,5-di-tert-butyl-4-hydroxyhydrogenated phenylacryl acetyl) hydrazine, pentaerythritol [3- (3,5-di-tert-butyl-4-hydroxybenzene Group) propionate], 3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate octadecyl ester, N, N′-hexamethylenebis (3,5-di- Tert-butyl-4-hydroxyhydrocinnamoylamide), 1,3,5-ginseng- (4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) -1,3 , 5-triazine-2,4,6- (1H, 3H, 5H) -trione, 2,2'-methylenebis (4-methyl-6-tert-butylphenol) monoacrylate or α-Tocopherol.

在一些實施例中,組合物基本上不包含或不包含受阻酚系抗氧化劑。基本上不意謂並非故意添加,且其中基於聚烯烴之重量,僅可存在無意量或痕量,例如按重量計≤ 500 ppm (百萬分之一)、≤ 400 ppm、≤ 300 ppm、≤ 200 ppm、≤ 150 ppm、≤ 100 ppm、≤ 75 ppm、≤ 50 ppm、≤ 25 ppm、≤ 20 ppm、≤ 15 ppm、≤ 10 ppm、≤ 5 ppm、≤ 4 ppm、≤ 3 ppm、≤ 2 ppm或≤ 1 ppm。In some embodiments, the composition contains substantially no or no hindered phenolic antioxidants. Basically, it does not mean that it is not intentionally added, and based on the weight of polyolefin, there can only be unintentional or trace amounts, such as ≤ 500 ppm (parts per million), ≤ 400 ppm, ≤ 300 ppm, ≤ 200 by weight ppm, ≤ 150 ppm, ≤ 100 ppm, ≤ 75 ppm, ≤ 50 ppm, ≤ 25 ppm, ≤ 20 ppm, ≤ 15 ppm, ≤ 10 ppm, ≤ 5 ppm, ≤ 4 ppm, ≤ 3 ppm, ≤ 2 ppm or ≤ 1 ppm.

硫代增效劑包括例如硫代二丙酸二月桂酯或硫代二丙酸二硬脂基酯。Thio synergists include, for example, dilauryl thiodipropionate or distearyl thiodipropionate.

除酸劑包括水滑石及非晶鹼性碳酸鋁鎂,諸如美國專利第4,427,816號、第5,106,898號及第5,234,981號中所描述之彼等者。水滑石亦被稱作hycite、DHT4A、DHT4V、DHT4Z、DHT4A2或DHT4C。水滑石為天然或合成的,且可包括塗層。天然水滑石仍然具有結構Mg6 Al2 (OH)16 CO3 .4 H2 O。合成水滑石之典型實驗式為Al2 Mg4 . 35 OH11 . 36 CO3 ( 1 . 67 ) .x H2 O。合成產物之實例包括Mg0 . 7 Al0 . 3 (OH)2 (CO3 )0 . 15 .0.54 H2 O、Mg4 . 5 Al2 (OH)13 CO3 .3.5 H2 O及Mg4 . 2 Al(OH)12 . 4 CO3Acid scavengers include hydrotalcite and amorphous basic aluminum magnesium carbonate, such as those described in US Patent Nos. 4,427,816, 5,106,898, and 5,234,981. Hydrotalcite is also known as hycite, DHT4A, DHT4V, DHT4Z, DHT4A2 or DHT4C. Hydrotalcite is natural or synthetic, and may include a coating. Natural hydrotalcite has a structure still Mg 6 Al 2 (OH) 16 CO 3. 4 H 2 O. A typical empirical formula of a synthetic hydrotalcite is Al 2 Mg 4. 35 OH 11 . 36 CO 3 (1. 67) .x H 2 O. Examples of the synthetic product include Mg 0. 7 Al 0. 3 (OH) 2 (CO 3) 0. 15 .0.54 H 2 O, Mg 4. 5 Al 2 (OH) 13 CO 3 .3.5 H 2 O and Mg 4 . 2 Al (OH) 12. 4 CO 3.

在一些實施例中,除酸劑包括脂肪酸之金屬鹽,例如脂肪酸之鹼或鹼土金屬鹽。在一些實施例中,除酸劑包括脂肪酸之鈣、鎂、鋅、鈉、鉀或鋁鹽。在一些實施例中,除酸劑包括硬脂酸鈣、硬脂酸鎂、硬脂酸鋅、硬脂酸鈉、硬脂酸鉀或硬脂酸鋁、山崳酸鈣、山崳酸鎂、山崳酸鋅、山崳酸鈉、山崳酸鉀或山崳酸鋁、蓖麻油酸鈣、蓖麻油酸鎂、蓖麻油酸鋅、蓖麻油酸鈉、蓖麻油酸鉀或蓖麻油酸鋁、或棕櫚酸鈣、棕櫚酸鎂、棕櫚酸鋅、棕櫚酸鈉、棕櫚酸鉀或棕櫚酸鋁。在某些實施例中,除酸劑包括硬脂酸鈣、硬脂酸鋅、山崳酸鎂、硬脂酸鎂、蓖麻油酸鈉及棕櫚酸鉀。在其他實施例中,除酸劑包括氧化鋅。In some embodiments, the acid scavenger includes metal salts of fatty acids, such as alkali or alkaline earth metal salts of fatty acids. In some embodiments, the acid scavenger includes calcium, magnesium, zinc, sodium, potassium, or aluminum salts of fatty acids. In some embodiments, the acid scavenger includes calcium stearate, magnesium stearate, zinc stearate, sodium stearate, potassium stearate or aluminum stearate, calcium behenate, magnesium behenate, Zinc behenate, sodium behenate, potassium or aluminum behenate, calcium ricinoleate, magnesium ricinoleate, zinc ricinoleate, sodium ricinoleate, potassium ricinoleate or aluminum ricinoleate, Or calcium palmitate, magnesium palmitate, zinc palmitate, sodium palmitate, potassium palmitate or aluminum palmitate. In certain embodiments, the acid scavenger includes calcium stearate, zinc stearate, magnesium behenate, magnesium stearate, sodium ricinoleate, and potassium palmitate. In other embodiments, the acid scavenger includes zinc oxide.

在一些實施例中,可採用一或多種除酸劑之組合。In some embodiments, a combination of one or more acid scavengers may be used.

紫外(UV)光吸收劑可選自由以下組成之群:羥基苯基苯并三唑、參-芳基-s-三嗪、羥基苯甲酸酯、2-羥基二苯甲酮及氰基丙烯酸酯紫外光吸收劑(UVA)。Ultraviolet (UV) light absorbers can be selected from the group consisting of hydroxyphenylbenzotriazole, gins-aryl-s-triazine, hydroxybenzoate, 2-hydroxybenzophenone and cyanoacrylic acid Ester ultraviolet absorber (UVA).

羥苯基苯并三唑UVA可包括美國專利第3,004,896號、第3,055,896號、第3,072,585號、第3,074,910號、第3,189,615號、第3,218,332號、第3,230,194號、第4,127,586號、第4,226,763號、第4,275,004號、第4,278,589號、第4,315,848號、第4,347,180號、第4,383,863號、第4,675,352號、第4,681,905號、第4,853,471號、第5,268,450號、第5,278,314號、第5,280,124號、第5,319,091號、第5,410,071號、第5,436,349號、第5,516,914號、第5,554,760號、第5,563,242號、第5,574,166號、第5,607,987號、第5,977,219號及第6,166,218號中所揭示之彼等者,諸如2-(2-羥基-5-甲基苯基)-2H-苯并三唑、2-(3,5-二-第三丁基-2-羥基苯基)-2H-苯并三唑、2-(2-羥基-5-第三丁基苯基)-2H-苯并三唑、2-(2-羥基-5-第三辛基苯基)-2H-苯并三唑、5-氯-2-(3,5-二-第三丁基-2-羥基苯基)-2H-苯并三唑、5-氯-2-(3-第三丁基-2-羥基-5-甲基苯基)-2H-苯并三唑、2-(3-第二丁基-5-第三丁基-2-羥基苯基)-2H-苯并三唑、2-(2-羥基-4-辛氧基苯基)-2H-苯并三唑、2-(3,5-二-第三戊基-2-羥基苯基)-2H-苯并三唑、2-(3,5-雙-α-茴香基-2-羥基苯基)-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-(ω-羥基-八-(伸乙基氧基)羰基-乙基)-, 苯基)-2H-苯并三唑、2-(3-十二烷基-2-羥基-5-甲基苯基)-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-辛氧基羰基)乙基苯基)-2H-苯并三唑、十二烷基取代之2-(2-羥基-5-甲基苯基)-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-辛氧基羰基乙基)苯基)-5-氯-2H-苯并三唑、2-(3-第三丁基-5-(2-(2-乙基己氧基)-羰基乙基)-2-羥基苯基)-5-氯-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-甲氧基羰基乙基)苯基)-5-氯-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-甲氧基羰基乙基)苯基)-2H-苯并三唑、2-(3-第三丁基-5-(2-(2-乙基己氧基)羰基乙基)-2-羥基苯基)-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-異辛氧基羰基乙基)苯基-2H-苯并三唑、2,2'-亞甲基-雙(4-第三辛基-(6-2H-苯并三唑-2-基)苯酚)、2-(2-羥基-3-α-茴香基-5-第三辛基苯基)-2H-苯并三唑、2-(2-羥基-3-第三辛基-5-α-茴香基苯基)-2H-苯并三唑、5-氟-2-(2-羥基-3,5-二-α-茴香基苯基)-2H-苯并三唑、5-氯-2-(2-羥基-3,5-二-α-茴香基苯基)-2H-苯并三唑、5-氯-2-(2-羥基-3-α-茴香基-5-第三辛基苯基)-2H-苯并三唑、2-(3-第三丁基-2-羥基-5-(2-異辛氧基羰基乙基)苯基)-5-氯-2H-苯并三唑、5-三氟甲基-2-(2-羥基-3-α-茴香基-5-第三辛基苯基)-2H-苯并三唑、5-三氟甲基-2-(2-羥基-5-第三辛基苯基)-2H-苯并三唑、5-三氟甲基-2-(2-羥基-3,5-二-第三辛基苯基)-2H-苯并三唑、3-(5-三氟甲基-2H-苯并三唑-2-基)-5-第三丁基-4-羥基氫化肉桂酸甲酯、5-丁基磺醯基-2-(2-羥基-3-α-茴香基-5-第三辛基苯基)-2H-苯并三唑、5-三氟甲基-2-(2-羥基-3-α-茴香基-5-第三丁基苯基)-2H-苯并三唑、5-三氟甲基-2-(2-羥基-3,5-二-第三丁基苯基)-2H-苯并三唑、5-三氟甲基-2-(2-羥基-3,5-二-α-茴香基苯基)-2H-苯并三唑、5-丁基磺醯基-2-(2-羥基-3,5-二-第三丁基苯基)-2H-苯并三唑及5-苯基磺醯基-2-(2-羥基-3,5-二-第三丁基苯基)-2H-苯并三唑。Hydroxyphenylbenzotriazole UVA may include U.S. Patent Nos. 3,004,896, 3,055,896, 3,072,585, 3,074,910, 3,189,615, 3,218,332, 3,230,194, 4,127,586, 4,226,763, 4,275,004 No. 4,278,589, 4,315,848, 4,347,180, 4,383,863, 4,675,352, 4,681,905, 4,853,471, 5,268,450, 5,278,314, 5,280,124, 5,319,091, 5,410,071, No. 5,436,349, No. 5,516,914, No. 5,554,760, No. 5,563,242, No. 5,574,166, No. 5,607,987, No. 5,977,219 and No. 6,166,218, etc., such as 2- (2-hydroxy-5-A Phenyl) -2H-benzotriazole, 2- (3,5-di-tert-butyl-2-hydroxyphenyl) -2H-benzotriazole, 2- (2-hydroxy-5- Tributylphenyl) -2H-benzotriazole, 2- (2-hydroxy-5-third octylphenyl) -2H-benzotriazole, 5-chloro-2- (3,5-di -Tert-butyl-2-hydroxyphenyl) -2H-benzotriazole, 5-chloro-2- (3-tert-butyl-2-hydroxy-5-methylphenyl) -2H-benzo Triazole, 2- (3-second butyl-5-third butyl-2-hydroxybenzene ) -2H-benzotriazole, 2- (2-hydroxy-4-octyloxyphenyl) -2H-benzotriazole, 2- (3,5-di-third-pentyl-2-hydroxybenzene Group) -2H-benzotriazole, 2- (3,5-bis-α-anisyl-2-hydroxyphenyl) -2H-benzotriazole, 2- (3-tert-butyl-2- Hydroxy-5- (2- (ω-hydroxy-octa- (ethyloxy) carbonyl-ethyl)-, phenyl) -2H-benzotriazole, 2- (3-dodecyl-2 -Hydroxy-5-methylphenyl) -2H-benzotriazole, 2- (3-tert-butyl-2-hydroxy-5- (2-octyloxycarbonyl) ethylphenyl) -2H- Benzotriazole, dodecyl substituted 2- (2-hydroxy-5-methylphenyl) -2H-benzotriazole, 2- (3-tert-butyl-2-hydroxy-5- ( 2-octyloxycarbonylethyl) phenyl) -5-chloro-2H-benzotriazole, 2- (3-tert-butyl-5- (2- (2-ethylhexyloxy) -carbonyl Ethyl) -2-hydroxyphenyl) -5-chloro-2H-benzotriazole, 2- (3-third butyl-2-hydroxy-5- (2-methoxycarbonylethyl) phenyl ) -5-chloro-2H-benzotriazole, 2- (3-tert-butyl-2-hydroxy-5- (2-methoxycarbonylethyl) phenyl) -2H-benzotriazole, 2- (3-tert-butyl-5- (2- (2-ethylhexyloxy) carbonylethyl) -2-hydroxyphenyl) -2H-benzotriazole, 2- (3-third Butyl-2-hydroxy-5- (2-isooctoxycarbonylethyl) benzene Yl-2H-benzotriazole, 2,2'-methylene-bis (4-third-octyl- (6-2H-benzotriazol-2-yl) phenol), 2- (2-hydroxyl -3-α-anisyl-5-third-octylphenyl) -2H-benzotriazole, 2- (2-hydroxy-3-third-octyl-5-α-anisylphenyl) -2H -Benzotriazole, 5-fluoro-2- (2-hydroxy-3,5-di-α-anisylphenyl) -2H-benzotriazole, 5-chloro-2- (2-hydroxy-3 , 5-di-α-anisylphenyl) -2H-benzotriazole, 5-chloro-2- (2-hydroxy-3-α-anisyl-5-third-octylphenyl) -2H- Benzotriazole, 2- (3-tert-butyl-2-hydroxy-5- (2-isooctyloxycarbonylethyl) phenyl) -5-chloro-2H-benzotriazole, 5-tris Fluoromethyl-2- (2-hydroxy-3-α-anisyl-5-third octylphenyl) -2H-benzotriazole, 5-trifluoromethyl-2- (2-hydroxy-5 -Third octylphenyl) -2H-benzotriazole, 5-trifluoromethyl-2- (2-hydroxy-3,5-di-third-octylphenyl) -2H-benzotriazole , 3- (5-trifluoromethyl-2H-benzotriazol-2-yl) -5-tert-butyl-4-hydroxyhydrocinnamic acid methyl ester, 5-butylsulfonyl-2- ( 2-hydroxy-3-α-anisyl-5-third octylphenyl) -2H-benzotriazole, 5-trifluoromethyl-2- (2-hydroxy-3-α-anisyl-5 -Third butylphenyl) -2H-benzotriazole, 5-trifluoro Methyl-2- (2-hydroxy-3,5-di-tert-butylphenyl) -2H-benzotriazole, 5-trifluoromethyl-2- (2-hydroxy-3,5-di -α-anisylphenyl) -2H-benzotriazole, 5-butylsulfonyl-2- (2-hydroxy-3,5-di-tert-butylphenyl) -2H-benzotriazole Azole and 5-phenylsulfonyl-2- (2-hydroxy-3,5-di-tert-butylphenyl) -2H-benzotriazole.

參-芳基-s-三嗪UVA可包括美國專利第3,843,371號、第4,619,956號、第4,740,542號、第5,096,489號、第5,106,891號、第5,298,067號、第5,300,414號、第5,354,794號、第5,461,151號、第5,476,937號、第5,489,503號、第5,543,518號、第5,556,973號、第5,597,854號、第5,681,955號、第5,726,309號、第5,736,597號、第5,942,626號、第5,959,008號、第5,998,116號、第6,013,704號、第6,060,543號、第6,242,598號及第6,255,483號,與美國公開申請案2015/329684號及2017/327475號中所揭示之彼等者,例如2,4,6-參(2-羥基-3-甲基-4-己氧基苯基)-1,3,5-三嗪、十二烷二酸、1,12-雙[2-[4-(4,6-二苯基-1,3,5-三嗪-2-基)-3-羥基苯氧基]乙基]酯、4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-辛氧基苯基)-s-三嗪、CYASORB 1164、4,6-雙-(2,4-二甲基苯基)-2-(2,4-二羥基苯基)-s-三嗪、2,4-雙(2,4-二羥基苯基)-6-(4-氯苯基)-s-三嗪、2,4-雙[2-羥基-4-(2-羥基乙氧基)苯基]-6-(4-氯苯基)-s-三嗪、2,4-雙[2-羥基-4-(2-羥基-4-(2-羥基乙氧基)苯基]-6-(2,4-二甲基苯基)-s-三嗪、2,4-雙[2-羥基-4-(2-羥基乙氧基)苯基]-6-(4-溴苯基)-s-三嗪、2,4-雙[2-羥基-4-(2-乙醯氧基乙氧基)苯基]-6-(4-氯苯基)-s-三嗪、2,4-雙(2,4-二羥基苯基)-6-(2,4-二甲基苯基)-s-三嗪、2,4-雙(4-聯苯基)-6-(2-羥基-4-辛氧基羰基亞乙基氧基苯基)-s-三嗪、2-苯基-4-[2-羥基-4-(3-第二丁氧基-2-羥基丙氧基)苯基]-6-[2-羥基-4-(3-第二戊基氧基-2-羥基丙氧基)苯基]-s-三嗪、2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-苯甲基氧基-2-羥基丙氧基)苯基]-s-三嗪、2,4-雙(2-羥基-4-正丁氧基苯基)-6-(2,4-二-正丁氧基苯基)-s-三嗪、2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-壬基氧基*-2-羥基丙氧基)-5-α-茴香基苯基]-s-三嗪(*表示辛氧基、壬氧基及癸氧基之混合物)、亞甲基雙-{2,4-雙(2,4-二甲基苯基)-6-[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-s-三嗪}、以5:4:1比率在3:5'、5:5'及3:3'位置處橋連之亞甲基橋連二聚體、2,4,6-參(2-羥基-4-異辛氧基羰基異亞丙基氧基苯基)-s-三嗪、2,4-雙(2,4-二甲基苯基)-6-(2-羥基-4-己氧基-5-α-茴香基苯基)-s-三嗪、2-(2,4,6-三甲基苯基)-4,6-雙[2-羥基-4-(3-丁氧基-2-羥基丙氧基)苯基]-s-三嗪、2,4,6-參[2-羥基-4-(3-第二丁氧基-2-羥基丙氧基)苯基]-s-三嗪、4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十二烷基氧基-2-羥基丙氧基)-苯基)-s-三嗪與4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-十三基氧基-2-羥基丙氧基)-苯基)-s-三嗪、TINUVIN 400、4,6-雙-(2,4-二甲基苯基)-2-(2-羥基-4-(3-(2-乙基己氧基)-2-羥基丙氧基)-苯基)-s-三嗪及4,6-二苯基-2-(4-己氧基-2-羥基苯基)-s-三嗪之混合物。Sen-aryl-s-triazine UVA may include U.S. Patent Nos. 3,843,371, 4,619,956, 4,740,542, 5,096,489, 5,106,891, 5,298,067, 5,300,414, 5,354,794, 5,461,151, No. 5,476,937, No. 5,489,503, No. 5,543,518, No. 5,556,973, No. 5,597,854, No. 5,681,955, No. 5,726,309, No. 5,736,597, No. 5,942,626, No. 5,959,008, No. 5,998,116, No. 6,013,704, Nos. 6,242,598 and 6,255,483, and those disclosed in US Published Application Nos. 2015/329684 and 2017/327475, such as 2,4,6-ginseng (2-hydroxy-3-methyl- 4-hexyloxyphenyl) -1,3,5-triazine, dodecanedioic acid, 1,12-bis [2- [4- (4,6-diphenyl-1,3,5- Triazin-2-yl) -3-hydroxyphenoxy] ethyl] ester, 4,6-bis- (2,4-dimethylphenyl) -2- (2-hydroxy-4-octyloxy Phenyl) -s-triazine, CYASORB 1164, 4,6-bis- (2,4-dimethylphenyl) -2- (2,4-dihydroxyphenyl) -s-triazine, 2, 4-bis (2,4-dihydroxyphenyl) -6- (4-chlorophenyl) -s-triazine, 2,4-bis [2-hydroxy-4- (2-hydroxyethoxy) benzene Group] -6- (4-chlorophenyl) -s-tri , 2,4-bis [2-hydroxy-4- (2-hydroxy-4- (2-hydroxyethoxy) phenyl] -6- (2,4-dimethylphenyl) -s-triazine , 2,4-bis [2-hydroxy-4- (2-hydroxyethoxy) phenyl] -6- (4-bromophenyl) -s-triazine, 2,4-bis [2-hydroxy- 4- (2-acetoxyethoxy) phenyl] -6- (4-chlorophenyl) -s-triazine, 2,4-bis (2,4-dihydroxyphenyl) -6- (2,4-dimethylphenyl) -s-triazine, 2,4-bis (4-biphenyl) -6- (2-hydroxy-4-octyloxycarbonylethyleneoxyphenyl ) -s-triazine, 2-phenyl-4- [2-hydroxy-4- (3-second butoxy-2-hydroxypropoxy) phenyl] -6- [2-hydroxy-4- (3-Second pentyloxy-2-hydroxypropoxy) phenyl] -s-triazine, 2,4-bis (2,4-dimethylphenyl) -6- [2-hydroxy- 4- (3-Benzyloxy-2-hydroxypropoxy) phenyl) -s-triazine, 2,4-bis (2-hydroxy-4-n-butoxyphenyl) -6- ( 2,4-di-n-butoxyphenyl) -s-triazine, 2,4-bis (2,4-dimethylphenyl) -6- (2-hydroxy-4- (3-nonyl Oxy * -2-hydroxypropoxy) -5-α-anisylphenyl] -s-triazine (* represents a mixture of octoxy, nonoxy and decoxy), methylenebis- { 2,4-bis (2,4-dimethylphenyl) -6- [2-hydroxy-4- (3-butoxy-2-hydroxypropoxy) phenyl] -s-triazine}, 5: 4: 1 Methylene-bridged dimers with a ratio of bridging at 3: 5 ', 5: 5' and 3: 3 'positions, 2,4,6-Shen (2-hydroxy-4-isooctyloxycarbonyl iso Propyleneoxyphenyl) -s-triazine, 2,4-bis (2,4-dimethylphenyl) -6- (2-hydroxy-4-hexyloxy-5-α-anisyl Phenyl) -s-triazine, 2- (2,4,6-trimethylphenyl) -4,6-bis [2-hydroxy-4- (3-butoxy-2-hydroxypropoxy ) Phenyl] -s-triazine, 2,4,6-Shen [2-hydroxy-4- (3-second-butoxy-2-hydroxypropoxy) phenyl] -s-triazine, 4 , 6-bis- (2,4-dimethylphenyl) -2- (2-hydroxy-4- (3-dodecyloxy-2-hydroxypropoxy) -phenyl) -s- Triazine and 4,6-bis- (2,4-dimethylphenyl) -2- (2-hydroxy-4- (3-tridecyloxy-2-hydroxypropoxy) -phenyl) -s-triazine, TINUVIN 400, 4,6-bis- (2,4-dimethylphenyl) -2- (2-hydroxy-4- (3- (2-ethylhexyloxy) -2 -Hydroxypropoxy) -phenyl) -s-triazine and a mixture of 4,6-diphenyl-2- (4-hexyloxy-2-hydroxyphenyl) -s-triazine.

羥基苯甲酸酯UV吸收劑可包括(例如)經取代及未經取代之苯甲酸的酯,例如水楊酸4-第三丁基苯酯、水楊酸苯酯、水楊酸辛基苯酯、二苯甲醯基間苯二酚、雙(4-第三丁基苯甲醯基)間苯二酚、苯甲醯基間苯二酚、3,5-二-第三丁基-4-羥基苯甲酸2,4-二-第三丁基苯酯、3,5-二-第三丁基-4-羥基苯甲酸十六酯、3,5-二-第三丁基-4-羥基苯甲酸十八酯、3,5-二-第三丁基-4-羥基苯甲酸2-甲基-4,6-二-第三丁基苯酯。Paraben UV absorbers may include, for example, esters of substituted and unsubstituted benzoic acid, such as 4-tert-butylphenyl salicylate, phenyl salicylate, octyl phenyl salicylate , Dibenzoyl resorcinol, bis (4- tertiary butyl benzoyl resorcinol) resorcinol, benzoyl resorcinol, 3,5-di- tertiary butyl-4 -Hydroxybenzoic acid 2,4-di-tert-butylphenyl ester, 3,5-di-tert-butyl-4-hydroxybenzoic acid hexadecyl ester, 3,5-di-tert-butyl-4- Octadecyl hydroxybenzoate, 2-methyl-4,6-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate.

2-羥基二苯甲酮UV吸收劑包括(例如)4-羥基、4-甲氧基、4-辛氧基、4-癸氧基、4-十二烷氧基、4-苯甲氧基、4,2',4'-三羥基及2'-羥基-4,4'-二甲氧基衍生物。2-Hydroxybenzophenone UV absorbers include, for example, 4-hydroxy, 4-methoxy, 4-octyloxy, 4-decyloxy, 4-dodecyloxy, 4-benzyloxy , 4,2 ', 4'-trihydroxy and 2'-hydroxy-4,4'-dimethoxy derivatives.

氰基丙烯酸酯UV吸收劑包括(例如)季戊四醇肆(2-氰基-3,3-二苯基丙烯酸酯)、α-氰基-β,β-二苯基丙烯酸乙酯或異辛酯及α-氰基-β-甲基-對甲氧基-肉桂酸甲酯或丁酯。Cyanoacrylate UV absorbers include, for example, pentaerythritol (2-cyano-3,3-diphenyl acrylate), α-cyano-β, β-diphenyl ethyl acrylate or isooctyl ester and α-cyano-β-methyl-p-methoxy-cinnamic acid methyl or butyl ester.

在一些實施例中,UVA可包括5-氯-2-(3-第三丁基-2-羥基-5甲基苯基)-2H-苯并三唑、2-(3,5-雙-α-茴香基-2-羥苯基)-2H-苯并三唑、4,6-二苯基-2-(4-己氧基-2-羥苯基)-s-三嗪、4,6-雙(2,4-二甲基苯基)-2-(2-羥基-4-辛氧基苯基)-s-三嗪、3,5-二-第三丁基-4-羥基苯甲酸十六酯或4-辛氧基-2-羥基二苯甲酮。In some embodiments, UVA may include 5-chloro-2- (3-t-butyl-2-hydroxy-5methylphenyl) -2H-benzotriazole, 2- (3,5-bis- α-anisyl-2-hydroxyphenyl) -2H-benzotriazole, 4,6-diphenyl-2- (4-hexyloxy-2-hydroxyphenyl) -s-triazine, 4, 6-bis (2,4-dimethylphenyl) -2- (2-hydroxy-4-octyloxyphenyl) -s-triazine, 3,5-di-tert-butyl-4-hydroxy Cetyl benzoate or 4-octyloxy-2-hydroxybenzophenone.

許多UVA為市售的,例如TINUVIN 326、TINUVIN 234、TINUVIN 1577、TINUVIN 1600、CYASORB UV 1164、CYASORB THT、CYASORB UV 2908、CHIMASSORB 81、UVINUL 3030、ADK LA-F70、ADK LA-1000、TINUVIN 400等。Many UVAs are commercially available, such as TINUVIN 326, TINUVIN 234, TINUVIN 1577, TINUVIN 1600, CYASORB UV 1164, CYASORB THT, CYASORB UV 2908, CHIMASSORB 81, UVINUL 3030, ADK LA-F70, ADK LA-1000, TINUVIN 400 .

羥胺安定劑可包括(例如) N,N-二苯甲基羥胺、N,N-二乙基羥胺、N,N-二辛基羥胺、N,N-二月桂基羥胺、N,N-二(十二基)羥胺、N,N-二(十四基)羥胺、N,N-二(十六基)羥胺、N,N-二(十八基)羥胺、N-十六基-N-十四基羥胺、N-十六基-N-十七基羥胺、N-十六基-N-十八基羥胺、N-十七基-N-十八基羥胺、N-甲基-N-十八基羥胺,或在某些實施例中,N,N-二(C16 -C18 烷基)羥胺。Hydroxylamine stabilizers can include, for example, N, N-benzylhydroxylamine, N, N-diethylhydroxylamine, N, N-dioctylhydroxylamine, N, N-dilaurylhydroxylamine, N, N-di (Dodecyl) hydroxylamine, N, N-di (tetradecyl) hydroxylamine, N, N-di (hexadecyl) hydroxylamine, N, N-di (octadecyl) hydroxylamine, N-hexadecyl-N -Tetradecyl hydroxylamine, N-hexadecyl-N-heptadecyl hydroxylamine, N-hexadecyl-N-octadecyl hydroxylamine, N-heptadecyl-N-octadecyl hydroxylamine, N-methyl- N-octadecylhydroxylamine, or in certain embodiments, N, N-di (C 16 -C 18 alkyl) hydroxylamine.

在某些實施例中,聚烯烴包含聚乙烯(PE)均聚物、聚乙烯無規或嵌段共聚物、聚丙烯(PP)均聚物、聚丙烯無規或嵌段共聚物、乙烯/丙烯共聚物、聚丙烯與聚乙烯之混合物或不同類型的聚乙烯之混合物。在某些實施例中,聚烯烴為聚丙烯。在一些實施例中,聚乙烯為線性低密度(LLDPE)、低密度(LDPE)、中等密度(MDPE)或高密度(HDPE)的。上述混合物為例如PP/HDPE、PP/LDPE及LDPE/HDPE。亦包括三元混合物,諸如PP/HDPE/LLDPE。可利用或不利用交聯來調配聚烯烴。In certain embodiments, the polyolefin comprises polyethylene (PE) homopolymer, polyethylene random or block copolymer, polypropylene (PP) homopolymer, polypropylene random or block copolymer, ethylene / Propylene copolymer, a mixture of polypropylene and polyethylene or a mixture of different types of polyethylene. In certain embodiments, the polyolefin is polypropylene. In some embodiments, the polyethylene is linear low density (LLDPE), low density (LDPE), medium density (MDPE), or high density (HDPE). The above mixture is, for example, PP / HDPE, PP / LDPE and LDPE / HDPE. It also includes ternary mixtures, such as PP / HDPE / LLDPE. Polyolefins can be formulated with or without crosslinking.

聚烯烴組合物含有(例如)以組合物之重量計≥約10重量百分比(wt%)的聚烯烴,例如≥約15 wt%、≥約20 wt%、≥約25 wt%、≥約30 wt%、≥約35 wt%、≥約40 wt%、≥約45 wt%、≥約50 wt%、≥約55 wt%、≥約60 wt%、≥約65 wt%、≥約70 wt%、≥約75 wt%、≥約80 wt%或≥約85 wt%的聚烯烴。The polyolefin composition contains (for example) ≥ about 10 weight percent (wt%) of polyolefin based on the weight of the composition, for example ≥ about 15 wt%, ≥ about 20 wt%, ≥ about 25 wt%, ≥ about 30 wt %, ≥about 35 wt%, ≥about 40 wt%, ≥about 45 wt%, ≥about 50 wt%, ≥about 55 wt%, ≥about 60 wt%, ≥about 65 wt%, ≥about 70 wt%, ≥ about 75 wt%, ≥ about 80 wt% or ≥ about 85 wt% polyolefin.

聚丙烯可為聚丙烯均聚物、聚丙烯無規共聚物、交替或分段共聚物,或含有一或多個共聚單體之嵌段共聚物,其選自由乙烯、C4 -C30 -α-烯烴、乙烯基環已烷、乙烯基環己烯、C4 -C20 -烷二烯、C5 -C12 -環烷二烯及降冰片烯衍生物組成之群;丙烯及共聚單體之總莫耳量為100%。The polypropylene may be a polypropylene homopolymer, a polypropylene random copolymer, an alternating or segmented copolymer, or a block copolymer containing one or more comonomers, selected from ethylene, C 4 -C 30- The group consisting of α-olefins, vinylcyclohexane, vinylcyclohexene, C 4 -C 20 -alkandiene, C 5 -C 12 -cycloaldiene and norbornene derivatives; propylene and copolymerized monomers The total molar amount of the body is 100%.

聚丙烯共聚物亦涵蓋長鏈分支鏈聚丙烯共聚物。Polypropylene copolymers also cover long-chain branched polypropylene copolymers.

合適的C4 -C30 α-烯烴之實例為1-丁烯、1-戊烯、1-己烯、1-庚烯、1-辛烯、1-壬烯、1-癸烯、1-十一烯、1-十二烯、1-十四烯、1-十六烯、1-十八烯、1-二十烯、4-甲基-1-戊烯、1-二十烯、1-二十二烯、1-二十四烯、1-二十六烯、1-二十八烯及1-三十烯。Examples of suitable C 4 -C 30 α-olefins are 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, 1-nonene, 1-decene, 1- Undecene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene, 1-eicosene, 4-methyl-1-pentene, 1-eicosene, 1-docosene, 1-tetracosene, 1-hexacosene, 1-octacosene, and 1-tricosene.

合適的C4 -C20 烷二烯的實例包括己二烯及辛二烯。合適的C5 -C12 環烷二烯的實例包括環戊二烯、環己二烯及環辛二烯。合適的降冰片烯衍生物之實例包括5-亞乙基-2-降冰片烯(ENB)、二環戊二烯(DCP)及亞甲基-二亞甲基-六氫萘(MEN)。Examples of suitable C 4 -C 20 alkadienes include hexadiene and octadiene. Examples of suitable C 5 -C 12 cycloalkane dienes include cyclopentadiene, cyclohexadiene and cyclooctadiene. Examples of suitable norbornene derivatives include 5-ethylene-2-norbornene (ENB), dicyclopentadiene (DCP) and methylene-dimethylene-hexahydronaphthalene (MEN).

丙烯/乙烯共聚物含有(例如)按重量計約50%至約99.9%,在一些實施例中約80%至約99.9%且在其他實施例中,約90%至約99.9%的丙烯。The propylene / ethylene copolymer contains, for example, about 50% to about 99.9% by weight, in some embodiments about 80% to about 99.9%, and in other embodiments, about 90% to about 99.9% propylene.

其中共聚單體為C9 -C20 α烯烴(諸如1-壬烯、1-癸烯、1-十一烯、1-十二烯、1-十四烯、1-十六烯、1-十八烯或1-二十烯);C9 -C20 烷二烯、C9 -C12 環烷二烯或降冰片烯衍生物(諸如5-亞乙基-2-降冰片烯(ENB)或亞甲基-二亞甲基-六氫萘(MEN)的丙烯共聚物可含有超過約90 mol%、約90 mol%至約99.9 mol%或約90 mol%至約99 mol%的丙烯。The comonomers are C 9 -C 20 alpha olefins (such as 1-nonene, 1-decene, 1-undecene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1- Octadecene or 1-eicosene); C 9 -C 20 alkadiene, C 9 -C 12 cycloalkane diene or norbornene derivatives (such as 5-ethylidene-2-norbornene (ENB ) Or a propylene copolymer of methylene-dimethylene-hexahydronaphthalene (MEN) may contain more than about 90 mol%, about 90 mol% to about 99.9 mol%, or about 90 mol% to about 99 mol% propylene .

其中共聚單體為C4 -C8 α烯烴(諸如1-丁烯、1-戊烯、1-己烯、1-庚烯、1-辛烯或4-甲基-1-戊烯);乙烯基環己烷、乙烯基環己烯、C4 -C8 烷二烯或C5 -C8 環烷二烯的丙烯共聚物可含有超過80 mol%、約80至約99.9 mol%或約80 mol%至約99 mol%的丙烯。Wherein the comonomer is C 4 -C 8 alpha olefin (such as 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene or 4-methyl-1-pentene); The propylene copolymer of vinylcyclohexane, vinylcyclohexene, C 4 -C 8 alkadiene or C 5 -C 8 alkadiene can contain more than 80 mol%, about 80 to about 99.9 mol% or about 80 mol% to about 99 mol% propylene.

聚丙烯之其他實例為丙烯/異丁烯共聚物、丙烯/丁二烯共聚物、丙烯/環烯烴共聚物、丙烯與乙烯及二烯(諸如己二烯、二環戊二烯或亞乙基-降冰片烯)之三聚物;丙烯/1-烯烴共聚物,其中就地產生1-烯烴;及丙烯/一氧化碳共聚物。Other examples of polypropylene are propylene / isobutylene copolymers, propylene / butadiene copolymers, propylene / cycloolefin copolymers, propylene and ethylene, and diene (such as hexadiene, dicyclopentadiene, or ethylene-nitrogen Terpolymer of norbornene); propylene / 1-olefin copolymer, in which 1-olefin is produced in situ; and propylene / carbon monoxide copolymer.

可將乙烯或丙烯之烯丙基或乙烯基封端之寡聚物用作與丙烯之聚合反應中之分支,以製備如以下中所揭示之高熔融強度之分支鏈聚丙烯:美國專利第8,399,725號及美國公開案第2013/0274425號、第2013/0274425號、第2013/0030135號及第2013/0137829號。Allyl or vinyl terminated oligomers of ethylene or propylene can be used as branches in the polymerization reaction with propylene to prepare branched polypropylenes with high melt strength as disclosed below: US Patent No. 8,399,725 No. and US Publication Nos. 2013/0274425, 2013/0274425, 2013/0030135, and 2013/0137829.

聚乙烯之直鏈結構產生聚合物,其呈現低熔融強度及缺乏應變硬化。此可導致需要聚合物可延展性的處理問題。對比而言,呈現高熔融強度之聚丙烯在工業轉換操作(諸如聚丙烯薄片之吹塑、熱成形或發泡)中有用。本發明之聚丙烯基組合物呈現可接受熔融強度、可延展性及應變硬化以產生經擠壓邊框及板壁。The linear structure of polyethylene produces polymers that exhibit low melt strength and lack strain hardening. This can lead to processing problems requiring polymer extensibility. In contrast, polypropylene exhibiting high melt strength is useful in industrial conversion operations such as blow molding, thermoforming, or foaming of polypropylene sheets. The polypropylene-based composition of the present invention exhibits acceptable melt strength, ductility, and strain hardening to produce extruded frames and panel walls.

有利地,聚烯烴包含具有適當高的熔融強度之聚丙烯均聚物或共聚物,其視情況與聚乙烯均聚物或共聚物摻合。摻合物可進一步包含第三聚合物,其適合於促進不同聚烯烴之相容性、部分混溶性或混溶性。此類材料被稱為「界面張力降低劑」或「相容劑」。Advantageously, the polyolefin contains a polypropylene homopolymer or copolymer with a suitably high melt strength, which is optionally blended with a polyethylene homopolymer or copolymer. The blend may further comprise a third polymer, which is suitable for promoting compatibility, partial miscibility or miscibility of different polyolefins. Such materials are called "interfacial tension reducing agents" or "compatibilizers".

合適的相容劑通常為含有兩種或多於兩種不同片段之聚合物,該等片段中之每一者與待摻合之個別組分混溶或相容。經配伍之聚合物摻合物不必充分混溶,亦不必滿足混合之所有熱動力學(例如,產生單相或單一玻璃轉移溫度),而不同聚合物結構之此類摻合物將呈現相比個別組分之經改良所得特性。Suitable compatibilizers are usually polymers containing two or more different segments, each of which is miscible or compatible with the individual components to be blended. Compatible polymer blends do not have to be sufficiently miscible, nor do they need to meet all the thermodynamics of mixing (eg, to produce a single phase or a single glass transition temperature), and such blends of different polymer structures will show a comparison Improved properties of individual components.

用於摻合PP與PE之一類相容劑為分段式「烯烴嵌段共聚物」或「OBC」,其含有丙烯、乙烯及視情況選用之額外α-烯烴序列,諸如Dow Global Technologies所產生及美國公開案第2011/032621號、第2011/060103號、第2010/298515號、第2011/054121號及第2011/015354號中所教示之彼等者。包括商品名為INFUSE之Dow產品及ExxonMobil VISTAMAXX產品。產生具有總體分子量分佈及片段分子量分佈之此等嵌段共聚物,使得Mw/Mn>1.4,每鏈上有兩種或多於兩種乙烯及α-烯烴嵌段及低分子量(Mw < 200,000 g/mol)。此等交替嵌段共聚物的特徵在於可結晶的剛性『硬嵌段』片段及非晶形彈性『軟嵌段』含量。硬嵌段含量在此等OBC中的範圍為12至84 wt%,且總1-辛烯含量(亦即賦予長鏈分支)的範圍為3至14 wt%。OBC可使PP與HDPE之摻合物相容,其中相比HDPE及PP之未經配伍摻合物,可達成斷裂伸長率及抗張強度的增加。One type of compatibilizer for blending PP and PE is a segmented "olefin block copolymer" or "OBC", which contains propylene, ethylene and optionally additional alpha-olefin sequences, such as those produced by Dow Global Technologies And those taught in US Publication Nos. 2011/032621, 2011/060103, 2010/298515, 2011/054121, and 2011/015354. Including Dow products under the trade name INFUSE and ExxonMobil VISTAMAXX products. These block copolymers with overall molecular weight distribution and fragment molecular weight distribution are produced so that Mw / Mn> 1.4, there are two or more ethylene and α-olefin blocks and low molecular weights (Mw <200,000 g per chain) / mol). These alternating block copolymers are characterized by crystallizable rigid "hard block" segments and amorphous elastic "soft block" content. The hard block content in these OBCs ranges from 12 to 84 wt%, and the total 1-octene content (ie, endowed with long chain branches) ranges from 3 to 14 wt%. OBC can make the blend of PP and HDPE compatible. Compared with the uncompatibilized blend of HDPE and PP, the increase in elongation at break and tensile strength can be achieved.

聚丙烯均聚物或共聚物或與視情況經配伍的聚乙烯之摻合物可經化學交聯以自聚丙烯主鏈中引出長鏈分支(LCB),從而相比大體上市售導致較高熔融強度及可延展性及較低溶體流動。Polypropylene homopolymers or copolymers or blends with optionally compatible polyethylene can be chemically cross-linked to draw long-chain branches (LCB) from the polypropylene main chain, resulting in a higher price compared to the general market Melt strength and ductility and lower solution flow.

聚丙烯均聚物或共聚物與另一聚丙烯或與聚乙烯均聚物或共聚物及/或與相容材料的化學交聯係有利的。此類交聯過程可賦予有助於本發明之擠塑製程之聚烯烴摻合物熔融強度、熔體可延展性、機械及抗張強度的重要增加。至聚丙烯上之此類交聯製程可在聚丙烯主鏈上產生長鏈分支(LCB)並形成導致較高聚合物熔融強度之增多量的聚合物鏈纏結。The chemical cross-linking of the polypropylene homopolymer or copolymer with another polypropylene or with polyethylene homopolymer or copolymer and / or with compatible materials is advantageous. Such cross-linking processes can impart important increases in melt strength, melt ductility, mechanical and tensile strength to polyolefin blends that contribute to the extrusion process of the present invention. Such crosslinking processes onto polypropylene can produce long chain branches (LCB) on the polypropylene main chain and form increased amounts of polymer chain entanglements that result in higher polymer melt strength.

可利用諸如有機過氧化物之試劑或藉由用輻射源(諸如紫外光、電子束或γ照射)處理而實現交聯。可在經減少氧或零氧環境中實現輻射。舉例而言,具有高熔融強度及溶體可延展性之聚丙烯可藉由在擠壓機中摻合直鏈聚丙烯與分支鏈聚丙烯(b-PP)而獲得。藉由使過氧化物與未經改質之聚丙烯及能夠移植至未經改質之聚丙烯視上的情況選用之雙官能不飽和單體反應以產生長鏈分支來製備b-PP,US2015175789。在另一實例中,美國專利第5,508,318號、第5,731,362號、第5,591,785號、第5,554,668號及第4,916,198號揭示混配適合於擠塑之經輻射及未經輻射的烯烴聚合物材料的摻合物。Crosslinking can be achieved using reagents such as organic peroxides or by treatment with radiation sources such as ultraviolet light, electron beam or gamma irradiation. Radiation can be achieved in a reduced or zero oxygen environment. For example, polypropylene with high melt strength and solution ductility can be obtained by blending linear polypropylene and branched polypropylene (b-PP) in an extruder. B-PP is prepared by reacting peroxide with unmodified polypropylene and bifunctional unsaturated monomers that can be transplanted to unmodified polypropylene depending on the circumstances to produce long-chain branches, US2015175789 . In another example, US Patent Nos. 5,508,318, 5,731,362, 5,591,785, 5,554,668, and 4,916,198 disclose the blending of irradiated and non-irradiated olefin polymer materials suitable for extrusion .

與下游擠塑或聚合物化學改質以形成交聯或長鏈分支以改良熔融強度相比,可在聚合物製造期間的上游進行在聚烯烴上形成長鏈分支。在一實例中,可在聚合單元中經由暴露於低含量的氧(被稱作『氧裁剪』)來對聚乙烯改質,導致形成長鏈分支及熔融強度增強,如美國公開案第2012/100357中所教示。In contrast to downstream extrusion or chemical modification of polymers to form cross-links or long-chain branches to improve melt strength, the formation of long-chain branches on polyolefins can be performed upstream of polymer manufacturing. In one example, polyethylene can be modified in the polymerization unit by exposure to low levels of oxygen (referred to as "oxygen pruning"), resulting in the formation of long chain branches and enhanced melt strength, such as U.S. Pub. Teaching in 100357.

聚烯烴可含有在將聚合物熔融轉換為成形物品後提昇高含量之結晶度的添加劑。此類添加劑被稱為「成核劑」。The polyolefin may contain additives that promote high levels of crystallinity after melt converting the polymer into shaped articles. Such additives are called "nucleating agents".

聚丙烯之結晶度係影響諸如模數、屈服應力、強度等的特性之重要參數。成核劑之使用在本發明之範疇內,成核劑之使用影響結晶度之有利形成,其在擠塑處理期間及最終用途物品之機械特性之改良期間改良聚合物熔體強度。合適的成核劑為例如苯甲酸鈉、2,2'-亞甲基-雙(4,6-二-第三丁基苯基)磷酸酯、甘油酸鋅、1,2-二甲酸環己烷之鈣鹽、芳族三醯胺化合物、順-內-雙環[2.2.1]庚烷-2,3-二甲酸二鈉鹽、羥基-雙[4-(第三丁基)苯甲酸]鋁及山梨糖醇,諸如1,3:2,4-雙(3,4-二甲基苯亞甲基)山梨醇、1,3:2,4-雙(4-甲基苯亞甲基)山梨醇或1,3:2,4-雙(3,4-二甲基苯亞甲基)山梨醇,如美國專利第7,423,088號、第7,790,793號及第8,183,312號及美國公開案第2012/0190797號中所教示。The crystallinity of polypropylene is an important parameter that affects characteristics such as modulus, yield stress, and strength. The use of nucleating agents is within the scope of the present invention. The use of nucleating agents affects the favorable formation of crystallinity, which improves the polymer melt strength during the extrusion process and during the improvement of the mechanical properties of the end-use articles. Suitable nucleating agents are, for example, sodium benzoate, 2,2'-methylene-bis (4,6-di-tert-butylphenyl) phosphate, zinc glycerate, 1,2-dicarboxylic acid cyclohexane Calcium salt, aromatic triamide compound, cis-endo-bicyclo [2.2.1] heptane-2,3-dicarboxylic acid disodium salt, hydroxy-bis [4- (third butyl) benzoic acid] aluminum And sorbitol, such as 1,3: 2,4-bis (3,4-dimethylbenzylidene) sorbitol, 1,3: 2,4-bis (4-methylbenzylidene) Sorbitol or 1,3: 2,4-bis (3,4-dimethylbenzylidene) sorbitol, such as U.S. Patent Nos. 7,423,088, 7,790,793, and 8,183,312 and U.S. Publication No. 2012/0190797 As taught in the number.

基於聚烯烴之重量,成核劑可例如按重量計以每百萬10份(ppm)至約10,000 ppm、約12 ppm至約1,000 ppm、約12 ppm至約500 ppm或約12 ppm至約300 ppm或約400 ppm存在。Based on the weight of the polyolefin, the nucleating agent may be, for example, 10 parts per million (ppm) to about 10,000 ppm, about 12 ppm to about 1,000 ppm, about 12 ppm to about 500 ppm, or about 12 ppm to about 300 by weight ppm or about 400 ppm exists.

聚烯烴有利地含有無機(礦物)填充劑來平衡熔融強度及可伸展性或可拉性以允許邊框及板壁的擠塑生產。下文更詳細地描述填充劑。Polyolefins advantageously contain inorganic (mineral) fillers to balance melt strength and stretchability or stretchability to allow extrusion production of frames and panel walls. The filler is described in more detail below.

包含視情況與聚乙烯均聚物或共聚物摻合之聚丙烯均聚物或共聚物之聚烯烴可呈現較高熔融強度,其中摻合物可進一步含有相容劑。聚烯烴之熔融強度在210℃下可為至少約4 centiNewtons (cN)。舉例而言,聚烯烴之熔融強度在210℃下為約4、約5、約6、約7、約8、約9、約10、約11、約12、約13、約14、約15、約16、約17、約18、約19、約20、約21、約22、約23、約24或約25 centiNewtons。舉例而言,熔融強度在210℃下為≥約5、≥約7、≥約9、≥約11、≥約13、≥約15、≥約17、≥約19、≥約21或≥約23 centiNewtons。Polyolefins containing polypropylene homopolymers or copolymers optionally blended with polyethylene homopolymers or copolymers can exhibit higher melt strengths, where the blend may further contain a compatibilizer. The melt strength of the polyolefin can be at least about 4 centiNewtons (cN) at 210 ° C. For example, the melt strength of polyolefins at 210 ° C is about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 11, about 12, about 13, about 14, about 15, About 16, about 17, about 18, about 19, about 20, about 21, about 22, about 23, about 24, or about 25 centiNewtons. For example, the melt strength at 210 ° C is ≥about 5, ≥about 7, ≥about 9, ≥about 11, ≥about 13, ≥about 15, ≥about 17, ≥about 19, ≥about 21, or ≥about 23 centiNewtons.

可藉由以下方法製備聚烯烴: a) 自由基聚合(一般在高壓下及在高溫下)或 b) 使用一般含有一個或超過一個週期表第IVb、Vb、VIb或VIII族之一種金屬的催化劑的催化性聚合。此等金屬通常具有一個或超過一個配位體,通常為氧化物、鹵化物、醇化物、酯、醚、胺、烷基、烯基及/或芳基,其可經π-配位或σ-配位。此等金屬錯合物可呈游離形式或固定於基質上,通常固定於活化氯化鎂、氯化鈦(III)、氧化鋁或氧化矽上。此等催化劑可溶於或不溶於聚合介質中。在聚合中可單獨使用催化劑或可使用其他活化劑,該等活化劑通常為金屬烷、金屬氫化物、金屬烷基鹵化物、金屬烷基氧化物或金屬烷基氧烷(metal alkyloxane),該等金屬為週期表之第Ia、IIa及/或IIIa族元素。活化劑可便利地以其他酯、醚、胺或矽烷基醚基團改質。此等催化劑系統通常稱為飛利浦(Phillips)、印第安納標準油(Standard Oil Indiana)、齊格勒(Ziegler) (-Natta)、TNZ (DuPont)、茂金屬或單一位點催化劑(SSC)。Polyolefins can be prepared by the following methods: a) free radical polymerization (generally under high pressure and high temperature) or b) using a catalyst that generally contains one or more metals of Group IVb, Vb, VIb or VIII of the periodic table Catalytic polymerization. These metals usually have one or more ligands, usually oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and / or aryls, which can be coordinated by π- or σ -Coordination. These metal complexes can be in free form or fixed on the substrate, usually fixed on activated magnesium chloride, titanium (III) chloride, aluminum oxide or silicon oxide. These catalysts are soluble or insoluble in the polymerization medium. In the polymerization, a catalyst may be used alone or other activators may be used. Such activators are usually metal alkanes, metal hydrides, metal alkyl halides, metal alkyl oxides, or metal alkyloxanes. Such metals are elements of Groups Ia, IIa and / or IIIa of the periodic table. The activator can be conveniently modified with other ester, ether, amine or silane ether groups. These catalyst systems are commonly referred to as Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single site catalysts (SSC).

藉由如文獻中所描述之製程產生聚丙烯,該文獻包括Kissin, Y. V. (2008), Alkene Polymerization Reactions with Transition Metal Catalysts, Elsevier, pp. 207-. ISBN 978-0-444-53215-2;Hoff, Ray and Mathers, Robert T. (2010), Handbook of Transition Metal Polymerization Catalysts, John Wiley & Sons, pp. 158- ISBN 978-0-470-13798-7;Moore, E. P. (1996) Polypropylene Handbook, Polymerization, Characterization, Properties, Processing, Applications, Hanser Publishers: New York, ISBN 1569902089;Benedikt, G. M.及Goodall, B. L. (編輯) (1998) Metallocene Catalyzed Polymers, ChemTech Publishing: Toronto, ISBN 978-1-884207-59-4;Malpass, D.B., Introduction to Industrial Polyethylene, Properties, Catalysts, Processes, Wiley Publ., (2010);及Malpass, D.B., Introduction to Industrial Polypropylene, Properties, Catalysts, Processes, Wiley Publ., (2012)。Polypropylene is produced by a process as described in the literature, which includes Kissin, YV (2008), Alkene Polymerization Reactions with Transition Metal Catalysts, Elsevier, pp. 207-. ISBN 978-0-444-53215-2; Hoff , Ray and Mathers, Robert T. (2010), Handbook of Transition Metal Polymerization Catalysts, John Wiley & Sons, pp. 158- ISBN 978-0-470-13798-7; Moore, EP (1996) Polypropylene Handbook, Polymerization, Characterization, Properties, Processing, Applications, Hanser Publishers: New York, ISBN 1569902089; Benedikt, GM and Goodall, BL (Editor) (1998) Metallocene Catalyzed Polymers, ChemTech Publishing: Toronto, ISBN 978-1-884207-59-4; Malpass, DB, Introduction to Industrial Polyethylene, Properties, Catalysts, Processes, Wiley Publ., (2010); and Malpass, DB, Introduction to Industrial Polypropylene, Properties, Catalysts, Processes, Wiley Publ., (2012).

在一些實施例中,聚烯烴包括原生聚烯烴、聚烯烴循環物或其混合物。聚烯烴循環物可自國內、商業或工業廢料或自有用材料集合獲得。循環物可來源於封裝材料,例如薄膜、袋、瓶及其他容器或發泡體。亦有可能使先前已由於使用、儲存或處理破壞的聚烯烴安定。此等材料例如源自可用材料集合或返回義務,例如源自汽車工業、電/電子工業、建築、農業或紡織工業。In some embodiments, the polyolefin includes virgin polyolefin, polyolefin recycle, or mixtures thereof. Polyolefin recycle can be obtained from domestic, commercial or industrial waste or from a collection of useful materials. Recyclables can be derived from packaging materials such as films, bags, bottles and other containers or foams. It is also possible to stabilize polyolefins that have previously been destroyed by use, storage or handling. Such materials originate, for example, from collection of available materials or return obligations, such as from the automotive industry, electrical / electronic industry, construction, agriculture, or textile industry.

本發明苯并呋喃酮及有機磷安定劑至聚烯烴中之併入例如在模製之前或之後藉由已知方法來進行或亦藉由將經溶解或分散添加劑混合物施加至聚烯烴並伴隨或不伴隨溶劑之後續蒸發來進行。本發明苯并呋喃酮及有機磷安定劑亦可呈母料形式添加至聚烯烴,該母料含有濃度基於母料之總重量為例如約2 wt%至約40 wt%之添加劑。在母料形式下,母料之聚合物不必與聚烯烴相同。可使用已知混合機器(例如混合器、捏合機或擠壓機)進行模製。The incorporation of the benzofuranone and organophosphorus stabilizers of the invention into the polyolefin is carried out, for example, by known methods before or after molding or also by applying a dissolved or dispersed additive mixture to the polyolefin with or It is not accompanied by subsequent evaporation of the solvent. The benzofuranone and organophosphorus stabilizers of the present invention may also be added to the polyolefin in the form of a masterbatch containing additives having a concentration of, for example, about 2 wt% to about 40 wt% based on the total weight of the masterbatch. In the form of a masterbatch, the polymer of the masterbatch does not have to be the same as the polyolefin. Molding can be carried out using known mixing machines, such as mixers, kneaders or extruders.

本發明苯并呋喃酮及有機磷安定劑可經預混合或個別地添加。本發明苯并呋喃酮及有機磷安定劑亦可在聚合之前或期間或在交聯之前進行添加。本發明苯并呋喃酮及有機磷安定劑可呈純淨形式併入至聚烯烴中或包封於蠟、油或聚合物中。The benzofuranone and the organophosphorus stabilizer can be pre-mixed or added separately. The benzofuranone and organophosphorus stabilizers of the present invention can also be added before or during polymerization or before crosslinking. The benzofuranone and organophosphorus stabilizer in the present invention can be incorporated into polyolefin in pure form or encapsulated in wax, oil or polymer.

本發明苯并呋喃酮及有機磷安定劑亦可經噴灑至聚烯烴上。其能夠稀釋其他添加劑或其熔體,使得其亦可連同此等添加劑一起噴灑至聚烯烴上。The benzofuranone and organophosphorus stabilizers of the present invention can also be sprayed onto polyolefins. It can dilute other additives or their melts, so that it can also be sprayed onto polyolefins along with these additives.

在某些實施例中,本發明苯并呋喃酮添加劑及有機磷安定劑係藉由在擠壓機中熔融摻合而併入至聚烯烴中。本發明苯并呋喃酮及有機磷安定劑可一起或分開添加。In certain embodiments, the benzofuranone additives and organophosphorus stabilizers of the present invention are incorporated into polyolefins by melt blending in an extruder. The benzofuranone and the organophosphorus stabilizer can be added together or separately.

在一些實施例中,製備聚烯烴組合物之製程包括量測按重量計之原材料,接著乾式摻合原始成分。以恆定進料速率將混合物進料至螺桿擠壓機以將材料擠壓成所需形式,之後水冷卻及乾燥。In some embodiments, the process of preparing the polyolefin composition includes measuring the raw materials by weight and then dry blending the original ingredients. The mixture is fed to the screw extruder at a constant feed rate to extrude the material into the desired form, after which the water is cooled and dried.

本發明之主題亦為物品,例如成形物品,其包含本發明之聚烯烴組合物。成形物品之實例包括且不限於列表I-1)至IIV-8)中所列的彼等者。 I-1) 浮動裝置、船舶應用、浮筒、浮標、用於甲板或碼頭、船、小輕艇、槳及海灘強化物之塑膠或複合板材。 I-2) 汽車應用、內部應用、外部應用,例如,保險桿、儀錶板、電池、背部及前部襯裡、罩下的模製部件、帽狀機箱、軀幹襯裡、內部襯裡、氣囊覆蓋物、用於配件(燈)之電子模製品、用於儀錶板之邊框、前燈玻璃、儀器面板、外部襯裡、椅墊、車燈、前照燈、停車燈、背燈、擋板燈、內部及外部邊條;門面板;氣體貯槽;鑲嵌玻璃之前側;後窗;座椅襯底、外部面板、電線絕緣體、用於密封之側面擠壓物、包層、支柱覆蓋物、底盤部件、排氣系統、燃料過濾器/填充器、燃料泵、燃料貯槽、主體模型、可轉換之頂部、外部鏡、外部邊條、扣件/固定件、前端模組、玻璃、鉸鏈、鎖定系統、行李/頂架、按壓/衝壓部件、密封件、側部衝擊保護件、消音器/絕緣體及天窗。 I-3) 道路交通裝置,例如路標、用於道路標記的柱子、汽車配件、警告三角、醫療狀況、頭盔、輪胎。 I-4) 用於飛機、鐵路、電動機車(汽車、摩托車、卡車)之裝置,包括陳設品。 I-5) 用於太空應用(例如火箭及衛星)之裝置,例如重返大氣層遮罩。 I-6) 用於架構與設計、採礦應用、靜聲系統、街道庇護區及避難所之裝置。 II-1) 一般電氣設備、箱及覆蓋物及電/電子裝置(個人電腦、電話、攜帶型電話、印表機、電視機、音訊及視訊裝置)、花盆、衛星TV碗及面板裝置。 II-2) 用於諸如鋼或紡織品之其他材料的護套。 II-3) 用於電子工業之裝置,例如用於插塞(尤其電腦插塞)之絕緣體、用於電及電子部件之外殼、印刷板及用於電子資料儲存裝置(諸如晶片、借記卡或信用卡)之材料。 II-4) 電氣設備,例如洗衣機、滾筒、烘箱(微波烘箱)、洗碗機、攪拌機及熨斗。 II-5) 用於燈(例如街道燈、燈罩)之覆蓋物。 II-6) 在電線及電纜(半導體、絕緣體及電纜護套)中之應用。 II-7) 用於電容器、冰箱、加熱裝置、空氣調節器、電子器件之封裝、半導體、咖啡機及真空吸塵器之箔。 III-1) 諸如嵌齒輪(齒輪)、滑桿配件、隔片、螺桿、螺釘、柄及旋鈕之技術物品。 III-2) 轉子葉片、通風筒及風車輪葉、太陽能裝置、泳池、泳池覆蓋物、泳池襯裡、水池襯裡、隔室、衣櫥、間壁、槽板、摺疊牆、屋頂、擋閘(例如捲閘)、配件,管道、套管及輸送機帶之間的接點。 III-3) 衛生物品,例如淋浴隔間、面盆支座、覆蓋物及水槽。 III-4) 衛生物品,例如尿布(嬰兒、成人失禁)、女性衛生物品、浴簾、刷子、墊子、浴盆、抽水馬桶、牙刷及便盆。 III-5) 用於水、廢水及化學品之管道(交聯或不交聯)、用於電線及電纜保護之管道、用於氣體、油及生活污水之管道、槽管、旁通管及排水系統。 III-6) 任何幾何結構(窗玻璃板)及板壁之邊框。 III-7) 玻璃替代物,尤其經擠出或共擠出之板,其為用於建築物(單體、雙或多壁)、飛機、學校之鑲嵌玻璃,經擠出之薄片,其為用於架構鑲嵌玻璃、火車、運輸、清潔物品及溫室之窗口膜。 III-8) 板(牆壁、砧板)、擠壓塗層(感光紙、四角包及管道塗層)、倉、木材替代物、塑膠板材、木材複合物、牆壁、表面、傢俱、裝飾箔、覆地板物(內部及外部應用)、地板、活動鋪板及瓷磚。 III-9) 入口及出口歧管。 III-10) 水泥、混凝土、複合物應用及覆蓋物、板壁及包層、扶手、欄桿、廚房操作台、屋面、屋面片材、瓷磚及防水布。 IV-1)板(牆壁及砧板)、塔盤、人造草、合成物(諸如Astro-Turf®)、用於運動場環(體育)之人造覆蓋物、用於運動場環(體育)之人造地面及膠帶。 IV-2) 連續編織品及短纖維、纖維(地毯/衛生物品/土工布/絲狀纖維;過濾器;擦拭物/簾幕(遮光物)/醫藥應用)、膨體纖維(諸如長袍/防護服之應用)、網、繩索、電纜、細繩、簾布、絲線、座椅安全帶、衣服、內衣、手套;靴子;橡膠靴、內衣、服裝、游泳衣、運動衣、傘(太陽傘、遮陽傘)、降落傘、滑翔傘、帆、「氣球綢」、露營物品、帳篷、氣墊床、太陽床、散裝袋及袋子。不織布,諸如醫療織品及相關服裝、工業服裝、戶外織品、家用式陳設及建築用織品。 IV-3) 薄膜、絕緣體、用於屋頂之覆蓋物及密封件、隧道、倉庫、水池、倉庫、牆體屋面薄膜、土工薄膜、泳池、窗簾(遮光物)/日光遮罩、遮篷、罩蓋、牆紙、食品包裝及包裹(彈性及實心)、醫療包裝(彈性及實心)、氣囊/安全帶、扶手及頭枕、地毯、中心控制台、儀錶板、座艙、門、頂置控制台模組、門邊條、標題字機、內部光照、內鏡、包裹架、後部行李箱蓋、座椅、轉向柱、方向盤、紡織品及軀幹邊條。 V) 薄膜(包裝、轉儲、層壓、農業及園藝(溫室覆蓋、隧道、低步行隧道、大棚、覆蓋物、青貯料、倉袋、筒形伸展物、薰蒸、氣泡、keder、solawrap、熱、包層、保育器、薄膜導管)、溫室、覆蓋物、隧道、青貯料)、包層、泳池、垃圾袋、牆紙、拉伸膜、酒椰葉纖維、淡化薄膜、電池組及接頭。膜可具有單層結構或多層結構,例如三層、五層或七層。實例包括膜結構,其由A-B-A、A-B-C、A-B-C-B-A、A-B-C-B-D、A-B-C-D-C-B-A、A-A-B-C-B-A-A表示,其中A、B、C及D表示不同聚合物或增黏劑。層亦可經佈置以提供具有偶數個層(亦即,兩層、四層或六層)之膜,諸如A-A-B-A、A-A-B-B、A-A-B-A-A、A-B-B-A-A、A-A-B-C-B、A-A-B-C-A-A及類似者。 VI-1) 食品包裝及包裹(彈性及實心)、瓶子。 VI-2) 儲存系統,諸如盒(板條箱)、行李箱、櫃子、家用盒、棧板、架子、播放軌、螺釘盒、包裝及罐子。 VI-3) 濾筒、注射器、醫療應用、用於任何運輸之容器、廢物筐及廢物箱、廢物袋、箱子、垃圾箱、塑料垃圾袋、有輪箱、一般容器、用於水/經使用之水/化學物質/氣體/油/汽油/柴油之槽;槽襯裡、盒、板條箱、電池外殼、凹槽、諸如活塞之醫療裝置、眼科應用、診斷裝置及藥劑氣泡包裝。 VII-1) 擠壓塗層(相紙、四角包、管道塗層)、任何種類之家庭物品(例如電氣設備、熱水瓶/衣服掛鉤)、諸如插塞之扣接系統、電線及電纜夾、拉鏈、封閉件、鎖及搭扣式封閉件。 VII-2) 支撐裝置、用於休閒時間之物品,諸如運動及健身器材、體操墊、滑雪靴、直排輪滑鞋、滑雪板、大腳、運動表面(例如網球場);螺旋蓋、瓶蓋及瓶塞以及罐頭。 VII-3) 一般傢俱、發泡物品(墊子、緩衝器)、發泡體、海綿、洗碟布、墊子、花園椅、體育場座椅、台子、長椅、玩具、建材(板/圖/球)、劇場、幻燈片及玩具汽車。 VII-4) 用於光學及磁性資料存儲之材料。 VII-5) 廚房器皿(食用、飲用、烹飪、儲存)。 VII-6) 用於CD、卡匣及視訊帶之盒;DVD電子物品、任何種類的辦公室供給(原子筆、郵票及墨墊、滑鼠、架子、播放軌)、任何體積及內含物(飲料、清潔劑、包括香料之化妝品)之瓶及膠帶。 VII-7) 鞋類(鞋/鞋底)、鞋墊、鞋套、黏著劑、結構黏著劑、食品盒(水果、蔬菜、肉、魚)、合成紙、用於瓶子之標籤、長椅、人造關節(人)、印刷板(柔性凸版)、印刷電路板及顯示器技術。 VII-8)填充聚合物(滑石、白堊、瓷土(高嶺土)、矽灰石、顏料、碳黑、TiO2 、雲母、奈米複合物、白雲石、矽酸鹽、玻璃、石棉)之裝置。The subject of the invention is also articles, for example shaped articles, which comprise the polyolefin composition of the invention. Examples of shaped articles include and are not limited to those listed in Lists I-1) to IIV-8). I-1) Floating devices, marine applications, buoys, buoys, plastic or composite sheets for decks or docks, boats, dinghys, paddles and beach reinforcements. I-2) Automotive applications, interior applications, exterior applications, such as bumpers, dashboards, batteries, back and front linings, molded parts under the hood, hat-like chassis, torso lining, interior lining, airbag covers, Electronic molded products for accessories (lights), frame for instrument panel, headlight glass, instrument panel, external lining, seat cushion, car light, headlight, parking light, backlight, bezel light, interior and Exterior edge strips; door panels; gas tanks; glass-inlaid front sides; rear windows; seat backings, exterior panels, wire insulators, side extrudates for sealing, cladding, pillar covers, chassis components, exhaust Systems, fuel filters / fillers, fuel pumps, fuel tanks, body models, convertible tops, external mirrors, external side strips, fasteners / fixtures, front end modules, glass, hinges, locking systems, luggage / top Frames, pressing / stamping parts, seals, side impact protectors, silencers / insulators and skylights. I-3) Road traffic devices, such as road signs, pillars used for road marking, auto parts, warning triangles, medical conditions, helmets, tires. I-4) Devices used in airplanes, railways, and electric locomotives (cars, motorcycles, trucks), including furnishings. I-5) Devices used in space applications (such as rockets and satellites), such as re-entry masks. I-6) Devices used in architecture and design, mining applications, silent systems, street shelters and shelters. II-1) General electrical equipment, boxes and coverings, and electrical / electronic devices (personal computers, telephones, portable phones, printers, televisions, audio and video devices), flower pots, satellite TV bowls and panel devices. II-2) Sheath for other materials such as steel or textiles. II-3) Devices for the electronics industry, such as insulators for plugs (especially computer plugs), housings for electrical and electronic components, printed boards, and electronic data storage devices (such as chips, debit cards) Or credit card). II-4) Electrical equipment such as washing machines, drums, ovens (microwave ovens), dishwashers, blenders and irons. II-5) Covers for lamps (eg street lamps, lampshades). II-6) Application in wires and cables (semiconductors, insulators and cable jackets). II-7) Foil for capacitors, refrigerators, heating devices, air conditioners, packaging of electronic devices, semiconductors, coffee machines and vacuum cleaners. III-1) Technical items such as cogs (gears), slide bar accessories, spacers, screws, screws, handles and knobs. III-2) Rotor blades, ventilators and wind turbine blades, solar installations, swimming pools, swimming pool covers, swimming pool linings, pool linings, compartments, wardrobes, partitions, grooved panels, folding walls, roofs, barriers (e.g. Roll gates), accessories, junctions between pipes, casings and conveyor belts. III-3) Hygiene items such as shower cubicles, basin supports, coverings and sinks. III-4) Hygiene items such as diapers (infants, adult incontinence), feminine hygiene items, shower curtains, brushes, cushions, bathtubs, toilet bowls, toothbrushes and potties. III-5) Pipes for water, waste water and chemicals (cross-linked or not), pipes for wire and cable protection, pipes for gas, oil and domestic sewage, tank pipes, bypass pipes and Drainage system. III-6) Any geometric structure (window glass panel) and the border of the panel wall. III-7) Glass substitutes, especially extruded or coextruded panels, which are mosaic glass used in buildings (single, double or multi-walled), airplanes, schools, extruded sheets, which are Used to construct window films for mosaic glass, trains, transportation, cleaning items and greenhouses. III-8) Boards (walls, cutting boards), extrusion coatings (photosensitive paper, square packs and pipe coatings), silos, wood substitutes, plastic sheets, wood composites, walls, surfaces, furniture, decorative foils, coatings Floor coverings (internal and external applications), flooring, mobile decking and ceramic tiles. III-9) Inlet and outlet manifolds. III-10) Cement, concrete, composite applications and coverings, siding and cladding, handrails, railings, kitchen operating tables, roofing, roofing sheets, ceramic tiles and tarps. IV-1) Boards (walls and cutting boards), trays, artificial grass, composites (such as Astro-Turf®), artificial coverings for sports ring (sports), artificial floors for sports ring (sports) and tape. IV-2) Continuous woven goods and short fibers, fibers (carpets / hygienic articles / geotextiles / filamentous fibers; filters; wipers / curtains (shade) / medical applications), bulked fibers (such as robes / protection Clothing applications), nets, ropes, cables, twines, curtains, silk threads, seat belts, clothing, underwear, gloves; boots; rubber boots, underwear, clothing, swimwear, sportswear, umbrellas (sun umbrellas, sunshades Umbrella), parachute, paraglider, sail, "balloon silk", camping items, tent, air bed, sun bed, bulk bags and bags. Non-woven fabrics, such as medical fabrics and related clothing, industrial clothing, outdoor fabrics, household furnishings and construction fabrics. IV-3) Films, insulators, coverings and seals for roofs, tunnels, warehouses, pools, warehouses, roofing films for walls, geomembrane, swimming pools, curtains (shades) / sunshades, awnings, hoods Covers, wallpapers, food packaging and wrapping (elastic and solid), medical packaging (elastic and solid), airbags / belts, armrests and headrests, carpets, center consoles, instrument panels, cockpits, doors, overhead console molds Groups, door edge strips, title markers, interior lighting, interior mirrors, parcel racks, rear trunk lids, seats, steering columns, steering wheels, textiles, and torso edge strips. V) Films (packaging, dumping, lamination, agriculture and horticulture (greenhouse covering, tunnels, low walk tunnels, greenhouses, coverings, silage, silo bags, tubular stretches, fumigation, air bubbles, keder, solawrap, Heat, cladding, incubators, film conduits), greenhouses, coverings, tunnels, silages), cladding, swimming pools, garbage bags, wallpaper, stretch films, raffia fiber, desalination films, battery packs and connectors. The film may have a single-layer structure or a multi-layer structure, for example, three layers, five layers, or seven layers. Examples include membrane structures, which are represented by ABA, ABC, ABCBA, ABCBD, ABCDCBA, AABCBAA, where A, B, C, and D represent different polymers or tackifiers. The layers can also be arranged to provide films with an even number of layers (ie, two layers, four layers, or six layers), such as AABA, AABB, AABAA, ABBAA, AABCB, AABCAA, and the like. VI-1) Food packaging and wrapping (elastic and solid), bottles. VI-2) Storage systems, such as boxes (crate), luggage, cabinets, household boxes, pallets, shelves, play rails, screw boxes, packaging and jars. VI-3) Filter cartridges, syringes, medical applications, containers for any transportation, waste baskets and waste bins, waste bags, boxes, garbage bins, plastic garbage bags, wheeled boxes, general containers, used for water / used Water / chemical / gas / oil / gasoline / diesel tanks; tank liners, boxes, crates, battery cases, grooves, medical devices such as pistons, ophthalmic applications, diagnostic devices, and medicinal bubble packaging. VII-1) Extrusion coating (photo paper, square bag, pipe coating), any kind of household items (such as electrical equipment, thermos / clothing hooks), fastening systems such as plugs, wire and cable clips, zipper , Closures, locks and snap closures. VII-2) Support devices, items for leisure time, such as sports and fitness equipment, gymnastic mats, ski boots, inline skates, snowboards, big feet, sports surfaces (such as tennis courts); screw caps, bottle caps and Corks and cans. VII-3) General furniture, foamed items (cushions, cushions), foams, sponges, dish cloths, cushions, garden chairs, stadium seats, tables, benches, toys, building materials (boards / pictures / balls) ), Theater, slides and toy cars. VII-4) Materials used for optical and magnetic data storage. VII-5) Kitchen utensils (eating, drinking, cooking, storage). VII-6) Cases for CDs, cassettes and video tapes; DVD electronic items, any kind of office supplies (ball pens, stamps and ink pads, mice, shelves, playback tracks), any volume and contents ( Bottles and tapes for beverages, detergents, cosmetics including fragrances). VII-7) Footwear (shoes / soles), insoles, shoe covers, adhesives, structural adhesives, food boxes (fruits, vegetables, meat, fish), synthetic paper, labels for bottles, benches, artificial joints (Person), printed board (flexographic letterpress), printed circuit board and display technology. VII-8) Devices filled with polymers (talc, chalk, porcelain clay (kaolin), wollastonite, pigments, carbon black, TiO 2 , mica, nanocomposite, dolomite, silicate, glass, asbestos).

在某些實施例中,成形物品為薄膜、管、邊框、瓶、貯槽、容器或纖維。成形物品可藉由模製(例如射出模製、吹塑模製、壓縮模製、旋轉模製、瀝鑄模製或擠塑模製)製備。In certain embodiments, the shaped article is a film, tube, frame, bottle, tank, container, or fiber. Shaped articles can be prepared by molding (eg, injection molding, blow molding, compression molding, rotational molding, cast molding, or extrusion molding).

本發明之方法及組合物在熔融加工期間提供聚烯烴的極好色彩表現及經增強熱安定性。熔融加工安定性可藉由改良分子量保持及維持聚合物分子架構來呈現。The methods and compositions of the present invention provide excellent color performance and enhanced thermal stability of polyolefins during melt processing. Melt processing stability can be demonstrated by improving molecular weight retention and maintaining polymer molecular architecture.

本文中之冠詞「一(a/an)」係指一個或一個以上(例如至少一個)語法對象。本文中引用之任何範圍為包含性的。通篇所使用之術語「約」用於描述且解釋小波動。舉例而言,「約」可意謂數值可由± 5%、± 4%、± 3%、±2%、±1%、±0.5%、±0.4%、±0.3%、±0.2%、±0.1%或±0.05%修飾。不論是否明確地指示,所有數值皆由術語「約」修飾。由術語「約」修飾之數值包括特定識別值。舉例而言,「約5.0」包括5.0。The article "a / an" refers to one or more (eg, at least one) grammatical objects. Any ranges cited herein are inclusive. The term "about" used throughout is used to describe and explain small fluctuations. For example, "about" can mean that the value can be ± 5%, ± 4%, ± 3%, ± 2%, ± 1%, ± 0.5%, ± 0.4%, ± 0.3%, ± 0.2%, ± 0.1 % Or ± 0.05% modification. Whether explicitly indicated or not, all numerical values are modified by the term "about". The numerical value modified by the term "about" includes a specific identification value. For example, "about 5.0" includes 5.0.

本文所論述之美國專利、美國專利申請及公開的美國專利申請皆以引用的方式併入本文中。The US patents, US patent applications, and published US patent applications discussed herein are all incorporated by reference.

除非另外指明,否則所有份數及百分比均以重量計。若無另外指示,則重量百分比(wt%)係以全部不含任何揮發物之組合物計。Unless otherwise specified, all parts and percentages are by weight. If not otherwise indicated, the weight percent (wt%) is based on the composition that does not contain any volatiles.

實例 在實例中採用以下添加劑: AO1為受阻酚系抗氧化劑,季戊四醇肆(3-(3,5-二-第三丁基-4-羥苯基)丙酸酯);AO2為受阻酚系抗氧化劑,即3-(3,5-二-第三丁基-4-羥苯基)丙酸十八酯;Phos1-Phos6為有機磷安定劑;亞磷酸參(2,4-二-第三丁基苯基)酯(Phos1);亞磷酸參壬基苯基酯(Phos2);雙(2,4-二-第三丁基苯基)季戊四醇二亞磷酸酯(Phos3);亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)乙酯(Phos4);2,2',2''-氮基[三乙基參(3,3'5,5'-四-第三丁基-1,1'-聯苯基-2,2'-二基)亞磷酸酯] (Phos5);雙(2,4-二-α-茴香基苯基)季戊四醇二亞磷酸酯(Phos6);DOVERPHOS LGP-11,專用液體亞磷酸酯安定劑(Phos7);2,4-雙(1,1-二甲基丙基)苯基與4-(1,1-二甲基丙基)亞磷酸苯酯(Phos8)之混合物。 Examples The following additives are used in the examples: AO1 is a hindered phenolic antioxidant, pentaerythritol (3- (3,5-di-third-butyl-4-hydroxyphenyl) propionate); AO2 is a hindered phenolic antioxidant Oxidizing agent, namely octadecyl 3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate; Phos1-Phos6 is an organophosphorus stabilizer; phosphorous acid ginseng (2,4-di-third Butylphenyl) ester (Phos1); sennonylphenyl phosphite (Phos2); bis (2,4-di-third butylphenyl) pentaerythritol diphosphite (Phos3); bisphosphite 2,4-di-tert-butyl-6-methylphenyl) ethyl ester (Phos4); 2,2 ', 2''-nitro [triethyl ginseng (3,3'5,5'- Tetra-tert-butyl-1,1'-biphenyl-2,2'-diyl) phosphite] (Phos5); bis (2,4-di-α-anisylphenyl) pentaerythritol di Asia Phosphate (Phos6); DOVERPHOS LGP-11, special liquid phosphite stabilizer (Phos7); 2,4-bis (1,1-dimethylpropyl) phenyl and 4- (1,1-dimethyl Propylpropyl) phosphite (Phos8) mixture.

添加劑負載的單位為按聚合物之重量計之重量ppm (百萬分之一)。在列出磷(P)之總量及調配物的情況下,其亦按聚合物之重量計的重量ppm為單位報告。The unit of additive loading is weight ppm (parts per million) based on the weight of the polymer. In the case of listing the total amount of phosphorus (P) and the formulation, it is also reported in units of ppm by weight based on the weight of the polymer.

根據ASTM-313利用DCI SF600分光光度計、大面積視圖;所包括的頻譜分量、2度觀測器測試聚合物斑塊之顯色。色彩以黃度係數(YI)表示。According to ASTM-313, use the DCI SF600 spectrophotometer, large area view; included spectral components, 2 degree observer to test the color of the polymer plaque. The color is represented by the yellowness factor (YI).

自零遍次及第五遍次擠出物測定聚合物樣本之熔體流動速率保持。在190℃下在Tinius-Olsen擠塑塑度計上根據ASTM-1238執行熔體流動速率;2.16 kg;在10分鐘內以自經定義孔口流出之聚合物之公克為單位來量測。The melt flow rate retention of the polymer sample was measured from the zeroth and fifth pass extrudates. The melt flow rate was performed on a Tinius-Olsen extruder at 190 ° C according to ASTM-1238; 2.16 kg; measured in grams of polymer flowing out of a defined orifice within 10 minutes.

氧化誘導時間(OIT)為聚合物之氧化安定性的量度。利用差示掃描量熱計(DSC)量測OIT。在50℃至190℃之氮氣下,使用10℃/min之加熱速率採集掃描,隨後轉換至氧氣且保持在等溫條件下直至嚴重氧化。以分鐘報告嚴重氧化之起始時間(觀測為強烈的發熱)。Oxidation induction time (OIT) is a measure of the oxidation stability of the polymer. The OIT was measured using a differential scanning calorimeter (DSC). Under nitrogen at 50 ° C to 190 ° C, the scan was collected using a heating rate of 10 ° C / min, and then switched to oxygen and kept under isothermal conditions until severe oxidation. Report the start time of severe oxidation in minutes (observed as intense fever).

實例 1 m-LLDPE 用下文所列之添加劑調配鑄造薄膜級茂金屬線性低密度聚乙烯(m-LLDPE)。 1) 500 ppm Phos1;24 ppm P 2) 1000 ppm Phos1;48 ppm P 3) 400 ppm Phos1;100 ppm苯并呋喃酮(109);23 ppm P 4) 375 ppm Phos1;125 ppm苯并呋喃酮(109);23 ppm P 5) 425 ppm Phos1;125 ppm苯并呋喃酮(109);25 ppm P 6) 450 ppm Phos2;100 ppm苯并呋喃酮(109);23 ppm P 7) 187 ppm Phos3;100 ppm苯并呋喃酮(109);23 ppm P 8) 304 ppm Phos4;100 ppm苯并呋喃酮(109);23 ppm P 9) 187 ppm Phos5;100 ppm苯并呋喃酮(109);23 ppm P 10) 264 ppm Phos6;100 ppm苯并呋喃酮(109);23 ppm P Example 1 m-LLDPE Use the additives listed below to formulate cast film grade metallocene linear low density polyethylene (m-LLDPE). 1) 500 ppm Phos1; 24 ppm P 2) 1000 ppm Phos1; 48 ppm P 3) 400 ppm Phos1; 100 ppm benzofuranone (109); 23 ppm P 4) 375 ppm Phos1; 125 ppm benzofuranone ( 109); 23 ppm P 5) 425 ppm Phos1; 125 ppm benzofuranone (109); 25 ppm P 6) 450 ppm Phos2; 100 ppm benzofuranone (109); 23 ppm P 7) 187 ppm Phos3; 100 ppm benzofuranone (109); 23 ppm P 8) 304 ppm Phos4; 100 ppm benzofuranone (109); 23 ppm P 9) 187 ppm Phos5; 100 ppm benzofuranone (109); 23 ppm P 10) 264 ppm Phos6; 100 ppm benzofuranone (109); 23 ppm P

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列添加劑之外,所有調配物與250 ppm AO2及200 ppm AO1摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。在260℃下露空地在裝配有Maddock混合部分的單螺桿擠出機中將經複合調配物擠壓多次。將第三遍次擠出物之粒化樣本壓縮模製成3.2 mm斑塊。結果如下。調配物 YI 熔體流動 ( 零遍次 ) 熔體流動 ( 第五遍次 ) OIT 1 3.5 3.68 3.07 74 2 2.8 3.70 3.42 110 3 3.2 3.70 3.16 111 4 3.1 3.78 3.45 113 5 2.9 3.86 3.73 122 6 2.2 3.71 3.13 109 7 1.6 3.75 3.09 124 8 2.2 3.70 3.16 108 9 2.0 3.71 3.40 107 10 1.3 3.72 3.31 84The additives are blended with the particulate polymer without any stabilizer additives. Except for the additives listed, all formulations are blended with 250 ppm AO2 and 200 ppm AO1. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The compounded compound was extruded multiple times in a single-screw extruder equipped with a Maddock mixing section in the open at 260 ° C. The granulated sample of the third extrudate was compression molded into 3.2 mm plaques. The results are as follows. Formulation YI Melt flow ( zero pass ) Melt flow ( fifth pass ) OIT 1 3.5 3.68 3.07 74 2 2.8 3.70 3.42 110 3 3.2 3.70 3.16 111 4 3.1 3.78 3.45 113 5 2.9 3.86 3.73 122 6 2.2 3.71 3.13 109 7 1.6 3.75 3.09 124 8 2.2 3.70 3.16 108 9 2.0 3.71 3.40 107 10 1.3 3.72 3.31 84

實例 2 吹塑級HMW Cr-HDPE 用下文所列之添加劑調配吹塑級鉻催化高分子量高密度聚乙烯(HMW Cr-HDPE),高負載熔融指數(HLMI) 5.5。 1) 620 ppm Phos1 2) 1250 ppm Phos1 3) 375 ppm Phos1;125 ppm苯并呋喃酮(109) 4) 450 ppm Phos1;150 ppm苯并呋喃酮(109) 5) 375 ppm之Phos1/Phos6的1:1重量混合物;125 ppm苯并呋喃酮(109) 6) 375 ppm之Phos1/Phos3的1:1重量混合物;125 ppm苯并呋喃酮(109) Example 2 Blow molding grade HMW Cr-HDPE Blow molding grade chromium catalyzed high molecular weight high density polyethylene (HMW Cr-HDPE) with high loading melt index (HLMI) 5.5 was formulated with the additives listed below. 1) 620 ppm Phos1 2) 1250 ppm Phos1 3) 375 ppm Phos1; 125 ppm benzofuranone (109) 4) 450 ppm Phos1; 150 ppm benzofuranone (109) 5) 1 of 375 ppm Phos1 / Phos6 : 1 weight mixture; 125 ppm benzofuranone (109) 6) 1: 1 weight mixture of 375 ppm Phos1 / Phos3; 125 ppm benzofuranone (109)

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列之添加劑以外,所有調配物與500 ppm AO1摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。將粒化樣本壓縮模製為3.2 mm斑塊。結果如下。調配物 YI OIT 1 6.8 93 2 6.8 146 3 7.9 103 4 8.3 98 5 5.8 94 6 3.8 108The additives are blended with the particulate polymer without any stabilizer additives. Except for the additives listed, all formulations are blended with 500 ppm AO1. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The granulated samples were compression molded into 3.2 mm plaques. The results are as follows. Formulation YI OIT 1 6.8 93 2 6.8 146 3 7.9 103 4 8.3 98 5 5.8 94 6 3.8 108

實例 3 m-LLDPE 用下文所列之添加劑調配吹塑薄膜級別茂金屬線性低密度聚乙烯(m-LLDPE)。 1) 500 ppm Phos1;24 ppm P 2) 1000 ppm Phos1;48 ppm P 3) 375 ppm Phos1;125 ppm苯并呋喃酮(109);23 ppm P 4) 500 ppm Phos2;21 ppm P 5) 1000 ppm Phos2;43 ppm P 6) 375 ppm Phos2;125 ppm苯并呋喃酮(109);21 ppm P 7) 500 ppm Phos7;24 ppm P 8) 1000 ppm Phos7;48 ppm P 9) 375 ppm Phos7;125 ppm苯并呋喃酮(109);22 ppm P 10) 500 ppm Phos8;27 ppm P 11) 1000 ppm Phos8;53 ppm P 12) 375 ppm Phos8;125 pp苯并呋喃酮(109);25 ppm P Example 3 m-LLDPE Use the additives listed below to formulate blown film grade metallocene linear low density polyethylene (m-LLDPE). 1) 500 ppm Phos1; 24 ppm P 2) 1000 ppm Phos1; 48 ppm P 3) 375 ppm Phos1; 125 ppm benzofuranone (109); 23 ppm P 4) 500 ppm Phos2; 21 ppm P 5) 1000 ppm Phos2; 43 ppm P 6) 375 ppm Phos2; 125 ppm benzofuranone (109); 21 ppm P 7) 500 ppm Phos7; 24 ppm P 8) 1000 ppm Phos7; 48 ppm P 9) 375 ppm Phos7; 125 ppm Benzofuranone (109); 22 ppm P 10) 500 ppm Phos8; 27 ppm P 11) 1000 ppm Phos8; 53 ppm P 12) 375 ppm Phos8; 125 pp benzofuranone (109); 25 ppm P

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列添加劑之外,所有調配物與500 ppm硬脂酸鋅及500 ppm AO2摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。在260℃下在裝配有Maddock混合部分的單螺桿擠出機中露空地將經複合調配物擠壓多次。將第三遍次擠出物之粒化樣本壓縮模製成3.2 mm斑塊。結果如下。調配物 YI 熔體流動 ( 零遍次 ) 熔體流動 ( 第五遍次 ) OIT 1 3.9 0.92 0.58 52 2 3.3 0.94 0.70 67 3 1.1 0.93 0.66 85 4 -0.4 0.94 0.80 59 5 -0.7 0.89 0.89 65 6 1.0 0.89 0.88 92 7 3.3 0.94 0.52 29 8 1.2 0.93 0.62 36 9 1.5 0.93 0.64 57 10 0.9 0.94 0.61 60 11 0.4 0.95 0.80 68 12 0.9 0.92 0.75 81The additives are blended with the particulate polymer without any stabilizer additives. Except for the additives listed, all formulations are blended with 500 ppm zinc stearate and 500 ppm AO2. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The compounded compound was extruded multiple times in a single-screw extruder equipped with a Maddock mixing section in the open at 260 ° C. The granulated sample of the third extrudate was compression molded into 3.2 mm plaques. The results are as follows. Formulation YI Melt flow ( zero pass ) Melt flow ( fifth pass ) OIT 1 3.9 0.92 0.58 52 2 3.3 0.94 0.70 67 3 1.1 0.93 0.66 85 4 -0.4 0.94 0.80 59 5 -0.7 0.89 0.89 65 6 1.0 0.89 0.88 92 7 3.3 0.94 0.52 29 8 1.2 0.93 0.62 36 9 1.5 0.93 0.64 57 10 0.9 0.94 0.61 60 11 0.4 0.95 0.80 68 12 0.9 0.92 0.75 81

實例 4 吹塑薄膜級別m-LLDPE 用下文所列之添加劑調配吹塑薄膜級別茂金屬線性低密度聚乙烯(m-LLDPE)。 1) 500 ppm AO2;0 ppm P 2) 500 ppm Phos1;500 ppm AO2;24 ppm P 3) 1000 ppm Phos1;500 ppm AO2;48 ppm P 4) 375 ppm Phos1;500 ppm AO2;125 ppm苯并呋喃酮(109);23 ppm P 5) 450 ppm Phos1;500 ppm AO2;150 ppm苯并呋喃酮(109);27 ppm P 6) 600 ppm Phos1;150 ppm苯并呋喃酮(109);34 ppm P 7) 800 ppm Phos1;200 ppm苯并呋喃酮(109);46 ppm P Example 4 blown film grade m-LLDPE blown film grade metallocene linear low density polyethylene (m-LLDPE) was formulated with the additives listed below. 1) 500 ppm AO2; 0 ppm P 2) 500 ppm Phos1; 500 ppm AO2; 24 ppm P 3) 1000 ppm Phos1; 500 ppm AO2; 48 ppm P 4) 375 ppm Phos1; 500 ppm AO2; 125 ppm benzofuran Ketone (109); 23 ppm P 5) 450 ppm Phos1; 500 ppm AO2; 150 ppm benzofuranone (109); 27 ppm P 6) 600 ppm Phos1; 150 ppm benzofuranone (109); 34 ppm P 7) 800 ppm Phos1; 200 ppm benzofuranone (109); 46 ppm P

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列之添加劑以外,所有調配物與500 ppm硬脂酸鋅摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。在260℃下在裝配有Maddock混合部分的單螺桿擠出機中露空地將經複合調配物擠壓多次。將第三遍次擠出物之粒化樣本壓縮模製成3.2 mm斑塊。結果如下。調配物 YI OIT 1 0.6 22 2 0.6 29 3 0.2 42 4 1.3 85 5 0.7 101 6 -0.6 8 7 -0.5 10The additives are blended with the particulate polymer without any stabilizer additives. Except for the additives listed, all formulations are blended with 500 ppm zinc stearate. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The compounded compound was extruded multiple times in a single-screw extruder equipped with a Maddock mixing section in the open at 260 ° C. The granulated sample of the third extrudate was compression molded into 3.2 mm plaques. The results are as follows. Formulation YI OIT 1 0.6 22 2 0.6 29 3 0.2 42 4 1.3 85 5 0.7 101 6 -0.6 8 7 -0.5 10

實例 5 zn-LLDPE 用下文所列之添加劑調配吹塑薄膜級別戚格勒-納他線性低密度聚乙烯(zn-LLDPE)。 1) ----;0 ppm P 2) 500 ppm Phos1;24 ppm P 3) 1000 ppm Phos1;48 ppm P 4) 300 ppm Phos1;100 ppm苯并呋喃酮(109);18 ppm P 5) 375 ppm Phos1;125 ppm苯并呋喃酮(109);23 ppm P 6) 450 ppm Phos1;150 ppm苯并呋喃酮(109);27 ppm P 7) 400 ppm苯并呋喃酮(109);15 ppm P 8) 500 ppm苯并呋喃酮(109);19 ppm P 9) 600 ppm苯并呋喃酮(109);22 ppm P Example 5 zn-LLDPE Blown film grade Ziegler-Natta linear low density polyethylene (zn-LLDPE) was formulated with the additives listed below. 1) ----; 0 ppm P 2) 500 ppm Phos1; 24 ppm P 3) 1000 ppm Phos1; 48 ppm P 4) 300 ppm Phos1; 100 ppm benzofuranone (109); 18 ppm P 5) 375 ppm Phos1; 125 ppm benzofuranone (109); 23 ppm P 6) 450 ppm Phos1; 150 ppm benzofuranone (109); 27 ppm P 7) 400 ppm benzofuranone (109); 15 ppm P 8) 500 ppm benzofuranone (109); 19 ppm P 9) 600 ppm benzofuranone (109); 22 ppm P

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列添加劑之外,所有調配物與AO1/AO2與800 ppm氧化鋅之450 ppm 4/5重量混合物摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。在260℃下在裝配有Maddock混合部分的單螺桿擠出機中露空地將經複合調配物擠壓多次。將第三遍次擠出物之粒化樣本壓縮模製成3.2 mm斑塊。結果如下。The additives are blended with the particulate polymer without any stabilizer additives. Except for the additives listed, all formulations were blended with a 450 ppm 4/5 weight mixture of AO1 / AO2 and 800 ppm zinc oxide. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The compounded compound was extruded multiple times in a single-screw extruder equipped with a Maddock mixing section in the open at 260 ° C. The granulated sample of the third extrudate was compression molded into 3.2 mm plaques. The results are as follows.

調配物 YI 熔體流動 ( 零遍次 ) 熔體流動 ( 第五遍次 ) OIT 1 3.4 1.79 1.32 25 2 1.0 1.94 1.65 40 3 1.3 1.96 1.85 58 4 2.2 2.00 1.70 43 5 2.0 2.01 1.78 64 6 2.9 2.00 1.86 72 7 2.2 1.96 1.79 89 8 2.4 1.96 1.84 109 9 3.2 2.00 1.86 114 Formulation YI Melt flow ( zero pass ) Melt flow ( fifth pass ) OIT 1 3.4 1.79 1.32 25 2 1.0 1.94 1.65 40 3 1.3 1.96 1.85 58 4 2.2 2.00 1.70 43 5 2.0 2.01 1.78 64 6 2.9 2.00 1.86 72 7 2.2 1.96 1.79 89 8 2.4 1.96 1.84 109 9 3.2 2.00 1.86 114

實例 6 m-LLDPE 用下文所列之添加劑調配鑄造薄膜級別茂金屬線性低密度聚乙烯(m-LLDPE)。 1) ----;0 ppm P 2) 500 ppm Phos1;24 ppm P 3) 1000 ppm Phos1;48 ppm P 4) 300 ppm Phos1;100 ppm苯并呋喃酮(109);18 ppm P 5) 375 ppm Phos1;125 ppm苯并呋喃酮(109);23 ppm P 6) 450 ppm Phos1;150 ppm苯并呋喃酮(109);27 ppm P 7) 400苯并呋喃酮(109);15 ppm P 8) 500苯并呋喃酮(109);19 ppm P 9) 600 ppm苯并呋喃酮(109);22 ppm P Example 6 m-LLDPE Use the additives listed below to formulate cast film grade metallocene linear low density polyethylene (m-LLDPE). 1) ----; 0 ppm P 2) 500 ppm Phos1; 24 ppm P 3) 1000 ppm Phos1; 48 ppm P 4) 300 ppm Phos1; 100 ppm benzofuranone (109); 18 ppm P 5) 375 ppm Phos1; 125 ppm benzofuranone (109); 23 ppm P 6) 450 ppm Phos1; 150 ppm benzofuranone (109); 27 ppm P 7) 400 benzofuranone (109); 15 ppm P 8 ) 500 benzofuranone (109); 19 ppm P 9) 600 ppm benzofuranone (109); 22 ppm P

將添加劑與不含任何安定添加劑的顆粒聚合物摻合。除了所列添加劑之外,所有調配物與AO1/AO2、300硬脂酸鈣及500 ppm水滑石之450 ppm 4/5重量混合物摻合。在雙螺桿擠壓機中在210℃下在氮氣下熔融複合徹底摻合的調配物。在260℃下在裝配有Maddock混合部分的單螺桿擠出機中露空地將經複合調配物擠壓多次。將第三遍次擠出物之粒化樣本壓縮模製成3.2 mm斑塊。結果如下。調配物 YI 熔體流動 ( 零遍次 ) 熔體流動 ( 第五遍次 ) OIT 1 3.7 4.07 2.70 63 2 4.4 4.10 3.43 93 3 4.4 4.06 3.83 111 4 3.5 4.10 3.69 112 5 3.6 4.08 3.76 119 6 4.9 4.09 3.84 129 7 4.4 4.04 3.68 141 8 4.4 4.05 3.75 139 9 5.3 4.08 3.87 150The additives are blended with the particulate polymer without any stabilizer additives. With the exception of the additives listed, all formulations were blended with a 450 ppm 4/5 weight mixture of AO1 / AO2, 300 calcium stearate, and 500 ppm hydrotalcite. In a twin-screw extruder at 210 ° C. under nitrogen, the thoroughly blended compound was melted and compounded. The compounded compound was extruded multiple times in a single-screw extruder equipped with a Maddock mixing section in the open at 260 ° C. The granulated sample of the third extrudate was compression molded into 3.2 mm plaques. The results are as follows. Formulation YI Melt flow ( zero pass ) Melt flow ( fifth pass ) OIT 1 3.7 4.07 2.70 63 2 4.4 4.10 3.43 93 3 4.4 4.06 3.83 111 4 3.5 4.10 3.69 112 5 3.6 4.08 3.76 119 6 4.9 4.09 3.84 129 7 4.4 4.04 3.68 141 8 4.4 4.05 3.75 139 9 5.3 4.08 3.87 150

Claims (24)

一種組合物,其包含 i)聚烯烴, ii)一或多種苯并呋喃酮化合物,其選自由式I-p1、I-p2、I-o1、I-o2、I-m1及I-m2組成之群 其中 X及Z獨立地為P或P=O;Yp 、Yo 及Ym 為氧或表示共價鍵; 當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或 R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或 R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代;R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基, Rm1 、Rm3 、Rm5 及Rm6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基 及 iii)一或多種有機磷安定劑。A composition comprising i) polyolefin, ii) one or more benzofuranone compounds selected from the group consisting of formulas I-p1, I-p2, I-o1, I-o2, I-m1, and I-m2 Group of Where X and Z are independently P or P = O; Y p , Y o and Y m are oxygen or represent covalent bonds; when Y p , Y o and Y m are oxygen, R 1p represents the sub-formula II-p , II-o or II-m R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m means sub-formula III, IV Or one of V Or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with the following: C 1 -C 8 alkyl group, C 1 -C 8 alkoxy group, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between or C 2 -C 16 alkyl group with a sulfur atom in between, R 2p represents one of sub-formula II-p, II-o or II-m, R 2o represents one of sub-formula II-o or II-m R 2m represents sub-formula II-m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represents one of sub-formulas III, IV or V, or R 2p , R 2o and R 2m is C 6 -C 10 aryl, which is unsubstituted or substituted by: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl group interrupted by one or more oxygen atoms of the C 2 -C 30 alkyl group or interrupted by a sulfur atom of a C 2 -C 16 alkyl; when Y p , Y o and Y m represent a covalent bond, R 1p represents one of the sub-formulas II-p, II-o or II-m, R 1o represents the sub-formula II-o Or one of II-m, R 1m represents the sub-formula II-m, or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group, C 1 -C 18 Alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms interspersed or a sulfur atom interspersed C 2 -C 16 alkyl, R 2p , R 2o and R 2m are C 6 -C 10 aryl, which are unsubstituted or C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen Or a phenyl or halogen substitution; R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, and R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently hydrogen or C 1 -C 8 alkyl, R m1 , R m3 , R m5 and R m6 are each independently hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 , R b2 , R b3 , R b4 , R b5 and R b6 Each is independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 8 alkyl and iii) one or more organic phosphorus stabilizers. 如請求項1 之組合物,其中該聚烯烴包含聚丙烯。The composition of claim 1 , wherein the polyolefin comprises polypropylene. 如請求項1 之組合物,其中該聚烯烴包含聚乙烯。The composition of claim 1 , wherein the polyolefin comprises polyethylene. 如請求項1至3中任一項之組合物,其中該等有機磷安定劑係選自由以下組成之群:亞磷酸三苯酯、亞磷酸二苯基烷基酯、亞磷酸苯基二烷基酯、亞磷酸參(2,4-二-第三丁基苯基)酯、亞磷酸參-(第二丁基苯基)酯、亞磷酸參(壬基苯基)酯、亞磷酸三(十二烷基)酯、亞磷酸三(十八烷基)酯、二硬脂基季戊四醇二亞磷酸酯、雙(2,4-二-α-茴香基苯基)季戊四醇二亞磷酸酯、二異癸基季戊四醇二亞磷酸酯、雙(2,4-二-第三丁基苯基)季戊四醇二亞磷酸酯、雙(2,6-二-第三丁基-4-甲基苯基)季戊四醇二亞磷酸酯、二異癸氧基-季戊四醇二亞磷酸酯、雙(2,4-二-第三丁基-6-甲基苯基)季戊四醇二亞磷酸酯、雙(2,4,6-三-第三丁基苯基)季戊四醇二亞磷酸酯、三硬脂基山梨醇三亞磷酸酯、肆(2,4-二-第三丁基苯基)4,4'-伸聯苯基-二亞膦酸二酯、6-異辛氧基-2,4,8,10-四-第三丁基-二苯并[d,f][1,3,2]二氧雜磷雜庚英、6-氟-2,4,8,10-四-第三丁基-12-甲基-二苯并[d,g][1,3,2]二氧磷雜八環、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)甲酯、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)乙酯、2,2',2''-氮基[三乙基參(3,3'5,5'-四-第三丁基-1,1'-聯苯基-2,2'-二基)亞磷酸酯]、亞磷酸雙(2,4-二-第三丁基苯基)辛酯、聚(4,4'-{2,2'-二甲基-5,5'-二-第三丁基苯基硫-}亞磷酸辛酯)、聚(4,4'{-亞異丙基二酚}-亞磷酸辛酯)、聚(4,4'-{亞異丙基雙[2,6-二溴苯酚]}-亞磷酸辛酯)、聚(4,4'-{2,2'-二甲基-5,5'-二-第三丁基苯基硫}-二亞磷酸季戊四醇酯),The composition according to any one of claims 1 to 3, wherein the organophosphorus stabilizers are selected from the group consisting of triphenyl phosphite, diphenyl alkyl phosphite, phenyl diphosphite Ester, ginseng phosphite (2,4-di-third butylphenyl) ester, ginseng phosphite- (second butylphenyl) ester, ginseng phosphite (nonylphenyl) ester, triphosphite (Dodecyl) ester, tris (octadecyl) phosphite, distearyl pentaerythritol diphosphite, bis (2,4-di-α-anisylphenyl) pentaerythritol diphosphite, Diisodecyl pentaerythritol diphosphite, bis (2,4-di-t-butylphenyl) pentaerythritol diphosphite, bis (2,6-di-t-butyl-4-methylphenyl ) Pentaerythritol diphosphite, diisodecoxy-pentaerythritol diphosphite, bis (2,4-di-third-butyl-6-methylphenyl) pentaerythritol diphosphite, bis (2,4 , 6-tri-tert-butylphenyl) pentaerythritol diphosphite, tristearyl sorbitol triphosphite, (2,4-di-tert-butylphenyl) 4,4'-biphenyl Phenyl-diphosphinic acid diester, 6-isooctyloxy-2,4,8,10-tetra-tert-butyl-dibenzo [d, f] [1,3,2] di Heterophosphazene, 6-fluoro-2,4,8,10-tetra-tert-butyl-12-methyl-dibenzo [d, g] [1,3,2] dioxaphospha Cyclic, bis (2,4-di-tert-butyl-6-methylphenyl) methyl phosphite, bis (2,4-di-tert-butyl-6-methylphenyl) phosphite Ester, 2,2 ', 2''-Azo [triethyl ginseng (3,3'5,5'-tetra-tert-butyl-1,1'-biphenyl-2,2'-di Group) phosphite], bis (2,4-di-tert-butylphenyl) octyl phosphite, poly (4,4 '-{2,2'-dimethyl-5,5'-di -Third butyl phenyl sulfide-} octyl phosphite), poly (4,4 '{-isopropylidene diphenol} -octyl phosphite), poly (4,4'-{isopropylidene Bis [2,6-dibromophenol]}-octyl phosphite), poly (4,4 '-{2,2'-dimethyl-5,5'-di-tert-butylphenyl sulfide} -Pentaerythritol diphosphite), . 如請求項1至3中任一項之組合物,其中該等有機磷安定劑係選自由以下組成之群:亞磷酸參(2,4-二-第三丁基苯基)酯、亞磷酸參-壬基苯基酯、雙(2,4-二-第三丁基苯基)季戊四醇二亞磷酸酯、亞磷酸雙(2,4-二-第三丁基-6-甲基苯基)乙酯、2,2',2''-氮基[三乙基參(3,3'5,5'-四-第三丁基-1,1'-聯苯基-2,2'-二基)亞磷酸酯]及雙(2,4-二-α-茴香基苯基)季戊四醇二亞磷酸酯。The composition according to any one of claims 1 to 3, wherein the organophosphorus stabilizers are selected from the group consisting of ginseng (2,4-di-tert-butylphenyl) phosphite, phosphorous acid Ginseng-nonylphenyl ester, bis (2,4-di-tert-butylphenyl) pentaerythritol diphosphite, bis (2,4-di-tert-butyl-6-methylphenyl phosphite ) Ethyl ester, 2,2 ', 2' '-Azo (triethyl ginseng (3,3'5,5'-tetra-tert-butyl-1,1'-biphenyl-2,2' -Diyl) phosphite] and bis (2,4-di-α-anisylphenyl) pentaerythritol diphosphite. 如請求項1至3中任一項之組合物,其包含亞磷酸參-(2,4-二-第三丁基苯基)酯。The composition according to any one of claims 1 to 3, which contains ginseng- (2,4-di-tert-butylphenyl) phosphite. 如請求項1至3中任一項之組合物,其進一步包含一或多種選自由受阻酚系抗氧化劑組成之群的化合物。The composition according to any one of claims 1 to 3, further comprising one or more compounds selected from the group consisting of hindered phenolic antioxidants. 如請求項1至3中任一項之組合物,其進一步包含一或多種選自由β-(3,5-二-第三丁基-4-羥苯基)丙酸酯組成之群的受阻酚系抗氧化劑。The composition of any one of claims 1 to 3, further comprising one or more hindered selected from the group consisting of β- (3,5-di-third-butyl-4-hydroxyphenyl) propionate Phenolic antioxidants. 如請求項13 中任一項之組合物,其中該組合物基本上不含受阻酚系抗氧化劑。The composition of any one of claims 1 to 3 , wherein the composition is substantially free of hindered phenolic antioxidants. 如請求項1至3中任一項之組合物,其中該一或多種苯并呋喃酮化合物按該聚烯烴之重量計以約20重量ppm至約1000重量ppm存在。The composition of any one of claims 1 to 3, wherein the one or more benzofuranone compounds are present from about 20 weight ppm to about 1000 weight ppm based on the weight of the polyolefin. 如請求項1至3中任一項之組合物,其中該一或多種有機磷安定劑按該聚烯烴之重量計以約20重量ppm至約1000重量ppm存在。The composition of any one of claims 1 to 3, wherein the one or more organophosphorus stabilizers are present from about 20 weight ppm to about 1000 weight ppm based on the weight of the polyolefin. 如請求項1至3中任一項之組合物,其中該一或多種苯并呋喃酮化合物與該一或多種有機磷安定劑之重量/重量比為約0.05至約1.0。The composition of any one of claims 1 to 3, wherein the weight / weight ratio of the one or more benzofuranone compounds to the one or more organophosphorus stabilizers is from about 0.05 to about 1.0. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮化合物係選自由式I-p1、I-p2及I-o1組成之群。The composition of any one of claims 1 to 3, wherein the benzofuranone compounds are selected from the group consisting of formulas I-p1, I-p2, and I-o1. 如請求項1至3中任一項之組合物,其中在該等苯并呋喃酮化合物中,X及Z為P且Y為O。The composition according to any one of claims 1 to 3, wherein in the benzofuranone compounds, X and Z are P and Y is O. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮化合物為式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -順-烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經以下取代:C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基、C1 -C18 烷基、C3 -C16 環烷基、C7 -C13 芳烷基、C2 -C18 烯基、間雜有一或多個氧原子之C2 -C30 烷基或間雜有一個硫原子之C2 -C16 烷基,R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C8 烷氧基、鹵素或一個苯基或鹵素取代;R4 及R6 為氫,R5 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 及Rp6 各自獨立地為氫或C1 烷基,Rp3 及Rp5 各自獨立地為氫或C1 -C4 烷基,Ro1 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ro2 為氫或C1 烷基,Ro5 為氫或C1 -C4 烷基,Rm1 為氫或C1 烷基,Rm3 及Rm5 各自獨立地為氫或C1 -C4 烷基,Rm6 為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C4 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C4 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C4 烷基。The composition of any one of claims 1 to 3, wherein the benzofuranone compounds are of formula I-p1, I-p2, I-o1, I-o2, I-m1, or I-m2, where Y p , Yo and Y m are oxygen or represent a covalent bond; when Y p , Yo and Y m are oxygen, R 1p represents one of the sub-formula II-p, II-o or II-m, R 1o represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m means sub-formula III, IV or One of V, or R 1p , R 1o and R 1m are C 6 -C 10 aryl, which are unsubstituted or substituted by the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, or a phenyl group, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 - cis - alkenyl group, intermingled with one or more C 2 oxygen atoms -C 30 alkyl group or C 2 -C 16 alkyl group with a sulfur atom in between, R 2p represents one of sub formula II-p, II-o or II-m, R 2o represents sub formula II-o or One of II-m, R 2m represents the sub-formula II-m, or R 2p together with R 1p , R 2o with R 1o and R 2m together with R 1m represents one of the sub-formulas III, IV or V, or R 2p, R 2o and R 2m is a C 6 -C 10 aryl group, which is unsubstituted or to Unsubstituted: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or phenyl, C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl , C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms interspersed or C 2 -C 16 alkyl with a sulfur atom interspersed; when Y p , Y o and Y m represent common In the case of a valence bond, R 1p represents one of sub-formulas II-p, II-o or II-m, R 1o represents one of sub-formulas II-o or II-m, and R 1m represents a sub-formula II-m , Or R 1p , R 1o and R 1m are C 6 -C 10 aryl groups, which are unsubstituted or substituted with the following: C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or a phenyl group , C 1 -C 18 alkyl, C 3 -C 16 cycloalkyl, C 7 -C 13 aralkyl, C 2 -C 18 alkenyl, C 2 -C 30 alkyl with one or more oxygen atoms in between Or a C 2 -C 16 alkyl group with a sulfur atom in between, R 2p , R 2o and R 2m are C 6 -C 10 aryl groups, which are unsubstituted or C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen or one phenyl or halogen substitution; R 4 and R 6 are hydrogen, R 5 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 and R p6 are each independently hydrogen or a C 1 alkyl group, R p3 and R p5 each independently hydrogen C 1 -C 4 alkyl, R o1 and R o6 are each independently hydrogen or C 1 -C 8 alkyl, R o2 is hydrogen or a C 1 alkyl group, R o5 hydrogen or C 1 -C 4 alkyl, R m1 is hydrogen or C 1 alkyl, R m3 and R m5 are each independently hydrogen or C 1 -C 4 alkyl, R m6 is hydrogen or C 1 -C 8 alkyl, R a1 , R a2 , R a3 And R a4 are each independently hydrogen or C 1 -C 4 alkyl, and R b1 , R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 -C 4 alkyl, and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 4 alkyl. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮屬於式I-p1、I-p2、I-o1、I-o2、I-m1或I-m2,其中Yp 、Yo 及Ym 為氧或表示共價鍵;當Yp 、Yo 及Ym 為氧時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 連同R2p ,R1o 連同R2o 及R1m 連同R2m 表示子式III、IV或V中之一者 或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代,且R2p 表示子式II-p、II-o或II-m中之一者,R2o 表示子式II-o或II-m中之一者,R2m 表示子式II-m,或R2p 連同R1p ,R2o 連同R1o 及R2m 連同R1m 表示子式III、IV或V中之一者,或R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代;當Yp 、Yo 及Ym 表示共價鍵時,R1p 表示子式II-p、II-o或II-m中之一者,R1o 表示子式II-o或II-m中之一者,R1m 表示子式II-m,或R1p 、R1o 及R1m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基、C1 -C18 烷基或C3 -C16 環烷基取代,且R2p 、R2o 及R2m 為C6 -C10 芳基,其未經取代或經C1 -C8 烷基或氟取代。The composition according to any one of claims 1 to 3, wherein the benzofuranone belongs to formula I-p1, I-p2, I-o1, I-o2, I-m1 or I-m2, wherein Y p , Y o and Y m are oxygen or represent a covalent bond; when Y p , Y o and Y m are oxygen, R 1p represents one of the sub-formula II-p, II-o or II-m, R 1o Represents one of sub-formula II-o or II-m, R 1m represents sub-formula II-m, or R 1p together with R 2p , R 1o together with R 2o and R 1m together with R 2m represents sub-formula III, IV or V One of R 1p , R 1o and R 1m is C 6 -C 10 aryl, which is unsubstituted or substituted by C 1 -C 8 alkyl, C 1 -C 18 alkyl or C 3 -C 16 ring Alkyl substitution, and R 2p represents one of sub formula II-p, II-o or II-m, R 2o represents one of sub formula II-o or II-m, R 2m represents sub formula II- m, or R 2p together with R 1p , R 2o together with R 1o and R 2m together with R 1m represent one of the sub-formula III, IV or V, or R 2p , R 2o and R 2m are C 6 -C 10 aryl , Which is unsubstituted or substituted with C 1 -C 8 alkyl, C 1 -C 18 alkyl, or C 3 -C 16 cycloalkyl; when Y p , Yo, and Y m represent a covalent bond, R 1p 1m represents sub-formulas II-p, II-o II-m, or one of those, R 1o represents the sub-formula II-o, or one of those II-m, R Shows the sub-formula II-m, or R 1p, R 1o, and R 1m is a C 6 -C 10 aryl group, which is unsubstituted or C 1 -C 8 alkyl, C 1 -C 18 alkyl or C 3 - C 16 cycloalkyl is substituted, and R 2p , R 2o and R 2m are C 6 -C 10 aryl, which are unsubstituted or substituted with C 1 -C 8 alkyl or fluorine. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧或表示共價鍵;當Yp 及Yo 為氧時,R1p 、R2p 、R1o 或R2o 並不表示子式II-m;當Yp 及Yo 表示共價鍵時,R1p 或R1o 並不表示子式II-m。The composition according to any one of claims 1 to 3, wherein the benzofuranone belongs to formula I-p1, I-p2, I-o1 or I-o2, wherein Y p and Y o are oxygen or Valence bond; when Y p and Y o are oxygen, R 1p , R 2p , R 1o or R 2o do not represent the sub-formula II-m; when Y p and Y o represent a covalent bond, R 1p or R 1o It does not mean sub-formula II-m. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮屬於式I-p1、I-p2、I-o1或I-o2,其中Yp 及Yo 為氧,R1p 連同R2p 及R1o 連同R2o 表示子式III、IV或V中之一者,R2p 連同R1p 及R2o 連同R1o 表示子式III、IV或V中之一者,R4 、R5 、R6 及R7 各自獨立地為氫或C1 -C8 烷基,Rp2 、Rp3 、Rp5 及Rp6 各自獨立地為氫或C1 -C8 烷基,Ro1 、Ro2 、Ro5 及Ro6 各自獨立地為氫或C1 -C8 烷基,Ra1 、Ra2 、Ra3 及Ra4 各自獨立地為氫或C1 -C8 烷基,Rb1 、Rb2 、Rb3 、Rb4 、Rb5 及Rb6 各自獨立地為氫或C1 -C8 烷基,且Rc1 、Rc2 、Rc3 及Rc4 各自獨立地為氫或C1 -C8 烷基。The composition according to any one of claims 1 to 3, wherein the benzofurans are of the formula I-p1, I-p2, I-o1, or I-o2, wherein Y p and Y o are oxygen, and R 1p Together with R 2p and R 1o together with R 2o represents one of sub-formulas III, IV or V, R 2p together with R 1p and R 2o together with R 1o represents one of sub-formulas III, IV or V, R 4 , R 5 , R 6 and R 7 are each independently hydrogen or C 1 -C 8 alkyl, R p2 , R p3 , R p5 and R p6 are each independently hydrogen or C 1 -C 8 alkyl, R o1 , R o2 , R o5 and R o6 are each independently hydrogen or C 1 -C 8 alkyl, and R a1 , R a2 , R a3 and R a4 are each independently hydrogen or C 1 -C 8 alkyl, R b1 and R b2 , R b3 , R b4 , R b5 and R b6 are each independently hydrogen or C 1 -C 8 alkyl, and R c1 , R c2 , R c3 and R c4 are each independently hydrogen or C 1 -C 8 alkyl. 如請求項1至3中任一項之組合物,其中該等苯并呋喃酮係選自由式(101)至(133)之化合物組成之群 The composition of any one of claims 1 to 3, wherein the benzofuranone is selected from the group consisting of compounds of formula (101) to (133) . 一種成形物品,其包含如請求項1至19中任一項之組合物。A shaped article comprising the composition of any one of claims 1 to 19. 一種製備如請求項20 之成形物品之方法,該方法包含熔融摻合該組合物。A method of preparing the shaped article of claim 20 , the method comprising melt blending the composition. 一種添加劑組合物,其包含ii) 一或多種選自由請求項1 之式I-p1、I-p2、I-o1、I-o2、I-m1及I-m2組成之群的苯并呋喃酮化合物;及iii)一或多種有機磷安定劑。An additive composition comprising ii) one or more benzofuranone selected from the group consisting of formulae I-p1, I-p2, I-o1, I-o2, I-m1 and I-m2 of claim 1 Compounds; and iii) one or more organophosphorus stabilizers. 如請求項22 之添加劑組合物,其中該一或多種苯并呋喃酮化合物與該一或多種有機磷安定劑之重量/重量比為約0.05至約1.0。The additive composition of claim 22 , wherein the weight / weight ratio of the one or more benzofuranone compounds to the one or more organic phosphorus stabilizers is from about 0.05 to about 1.0. 光及氧之有害效應使聚烯烴安定之方法,該方法包含將以下物質併入至該聚烯烴中:ii) 一或多種選自由請求項1 之式I-p1、I-p2、I-o1、I-o2、I-m1及I-m2組成之群的苯并呋喃酮化合物及iii)一或多種有機磷安定劑。The harmful effect of light and oxygen stability of the polyolefin, the method comprises incorporating into the polyolefin the following species: ii) one or more selected from the group consisting of Formula request entry of 1 I-p1, I-p2 , I-o1 , I-o2, I-m1 and I-m2 group of benzofuran compounds and iii) one or more organic phosphorus stabilizers.
TW107123289A 2017-07-06 2018-07-05 Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers TW201920427A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17180079 2017-07-06
EP17180079.0 2017-07-06
US201862691193P 2018-06-28 2018-06-28
US62/691,193 2018-06-28

Publications (1)

Publication Number Publication Date
TW201920427A true TW201920427A (en) 2019-06-01

Family

ID=67702079

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107123289A TW201920427A (en) 2017-07-06 2018-07-05 Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers

Country Status (10)

Country Link
EP (1) EP3649139A4 (en)
JP (1) JP2020526610A (en)
KR (1) KR20200027523A (en)
CN (1) CN111051322A (en)
AU (2) AU2018298021B2 (en)
BR (1) BR112020000132A2 (en)
CA (1) CA3068831A1 (en)
MX (1) MX2020000231A (en)
TW (1) TW201920427A (en)
ZA (1) ZA202000592B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI815075B (en) * 2020-07-30 2023-09-11 台灣積體電路製造股份有限公司 Semiconductor device structure and method of forming the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3068985A1 (en) * 2017-07-06 2019-01-10 Basf Se Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants
JP7443260B2 (en) * 2018-06-21 2024-03-05 ビーエーエスエフ ソシエタス・ヨーロピア 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308901A (en) * 1988-07-25 1994-05-03 General Electric Company 3-9-diphosphaspiroundecane-stabilized polymer compositions
JP2001081250A (en) * 1999-07-14 2001-03-27 Mitsui Chemicals Inc Polyolefin resin composition
DK1910455T3 (en) * 2005-07-21 2012-11-19 Basf Se Stabilization of Polyolefins with Liquid Tris (Monoalkyl) Phenyl Phosphites
JP6445033B2 (en) * 2014-02-17 2018-12-26 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Phosphorus-containing 3-phenyl-benzofuran-2-one derivatives as stabilizers
US10072136B2 (en) * 2014-08-05 2018-09-11 Basf Se 3-phenyl-benzofuran-2-one diphosphite derivatives as stabilizers
WO2017025431A1 (en) * 2015-08-10 2017-02-16 Basf Se 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
CA3068985A1 (en) * 2017-07-06 2019-01-10 Basf Se Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants
CA3067111A1 (en) * 2017-07-06 2019-01-10 Basf Se A polyethylene pipe
JP7443260B2 (en) * 2018-06-21 2024-03-05 ビーエーエスエフ ソシエタス・ヨーロピア 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI815075B (en) * 2020-07-30 2023-09-11 台灣積體電路製造股份有限公司 Semiconductor device structure and method of forming the same

Also Published As

Publication number Publication date
AU2018298021B2 (en) 2023-02-23
ZA202000592B (en) 2021-07-28
CA3068831A1 (en) 2019-01-10
CN111051322A (en) 2020-04-21
JP2020526610A (en) 2020-08-31
AU2018298021A1 (en) 2020-01-30
AU2022203873A1 (en) 2022-06-23
BR112020000132A2 (en) 2020-07-07
KR20200027523A (en) 2020-03-12
EP3649139A1 (en) 2020-05-13
MX2020000231A (en) 2020-09-25
EP3649139A4 (en) 2021-05-05

Similar Documents

Publication Publication Date Title
US10934423B2 (en) Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers
TW201908391A (en) Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants
TW201920427A (en) Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers
US20220259405A1 (en) Stabilized Polyolefin Compositions Comprising Benzofuranones and Hindered Amine Light Stabilizers
TW201920425A (en) Stabilized polyolefin compositions comprising benzofuranones and acid scavengers